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Summary 
 
 
In the present doctoral thesis, a series of novel chiral thiourea derivatives was firstly designed 
and synthesized, and their potential applications as organocatalysts were widely investigated 
in several important synthetic transformations, such as transfer hydrogenation of aldimines, 
biomimetic reduction of nitroolefins, cyanosilylation of ketones, and hydrophosphonylation of 
imines.  Since the newly designed thiourea-based catalysts were generally inefficient for the 
promotion of reduction with trichlorosilane, various amino acids derived N-formamides were 
developed for the asymmetric reductions of ketimines using trichlorosilane as the hydrogen 
donor.  The main results of this dissertation can be summarized as follows:   
 
¾ Chapter 3 describes our efforts in organocatalytic reductions: 
 
3.1 challenging reported results from another group, we first reported that thiourea 
derivatives can catalyze transfer hydrogenation of aldimines through hydrogen bonding 
activation with Hantzsch ester as the hydrogen source. 
 
3.2 describes a thiourea-catalyzed biomimetic reduction of nitroolefins with Hantzsch 
ester as the hydrogen donor, which may provide insights into the mechanism of redox 
reactions in biological systems. 
 
3.5 a series of novel proline based N-formamides was firstly synthesized and 
characterized. Their catalytic efficiencies were investigated in asymmetric reductions of 
ketimines with trichlorosilane as the hydrogen source.  
 
¾ In chapter 4, we firstly demonstrated that the asymmetric addition of TMSCN to 
ketones can be promoted by one chiral module involving thiourea and anion moieties.  
In addition, n-BuLi was found to be an efficient agent for initiating this transformation. 
 
¾ In chapter 5, a one-pot three component addition of carbonyls, amines, and diethyl 
phosphite was found to proceed smoothly under neat conditions without catalysts and 
solvents.  Moreover, the possibility of autocatalysis for the asymmetric addition of 
diethyl phosphite to imine was also investigated with kinetic and preparative methods. 
 
ii 
iii 
Zusammenfassung 
 
 
Im Rahmen dieser Dissertation wurden zahlreiche neue chirale Thioharnstoffderivate 
dargestellt und deren mögliche Anwendung als Organokatalysatoren für verschiedenste 
Reaktionen, wie zum Beispiel in der Transferhydrierung von Aldiminen, der biomimetischen 
Reduktion von Nitroolefinen, der Cyanosilylierung von Ketonen und Hydrophosphonylierung 
von Iminen untersucht.  Da sich die dargestellten Thioharnstoff-basierten Katalysatoren als 
generell inaktiv für die Reduktion mit Trichlorsilan zeigten, wurden verschiedene von 
Aminosäuren abgeleitete N-Formamide synthetisiert und diese in der asymmetrischen 
Reduktion von Ketiminen, mit Trichlorsilan als Wasserstoffquelle, eingesetzt. Die wichtigsten 
Ergebnisse dieser Dissertation können wie folgt zusammengefasst werden: 
 
¾ In Kapitel 2 wird organokatalytische Reduktion dargestellt: 
 
3.1 auf der Grundlage von bereits veröffentlichten Ergebnissen anderer Arbeitsgruppen 
wird beschrieben, wie ein zweifach substituierter Thioharnstoff die Transferhydrierung 
von Aldiminen über H-Brücken Katalyse beschleunigt.  Hierbei dient der Hantzsch-
Ester als Wasserstoffquelle. 
 
3.2 beschreibt die Thioharnstoff-katalysierte, biomimetische Reduktion von 
Nitroolefinen mit Hantzsch-Ester als Wasserstoffquelle.  Diese Reaktion kann das 
Verständnis von Redoxmechanismen in biologischen Systemen verbessern. 
 
3.3 stellt die Darstellung von einer Bibliothek von neuen N-Formamiden vor. Deren 
katalytische Effizienz wurde für die asymmetrische Reduktion von Ketiminen mit 
Trichlorsilan als Wasserstoffquelle untersucht. 
 
¾ In Kapitel 4 konnten wir erstmals zeigen, dass die asymmetrische Addition von 
TMSCN an Ketone durch ein chirales Katalysatorsystem, welches das 
Thioharnstoffmotiv und einen anionischen Rest enthält, beschleunigt werden kann. 
Zusätzlich zeigte sich n-BuLi als effizienter Initiator dieser Umsetzung. 
 
¾ In Kapitel 5 wird die Ein-Topf-Drei-Komponenten-Synthese von 
Carbonylverbindungen, Aminen und Diethylphosphit unter lösungsmittel- und 
katalysatorfreien Bedingungen beschrieben.  Weiterhin wurde die Möglichkeit der 
Autokatalyse für die asymmetrische Addition von  Diethylphosphit an Imine mit 
experimentellen Methoden untersucht. 
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Chapter 1  Introduction and State-of-the-Art 
 
1.1 Organocatalysis 
 
Organocatalysis is defined as the acceleration of chemical reactions with a substoichiometric 
amount of organic molecules, which do not contain an active metal reaction center.[1]  
Although the roots of organocatalysis have run as deep as organic chemistry itself, 
asymmetric organocatalysis has just received much attention in the past few years as a result 
of organocatalysis has developed into a practical synthetic paradigm and started to serve as an 
important segment in common with biocatalysis and metal catalysis.[2]  The operational 
simplicity, ready availability of these mostly inexpensive bench-stable catalysts, which are 
incomparably more robust than enzymes or other bioorganic catalysts makes organocatalysis 
an attractive method for the synthesis of complex structures.  In contrast to any other system 
developed earlier, organocatalytic reactions provide a rich platform for multicomponent, 
tandem, or domino-type multistep reactions,[3-5] allowing the increase of the structural 
complexity of the product in a highly stereocontrolled manner.  There are usually fewer 
toxicity issues associated with organocatalysis although this only applies when dealing with 
the more notorious metals and it should be pointed out that little is known about the toxicity 
of many of the organic catalysts.  Moreover, there is no risk of metal leakage and also no 
expensive recovery process is required in the waste treatment.  Such protocols are 
increasingly finding application in the synthesis of both biologically active natural products 
and therapeutically important synthetic compounds.  Nowadays, the environmentally friendly 
“green” aspect of this chemistry coupled with the sustainability of the catalysts is considered 
widely for replacing standard, metal-based reactions.[6-11]  Some representative 
organocatalysts are shown in Scheme 1. 
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Scheme 1. Some representative organocatalysts. 
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Our understanding of the mechanistic details of individual reaction pathway is improving. 
Organocatalytic reactions proceed usually either by a much “tighter” or a much “looser” 
transition structure than chiral metal complex mediated ones.  The former class involves 
compounds which are acting as covalently (truly) bonded reagents such as enamine and 
iminium activation.  The latter class includes reactions via noncovalent complexes such as ion 
pairing and hydrogen bonding.  It should be noted that these two types of activation are often 
complementary and can therefore sometimes be used as alternatives in the same 
transformations.[12] 
 
1.2 Organocatalysis mediated through hydrogen bonding 
 
Hydrogen bonding acts as an ubiquitous glue to sustain the intricate architecture and 
functionality of proteins, nucleic acids and many supramolecular assemblies, and thus is 
responsible for the structure of much of the world around us.[13]  In addition to its primacy as a 
structural determinant, hydrogen bonding also plays a crucial role in catalysis.  Hydrogen 
bonding to an electrophile serves to decrease the electron density of this species, activating it 
toward nucleophilic attack.  This principle is employed frequently by Nature’s catalysts, 
enzymes, for the acceleration of a wide range of chemical processes.  Recently, organic 
chemists have begun to appreciate the tremendous potential offered by hydrogen bonding as a 
mechanism for electrophile activation in small-molecule, synthetic catalyst systems.  In 
particular, chiral hydrogen-bond donors have emerged as a broadly applicable class of 
catalysts for enantioselective synthesis. 
Years of study have provided chemists with a relatively detailed understanding of catalysis 
by proton donors.[14-17]  Brønsted acids can accelerate organic reactions by either of two 
fundamental mechanisms: reversible protonation of the electrophile in a pre-equilibrium step 
prior to nucleophilic attack (specific acid catalysis); or proton transfer to the transition state in 
the rate-determining step (general acid catalysis). 
An increased appreciation of the scope of enzyme-catalyzed processes involving general 
acid catalysis likely contributed to the research efforts into synthetic H-bonding catalysts that 
began in the late 1990s.  Organic chemists at this time also benefited from a relatively 
sophisticated understanding of the opportunities offered by H-bonding as a structural and 
functional element, due to research in several subdisciplines.  Advances in supramolecular 
chemistry demonstrated that multiple, appropriately oriented H-bonds are sufficiently strong 
and directional to program the assembly of complex noncovalent structures, both in the solid 
state[18, 19] and in solution.[20]  The ability of well-defined achiral hydrogen bond donors to 
catalyzed useful organic transformations was discovered in pioneering studies beginning in 
the mid 1980s.  Rapid progress in other areas of organocatalysis, which occurred 
contemporaneously with early developments in chiral hydrogen-bond-donor catalysis, 
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rendered chemists keenly aware of the potential of simple organic molecules in asymmetric 
catalysis.[12, 21-25] 
Although the concept of hydrogen donor catalysts has been widely accepted, information 
about the mechanism is quite limited.  Jacobsen et al. classified this type of catalysts into 
three categories according to their features.[26] 
¾ Double hydrogen-bond-donor catalysts, such as ureas, thioureas, as well as 
guanidinium and amidinium ions. 
¾ Bifunctional hydrogen-bond-donor catalysts, such as proline and amino thioureas. 
¾ Single hydrogen-bond-donor catalysts, such as BINOL derived phosphoric acids. 
 
1.3 Organocatalysts based on ureas and thioureas 
 
1.3.1 General evolutions from biphenylenediols to efficient N,N’-diarylthio(urea) 
catalysts 
 
The enormous potential of hydrogen bonding as an activating intermediate has been 
recognized only recently, but the notion that ureas and thioureas could act as catalysts by 
activating electrophiles through hydrogen bonding finds solid precedent in the work of a 
number of research groups.  Detailed investigations into the mechanism of action of various 
enzymes identified a key role for hydrogen bonding (abbreviated H-bond) in electrophile 
activation.[13, 27, 28]  Independently, and more of less simultaneously, well-defined achiral H-
bond donors were discovered to catalyzed organic transformations.  In pioneering studies, 
Hine and co-workers identified meta- and para-substituted phenols and biphenylenediols as 
catalysts for addition of diethylamine to phenyl glycidyl ether (Scheme 2).[29-32]  Hine and co-
workers proposed that the enhanced activity of the biphenylenediol (11a) in solution relative 
to phenol resulted from simultaneous donation of two H-bonds to the electrophile, a model 
that was given strong support from a solid-state 1:1 structure of the catalyst and substrate.[33-35]  
 
O
O
11a (15–75 mol%)
butanone, 30 °C
HNEt2
O
OH
NEt2
OH OR1
11a R1 = H
11b R1 = Me
catalyst           pKa         Krel
phenol             9.98          1.0
m-nitrophenol  8.40          2.4
p-nitrophenol   7.15          2.8
catechol           9.49          2.0
11b                  9.15          1.2
11a                  8.00          12.5
 
Scheme 2. Biphenylenediol-Promoted Epoxide-Opening Reactions. 
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Later Kelly and co-workers reported the promotion of the Diels-Alder reaction between 
cyclopentadiene and α,β-unsaturated aldehydes and ketones by biphenylenediol derivatives, 
and proposed double hydrogen-bond donation to the dienophile (12; Figure 1) as an 
explanation for the catalysis observed.[36]  This was consistent with a theory proposed by 
Jorgensen based on computational studies to rationalize the observed acceleration of Diels-
Alder reactions and Claisen rearrangements in H2O relative to nonprotic solvents (13; Figure 
1).[37, 38] 
Although the biphenylenediol catalysts possessed only moderate reactivity and solubility 
profiles, the pioneering work of Hine and Kelly established that general acid catalysis by 
conformationally restricted metal-free diprotic acids is a valid strategy upon which to base 
organocatalyst design.  At around this time, Etter et al.[39, 40] observed hydrogen bond-directed 
co-crystallisation of N,N’-diaryureas (in particular 3,3’-dinitrocarbanilide (14) with 
compounds incorporating a wide variety of Lewis basic functional groups, such as 
nitroaromatics, ethers, ketones, and sulfoxides.  In each case the bidentate nature of the 
binding interaction is particularly attractive because it removes some conformational degrees 
of freedom.  To avoid entropic loss upon coordination, this also means that the hydrogen-
bond donor must be relatively rigid.[41]  The precedents set by the aforementioned studies for 
efficient catalysis by rigid bidentate hydrogen-bond donors and the demonstration of binding 
between (thio)ureas and Lewis bases provided the basis for the development of (thio)urea-
based organocatalysts. 
The first such example came from Curran et al. who found that substoichiometic amounts 
of diarylurea 15 enhanced both the yield and diastereoselectivity of the allylation of cyclic α-
sulfinyl radicals with allyltributylstannane.[42]  Later the same group reported the promotion of 
the Claisen rearrangement by using catalytic quantities of 15a (Scheme 3).[43]  For the first 
time thiourea derivatives (e.g., 15b) were also shown to hold promise as hydrogen-bonding 
catalysts. 
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Figure 1. Bis-H-bond interaction. 
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Scheme 3. Diaryl(thio)urea catalysis of the Claisen rearrangement. 
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Schreiner’s group took these ideas together and settled for using thioureas because they 
are a) more soluble in a variety of solvents, b) easier to prepare (thiophosgene is much easier 
to handle than phosgene) c) the thiocarbonyl group is a much weaker hydrogen-bond 
acceptor.[44, 45]  As expected, the introduction of electron-withdrawing groups in the meta-
position that not capable of much hydrogen bonding themselves, increases the catalytic 
efficiency; this observation is also in line with the fact that co-crystals are of higher quality 
when trifluoromethyl groups are present in the thiourea derivatives.[39]  In a systematic study, 
N,N’-bis[3,5-bis(trifluoromethyl)phenyl]thiourea (5) was identified as the most active for the 
promotion of Diels-Alder and dipolar cycloaddition reactions, even with water as the reaction 
solvent (Scheme 4). 
O
+
5 (1 mol%), CHCl3
Krel(cat.)/Krel(uncat.) = 5 CH2OMe
N NF3C CF3
CF3CF3
H H
5
S
 
Scheme 4. Thiourea-catalyzed Diels-Alder reaction. 
 
In view of the generally weak enthalpic binding between thioureas and carbonyl 
compounds,[46] the results were rationalised in terms of the importance of entropic effects; 
specially, it was proposed that the (computationally determined)[41] rotational barrier of 
catalyst 5 is relatively high due to an attractive interaction between the ortho-hydrogen atoms, 
which are polarised by the adjacent electron-withdrawing substituent, and the Lewis basic 
sulphur heteroatom (Scheme 4).  This rigidifying interaction would minimise entropy loss 
upon binding of the substrate and thus facilitate catalysis.  It is also likely, however, that 
enthalpic factors also contribute to the high activity of 5; that is, the m-CF3 substituents (σm = 
0.46)[47] would significantly augment the acidity of the N–H protons. 
 
To date, the applications of thiourea 5 have been extended for a wide range of useful 
organic transformations by our group as well as by other groups, such as nucleophilic 
addition,[48] Baylis-Hillman reactions,[49] Friedel-Crafts alkylation,[50] acetalization,[51] 
epoxide opening,[52] acyl-Strecker reaction,[53] as well as transfer hydrogenations[54, 55] 
Moreover, by incorporation of the electron-poor 3,5-bis(trifluorophenyl) thiourea moiety, 
various achiral/chiral mono-, bifunctional organocatalysts have been developed for a broad 
spectrum of reactions through H-bond activation. 
 
1.3.2 Chiral (thio)ureas for asymmetric organocatalysis  
 
The ready availability of enantiopure chiral building blocks bearing primary amino 
functionalities from the chiral pool and other sources greatly facilitates the synthesis of 
asymmetric (thio)ureas.  It is perhaps unsurprising that chiral analogues are rapidly emerging 
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as versatile, functional group tolerant and easily prepared/modified catalyst templates for the 
promotion of wide range of synthetically useful asymmetric carbon-carbon bond forming 
processes. 
 
1.3.2.1 Double hydrogen-bond-donor (thio)ureas 
 
The most remarkable advances in this field were achieved by Jacobsen’s group.[56-61]  
Focusing on the activation of alkyl- or acyl-substituted imines, they identified and optimized a 
series of urea- and thiourea-containing Schiff-base catalysts for various types of asymmetric 
reactions such as Strecker, Mannich, hydrophosphonylation, nitro-Mannich, and acyl Pictet-
Spengler reactions. 
The discovery that Schiff bases 8a-c catalyze asymmetric hydrocyanation reactions of a 
wide variety of imine substrates revealed for the first time that chiral urea and thiourea 
derivatives are capable of mediating highly enantioselective transformations (Scheme 5, eq. 
1).[60-62]  These compounds had been designed originally as potential ligands for Lewis acidic 
metals, and the observation that highest enantioselectivity was observed in the absence of 
metal additives was unanticipated.  Systematic optimization led to identification of 8c as 
remarkably general catalyst for the Strecker reaction.  Furthermore, the catalyst can be reused 
without loss of either activity or enantioselectivity, and the immobilized catalysts 8e and 8f on 
a polystyrene bead facilitate Strecker product purification by simple filtration and solvent 
removal without impacting the enantioselectivity of the reaction.  The mechanism by which 
these catalysts activate imines was subsequently investigated by using a number of 
approaches, such as structural modification, NMR, kinetic, and computational studies.[59]  The 
data thus obtained were all consistent with a double H-bond between the acidic NH protons 
and the imine lone pair serving to activate the electrophile towards attack by cyanide.  A very 
recent investigation by List and co-workers identified acetyl cyanide as the cyanation reagent 
for thiourea 8c-catalyzed enantioselective acyl-Strecker reaction.[63, 64] 
R
N R' 1. TMSCN/MeOH
8c (2 mol%)
toluene, –78 °C
2. TFAA
R CN
R'
R1 N
H
N
H
R2
O
tBu S
N
HO
t-Bu R3
8a: R1 = Bn, R2 = H, R3 = OCH3, X = S
8b: R1 = Bn, R2 = H, R3 = OCOtBu, X = O
8c: R1 = Me, R2 = Me, R3 = OCOtBu, X = S
8d: R1 = Bn, R2 = Me, R3 = tBu, X = S
8e: R1 = polystyrene, R2 = H, R3 = OCOtBu, X = S
8f:  R1 = polystyrene, R2 = H, R3 = OCOtBu, X = O
R H
N
Boc
+
OTBS
OiPr
1. 8d (5 mol%)
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2. TFA R OiPr
NH O
Boc
R H
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+ (R'O)2P(O)H
8c (10 mol%)
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NH
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O
Ar H
N
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+
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Ar
HN
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CO2Me
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Scheme 5. (Thio)urea-catalyzed asymmetric reactions. 
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In addition to hydrogen cyanide, a number of nucleophiles undergo enantioselective 
addition to N-benzyl imines in the presence of thiourea catalysts 8.  Addition of di-(2-nitro-
benzyl) phosphite to imines derived from aliphatic and aromatic aldehydes, followed by 
hydrogenolysis of the N- and O-benzyl groups, constitutes an efficient asymmetric synthesis 
of aminophosphoric acids (Scheme 4).[57]  It is remarkable, however, that highly 
enantioselective additions to a range of functionally diverse electrophiles are promoted by 
thiourea catalysts.  The first indications of this generality arose from studies of Mannich 
reactions of N-tert-butoxycarbonyl (Boc) imines, a reaction of interest for the preparation of 
enantioenriched β-amino acid derivatives.  Thiourea 8d catalyzes this reaction with high 
enantiomeric excess, despite the significant steric and electronic differences between N-Boc 
imines and the N-benzyl and N-allyl imines employed in the Strecker reaction (Scheme 4).[58]  
The scope of thiourea catalysis was extended to include N-(2-nitrobenzene)sulfonyl (nosyl, 
Ns) imines, useful substrates by virtue of their high electrophilicity and the ease of removal of 
the nosyl group (Scheme 4).[65]  In the presence of 8d and stoichiomeric quantities of 
diazabicyclo[2.2.2]octane (DABCO) as nucleophilic activator, N-nosyl imines undergo 
enantioselective aza-Baylis-Hillman reactions with methyl acrylate. 
N-Acyliminium ions are among the most reactive imine derivatives, and methodology 
based upon these intermediates has been applied extensively to the synthesis of nitrogen-
containing compounds.[66]  The Jacobsen group discovered that pyrrole-containing thiourea 16 
promotes the intramolecular addition of indoles to N-acyliminium ions generated in situ from 
imines and acetyl chloride (Scheme 6).[56]  Subsequently, the same group found that catalyst 
16 is also effective for Mannich-type additions of silyl ketene acetals to isoquinolines in the 
presence of 2,2,2-trichloroethyl chloroformate, providing access to enantioenriched 
dihydroisoquinoline products (Scheme 7).[67] 
16 (10 mol%)
AcCl, 2,6-lutidine
–78 –30 °C, Et2O
70% yield, 93% ee
i-Bu
N
N
H
N
H
i-Bu
O
t-Bu S
NMe Ph
16
N
H
N
CH(CH2CH3)2
NAc
CH(CH2CH3)2
 
Scheme 6. Thiourea-catalyzed asymmetric acyl-Pictet-Spengler reaction. 
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1. TrocCl, Et2O
0 °C 23 °C
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–78 –65 °C, Et2O
NTroc
CO2Me
55% yield, 85% ee
i-Bu
N
N
H
N
H
i-Bu
O
t-Bu S
NMe Ph
16
 
Scheme 7. Thiourea-catalyzed addition to N-acyliminium ions. 
 
Formal dehydration of hydroxylactams provides an alternative synthetic route to N-
acyliminium ions.  Jacobsen and co-workers have shown that hydroxylactams, in the presence 
of TMSCl as a dehydrating agent, are substrates for thiourea 17-catalyzed enantioselective 
Pictet-Spengler cyclizations (Scheme 8).[68]  The observation of enhanced reactivity of 
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alkylated versus reduced derivatives suggests that an SN2-type mechanism displacement of 
chloride is not operative in the cyclization reaction.  In order to explain the reactivity and 
enantioselectivity with thiourea 17-catylzed addition to N-acyliminium ions, the Jacobsen 
group proposed that the thiourea catalyst binds to the chloride counteranion of the charged 
electrophile.  This proposal is consistent with the substitution and pronounced halide 
counteranion effects observed in the acyl-Pictet-Spengler and acyl-Mannich reactions (vide 
supra) and asymmetric catalysis via anion-transformations mechanism might be applicable to 
a wide variety of valuable transformations involving highly reactive cationic intermediates. 
N
H
N
O
OH
17 (10 mol%)
TMSCl, TBME, –55 °C NH
N
H
O
90% yield, 97% ee
n-C5H11
N
N
H
N
HO
t-Bu S
NMe Ph
17
Me
 
Scheme 8. Thiourea-catalyzed cyclization of hydroxylactams. 
 
Nagasawa and co-workers found that trans-1,2-Diaminocyclohexane-derived bis-thiourea 
18 promoted the N,N-4-dimethylaminopyridine (DMAP)-mediated addition of cyclohexenone 
to a range of activated aldehydes (Scheme 9, top).[69]  Although detailed mechanistic studies 
were not reported, a proposal involving H-bonding to both the aldehyde electrophile and the 
enone (or enolate) was advanced.  More recently, Berkessel and co-workers reported an 
improved bis-thiourea catalyst 19, derived from the 1,4-diamine IPDA (3-(aminomethyl)-
3,5,5-trimethyl-cyclohexyl-amine), for Baylis-Hillman reactions of aromatic and aliphatic 
aldehydes (Scheme 9, bottom).[70]  Cyclohexenone and cyclopentenone were shown to be 
capable Michael acceptors for the enantioselective Baylis-Hillman reactions in the presence of 
19 and DABCO as the nucleophilic promoter. 
CHO
+
O
18 (40 mol%)
DMAP (40 mol%)
–5 °C, neat
OH O
55% yield, 86% ee
NH HN
NH HN
S S CF3
CF3
F3C
F3C
18
 
H
O
+
O 19 (20 mol%)
DABCO (20 mol%)
no solvent, 10 °C
OH O
81% yield, 90% ee
NH
NH
NH
S
CF3
F3C
NH
CH3
H3C
CH3
SF3C
F3C
19
 
Scheme 9. Bis-thiourea-catalyzed Baylis-Hillman reaction. 
 
Connon and co-workers developed an axially (S)-(+)-1,1'-Bi(2-naphthylamine) derived 
bis-thiourea catalyst 20 for asymmetric Friedel-Crafts type addition of N-methylindole to 
nitroolefins, affording the corresponding product in good yield and with comparable (albeit 
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lower) levels of enantioselectivity (Scheme 10, top).[71]  It is noteworthy that the challenging 
nitroolefin substrates such as β-aliphatic substituents undergo FC addition with considerably 
higher enantioselectivity than the literature reported before.  Recently, the enantiomer of (S)-
20 has also been used for catalytic asymmetric carbonyl-ene reaction (Scheme 10, bottom).[72] 
N
H
H
N
N
H
H
N
S
S
CF3
CF3
CF3
CF3
N
Me
+ Ph
NO2
S-20 (10 mol%)
CDCl3 (0.72 M)
–30 °C N
Me
Ph
NO2*
S-20
98% yield, 30% ee
+
F3C CO2Et
O R-20 (10 mol%)
CH2Cl2, –20 °C
OH
CF3
CO2Et
89% yield, 33% ee  
Scheme 10. Axially bis-thiourea catalyzed FC addition and carbonyl-ene reactions. 
 
1.3.2.2 Chiral bifunctional (thio)ureas for asymmetric organocatalysis 
 
The excellent functional group tolerance of the thio(urea) catalysts stem from their relatively 
weak enthalpic binding with organic Lewis basic nucleophiles, such as alcohols and amines.  
As is often the case, the penalty for high (chemo)selectivity can be a general lack of activity 
relative to benchmark metal(-ion)-based catalyst systems, often leading to restriction in 
reaction scopes.  Recently the concept of exploiting the high functional group tolerance of 
these materials by incorporating a Lewis basic nucleophile-activating functionality into the 
catalyst structure has begun to be explored.  Such bifunctional catalysts mimic natural 
enzymatic systems by activating both electrophile and nucleophile simultaneously,[73, 74] 
allowing scope for significantly improved catalytic activity, and perhaps, more importantly, 
allowing a greater degree of stereocontrol over the addition event.  The majority of these 
prototype systems represent a hybrid strategy that borrows heavily from the design principles 
set down in the seminal work of Curran, Jacobsen, and Schreiner group outlined above 
involving the installation of readily tunable aromatic functionality (to maximize the catalyst’s 
rigidity and hydrogen-bond-donating ability) at one (thio)urea nitrogen atom, and chiral (in 
this case Lewis basic) functionality at the other. 
 
1.3.2.2.1 Tertiary amine-thiourea 
 
In 2003, Takemoto and co-workers reported the first (thio)urea-based bifunctional catalyst 9 
bearing a dimethyl amino group, which was capable of the efficient promotion of the addition 
of malonate esters to β-nitrostyrenes with excellent enantioselectivity (Scheme 11, eq. 1).[75]  
The authors found that both the tertiary amine and the thiourea moieties were requisite for 
efficient and selective catalysis.  Reaction kinetic and catalyst modification studies are 
consistent with the mechanistic proposal that the catalyst serves to activate both nucleophile, 
by general base catalysis, and electrophile, by H-bonding to the nitro group.  In subsequent 
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studies, a range of 1,3-dicarbonyl nucleophiles were shown to be compatible with the reaction 
conditions.  Prochiral 1,3-dicarbonyl nucleophiles undergo C–C bond formation with the 
generation of adjacent tertiary and quaternary stereocenters in high enantio- and 
diastereoselectivity.[76]  Additionally, γ,δ-unsaturated β-ketoesters undergo double Michael 
addition reactions, a transformation that was applied to the enantioselective synthesis of the 
medicinally relevant alkaloid (–)-epibatidine (Scheme 12).[77, 78]  This reactivity has been 
extended to include diastereo- and enantioselective additions of substituted ketoesters, and 
double Michael additions of γ,δ-unsaturated β-ketoesters.[76, 77]   
Ph
NO2 + EtO2C CO2Et
9 (10 mol%)
toluene, 23 °C
Ph
NO2
CO2EtEtO2C
86% yield, 93% ee
N
H
N
H N(CH3)2
S
CF3
F3C
9Ph
NO2 +
O
CO2Me
9 (10 mol%)
toluene, –50 °C
O
NO2
Ph
CO2Me
96% yield, 93:7 dr, 93% ee  
Scheme 11. Enantioselective conjugate addition reactions. 
N
NO2
Cl
+ MeO O
O O 1) 9 (10 mol%)
     toluene, rt
2) KOH, EtOH, 0 °C
OH O
NO2
MeO
N Cl
H
N
H
(–)-epibatidine
N Cl
 
Scheme 12. Enantioselective synthesis of (–)-epibatidine. 
 
Theoretical investigations conducted by Soós, Pápai, and co-workers support a dual 
activation mechanism of catalysis.[79]  However, in contrast to qualitative models proposed by 
Takemoto and co-workers that involve electrophile activation through substrate binding of the 
thiourea,[75, 76] the authors proposed a reaction mechanism wherein the thiourea activates the 
deprotonated β-ketoesters nucleophile and the protonated amino group of the catalyst 
activates the nitroalkene electrophile. 
Takemoto and co-workers have also reported the enantioselective addition of 
malononitrile to α,β-unsaturated imides in the presence of bifunctional catalyst 9, furnishing 
the products with high enantioselectivity (Scheme 13).[80]  It is of interest that while 
malononitrile is an excellent pronucleophilic substrate in the addition to α,β-unsaturated 
imides, it gave poor selectivtity in the addition to nitroolefins, while the best 1,3-dicarbonyl 
substrates for the nitroolefin addition reaction (vide supra) gave no reaction with α,β-
unsaturated imides.  Further studies demonstrated that the N-acylbenzamide derivatives are 
the best Michael acceptors, to which the addition of other carbonnucleophiles such as methyl 
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α-cyanoacetate and nitromethane proceeds at elevated temperature, giving the corresponding 
Michael adducts with good enantioselectivity (Scheme 13).[81] 
H3C N
O O
+ NC CN
9 (10 mol%)
toluene, 23 °C
H3C N
O O
CNNC
86% yield, 93% ee N
H
N
H N(CH3)2
S
CF3
F3C
9
Ph N
H
O O
MeO
+ NC CN
9 (10 mol%)
toluene, 23 °C
Ph N
H
O
CNNC
95% yield, 91% ee
MeO
O
 
Scheme 13. Enantioselecive Michael addition to α,β-unsaturated imides. 
 
Recently, the scope of the Takemoto catalyst 9 has been expanded to encompass reactions 
in which both the nucleophile and electrophile differ substantially from those for which it was 
initially developed.  Takemoto and co-workers applied catalyst 9 to promote nitro Mannich 
(aza Henry) reactions of N-phosphinoyl and N-Boc imines with nitroalkanes,[82, 83] as well as 
direct Mannich reaction.[84]  Chen and co-workers reported that 9 catalyzes enantioselective 
conjugate additions of arenethiols to 2-cycloalkenones and α,β-unsaturated N-benzoyl 
imides.[85]  Other recent results include asymmetric conjugate addition of thioacetic acid to β-
nitrostyrenes[86] and enones[87], enantioselective domino Michael-aldol reactions between 2-
mercaptobenzaldehydes and maleimides,[88] as well as Michael addition of α-substituted 
cyanoacetates to vinyl keotnes.[89]  Remarkably, the catalyst 9 has also exhibited exceptional 
selectivity in the ring-opening polymerization of lactide for the synthesis of well-defined 
poly(lactide)s of narrow polydispersity, offering exciting opportunities for supramolecular 
recognition and the synthesis of well-defined polylactide architectures with end-group 
fidelity.[90] 
Berkessel and co-workers have also employed bifunctional ureas for activation of 
carbonyl compounds, but in quite a different context: in the presence of urea 21 and allyl 
alcohol, chiral racemic azlactones undergo dynamic kinetic resolution, giving rise to protected, 
enantioenriched α-amino acid derivatives (Scheme 14).[91, 92]  In the proposed mechanism for 
this transformation, the catalyst performs the general functions of a serine protease: the 
carbonyl group is activated by a double H-bond, while allyl alcohol is activated by general 
base catalysis.  An improvement in selectivity was achieved with thiourea 22 incorporating 
the tert-leucine amide structural motif used frequently by Jacobsen group.  
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N
O
O
t-Bu
Ph
+ HO
21 or 22 (5 mol%)
toluene, 23 °C
Ph
H
N
O
O tBu
O
N
H
N
H N(CH3)2
O
CF3
F3C
21
N
N
H
N
HO
tBu S
N(CH3)2
CH3
Ph
22
with 21:74% conv.,  85% ee
with 22: 77% conv., 91% ee
 
Scheme 14. Dynamic kinetic resolution of alzactones. 
 
More recently, a thiourea-tertiary amine catalyst 23 was discovered by Fuerst and 
Jacobsen for the asymmetric cyanosilylation of carbonyl compounds (Scheme 15).[93]  This 
represents one of the most effective and selective general cyanation catalysts for aromatic 
aldehydes and ketones.  At this stage, this system is one of only a few examples of 
enantioselective thiourea catalysis in 1,2-carbonyl addition chemistry.  DFT calculations of 
the catalytic system support a mechanism wherein the tertiary amino group of 23 activates 
HNC, the active nucleophile generated upon tautomerizaiton of HCN, toward 1,2-addition to 
a thiourea-bond ketone or aldehyde.[94]  Calculated transition-state energies correlate well 
with the experimentally observed sense and degree of  enantioinduction for a variety of 
ketone electrophiles.  Insights from these studies have led to the design and evaluation of 
improved dipeptide catalyst 24 for substrates such as dialkyl ketones that underwent 
trimethylsilylcyanation with low ee’s with 23. 
R1 R2
O
+ TMSCN
23 (5 mol%)
CF3CH2OH, CH2Cl2
–78 °C
R1 R2
TMSO CN
Me
H
N
N
H
N
HO
t-Bu S
N(n-Pr)223
H
N
N
H
N
HO
t-Bu S
N(n-Pr)224
H3C
CH3
O
CH3
CH3
O
+ TMSCN
24 (5 mol%)
CF3CH2OH, CH2Cl2
–78 °C
CH3
NC OTMS
95% yield, 85% ee
 
Scheme 15. Enantioselective, thiourea-catalyzed cyanosilylation of ketones. 
 
Gennari and co-workers reported the use of a diastereomeric mixture of atropisomeric 
thioureas 25 as a bifunctional orgnocatalytic system for enantioselective cyanosilylation of 
aldehydes (Scheme 16).[95]  It is noteworthy that the diastereomeric mixture performs better, 
in terms of enantioselectivity, than either of the single diastereomer alone. The authors 
suggested that this surprising effect may arise from a co-operation of the two diastereomeric 
thioureas in the transition state.  In the presence of 10 mol% 25, a variety of aldehydes were 
converted to the corresponding products in good to excellent yields with moderate 
enantioselectivities. 
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R H
O 25 (10 mol%)
TMSCN (3.0 equiv)
CH2Cl2, –20 °C
R H
NC OTMS H
N
H
N
NMe2
S
N
S
S
(aR/aS)-(R,R)-25
up to 100% yield
up to 69% ee
 
Scheme 16. Asymmetric cyanosilylation of aldehydes catalyzed by diastereomer 25. 
 
An axially binaphthyl-derived amine thiourea catalyst 26 has been recently developed by 
Wang et al. for the promotion of challenging enantioselective Morita-Baylis-Hillmann 
reactions.  The addition of cyclohexenone to a wide range of aromatic and aliphatic aldehydes 
gave the corresponding products with good to excellent yields and selectivities (Scheme 
17).[96]  Compound 26 serves also as an efficient organocatalyst for asymmetric Michael 
addition of 2,4-pentadione to (E)-β-nitrostyrenes (Scheme 17).[97]  Utilization of the catalyst 
in amounts as low as 1 mol% is sufficient for this transformation with comparable yields and 
enantioselectivities.  Moreover, the Michael addition products can be readily converted into 
the valuable α-substituted-β-amino acids building blocks. 
R
O 26 (10 mol%)
O
CH3CN, 0 °C
O OH
up to 94% ee
63–84% yield N
H
S
N
H
CF3
CF3
NMe2
26
O O
+ Ar
NO2
26 (1 mol%)
24–60 h
rt, Et2O
O O
Ar
NO2
up to 97% ee
78–92% yield
H
+
 
Scheme 17. Asymmetric Morita-Baylis-Hillman reaction and Michael addition. 
 
Chen and co-workers discovered that the bifunctional thiourea-tertiary amine derivative 27 
as highly enantioselective catalyst for the Michael addition of α-substituted cyanoacetates to 
vinyl sulfones, giving an efficient protocol for the construction of an all-carbon substituted 
quaternary stereocenter (Scheme 18).[98]  Excellent enantioselectivities were achieved for both 
α-aryl and alkyl cyanoacetates in the presence of 20 mol% catalyst 27.  The authors proposed 
that a double-hydrogen bonding interaction between the NH of thiourea and a sulfone and 
tertiary amine functionalities might be indispensable for the activation of this reaction.  
Recently, Chen and co-workers reported that analogues of Takemoto’s catalyst 28 and 29 are 
efficient for asymmetric direct vinylogous carbon-carbon bond formation, namely vinylogous 
Mannich and vinylogous Michael reactions respectively (Scheme 18).[99, 100] 
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Ph
CN
CO2Et
+ SO2Ph
27 (20 mol%)
toluene, –40 °C
4 Å MS, 96 h
Ph
NC
CO2Et
SO2Ph
83% yield, 94% ee
N
H
N
HN
S
CF3
CF3
27
 
S
NC CN
+ N
Ph
Boc 28 (2 mol%)
toluene, rt S
NC CN
Ph
NHBoc
H
99% yield
99% ee
N
HN
N
H
S
28
 
 
S
NC CN
Ph
NO2+
S
NC CN
29 (2 mol%)
CH2Cl2, rt
NO2
H
H
64 % yield
86% ee
N
HN
N
H
S
29
CF3
 
Scheme 18. Tertiary amine-thiourea catalyzed asymmetric reactions. 
 
1.3.2.2.2 Cinchona alkaloids-thioureas 
30
N
MeO
H
N
H
N
S
CF3
CF3
N
32
N
MeO
H
N
H
N
S
CF
3
CF3
N
33
N
MeO
H
N
H
N
S
CF3
CF3
N
34
N
H
N
OBn
N
H
N
S
F3C
CF3
31
N
H
N
H
N
S
CF3
CF3
N
 
The groups of Soόs, Connon, and Dixon independently developed H-bond donor catalysts 
by derivatizing C-9 hydroxy group of cinchona alkaloids with thiourea moiety.  Soόs and co-
workers found that catalyst 30 promotes highly enantioselective Michael additions of 
nitroalkanes to chalcones, a reaction for which quinine itself is poorly reactive and only 
moderately enantioselective (Scheme 19).[101]  This method offers a new alternative for highly 
enantioselective synthesis of pharmaceutically important γ-amino acids.  It is noteworthy that 
the analogous quinine-derived catalyst was inactive, highlighting the importance of correct 
relative orientation of acidic and basic functional groups.  Connon and McCooey prepared a 
range of (thio)urea-substituted derivatives of cinchona alkaloids for the asymmetric catalysis 
of the addition of dimethylmalonate to nitroolefins.  They found that the thiourea moiety and 
its relative stereochemistry at C-8/C-9 were shown to be essential for the 30-catalyzed 
enantioselective conjugate addition of dimethyl and diethylmalonate to aryl, heteroaryl, and 
alkyl β-substituted nitroalkenes (Scheme 19).[102]  Interestingly, the analogous C-9 quinine-
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derived catalyst proved to be substantially less enantioselective and reactive than 30.  The 
catalyst is remarkably active and can be used in loading as low as 0.5 mol% without 
compromising the efficiency or selectivity of the transformations.  Connon and co-workers 
extended the methodology to a one-pot conjugate addition-cyclization reaction with dimethyl 
chloromalonate to generate enantioenriched nitrocyclopropanes as single diasteromers.[103]  
Dixon et al. disclosed a similar results using cinchonine-derived catalyst 31 for addition of 
malonate esters to nitro olefins and further expanded the application to promote the addition 
of malonate and β-keto esters to N-Boc and N-Cbz aldimines (Scheme 14).[104, 105]  Recently, 
they developed an efficient diastereo- and enantioselective Michael addition of 5-aryl-1,3-
dioxane-4-ones to nitro olefins (Scheme 19).[106]  Chen and co-workers recently reported 
cinchonine-derived catalyst 31 promoted effieciently asymmetric Michael-type Friedel-Crafts 
reaction of naphthols with nitroolefins and highly stereoselective direct vinylogous Mannich 
reactions.[99, 107] 
Ph Ph
O
+ MeNO2
30 (10 mol%)
toluene, 25 °C, 99 h Ph Ph
O
O2N
93% yield, 96% ee  
NO2S
+ MeOOC COOMe
30 (0.5 mol%)
toluene, 0 °C, 46 h
NO2
S
MeOOC
COOMe
92% yield, 94% ee  
NO2
Br
1. CHCl(CO2Me)2
    CH2Cl2, –30 °C
    30 (2 mol%)
2. DBU (1.0 equiv.)
HMPA
NO2
Br
MeO2C CO2Me
67% yield, >98% de, 47% ee  
 
Ph
NO2 + MeOOC COOMe
31 (10 mol%)
CH2Cl2, –20 °C Ph
NO2
CO2MeMeO2C
95% yield, 94 % ee  
O
OMe
O
+ N
Ph
O
t-Bu
31 (10 mol%)
toluene, –78 °C
O
CO2Me
HN
Ph
t-Bu
O
70% yield, 16 : 1 dr, 85% ee  
O
O CF3
CF3
O
Ph
+ Ph
NO2 31 (10 mol%)
toluene, 0 °C O2N O
O CF3
CF3
O
Ph
Ph
>98% yield, >98% de, 76% ee  
 Scheme 19. Cinchona alkaloid-thioureas catalyzed asymmetrc reactions. 
 
Recently, the cinchona-derived thioureas have represented an important and broadly 
applicable class of catalysts for enantioselective synthesis.  Wang and co-workers reported the 
application of catalyst 30 in enantioselective 1,4-addition to enones.  A variety of 1,3-
dicarbonyl compounds are competent nucleophiles for 30-catalyzed enantioselective additions 
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to chalchones.[108]  Jørgensen and co-workers demonstrated the first catalytic highly 
stereoselective conjugate hydroxylation of nitroalkenes using oximes as easily accessible 
oxygen sources and 32 as catalyst.[109]  This methodology gives access to both optically active 
nitro- and aminoalcohols.  Deng and co-workers expanded applications of cinchona-thioureas 
in several reactions, such as asymmetric Mannich reaction,[110, 111] addition of N-Heterocycles 
to enones,[112] Friedel-Crafts reaction,[113] asymmetric Diels-Alder reaction.[114]  The cinchona 
alkaloids C9-derived thioureas also demonstrated the efficacy in control of 
diastereoselectivity in asymmetric tandem reactions.  Deng and co-workers developed an 
highly enantioselective catalytic conjugate addition with arylonitrile and an asymmetric 
tandem conjugate addition (Scheme 20).[115]  It revealed that hydrogen-bonding-based 
cooperative catalysis not only is applicable to the development of highly enantioselective and 
diastereoselective tandem reactions but also could be manipulated to achieve 
diastereoselective control, thus allowing direct and stereoselective construction of two 
nonadjacent stereocenters.  Wang and co-workers described an efficient, highly 
enantioselective and diastereoselective organocatalytic tandem Michael-aldol process for the 
preparation of synthetically useful and medicinally important chiral thiochromanes (Scheme 
20).[116]  The new one-pot process is promoted by using as low as 1 mol% of the cinchona 
alkaloid-derived thiourea 32 and closely mimicked the action mode of enzyme catalysis. 
O
CN + CN
Cl 32 (10 mol%)
O
CN
CN
Cl
99% yield, 10 : 1 dr, 97% ee
O
H
SH
+
Ph
O
N O
O
32 (1 mol%)
Cl(CH2)2Cl, rt
>20:1 dr
O
N O
O
OH
OH
90% yield, 99% ee
toluene, rt
 
Scheme 20. Asymmetric tandem reaction catalyzed by cinchona-thiourea. 
 
Rouden and co-workers found that thiourea derived cinchona alkaloid 33 promotes the 
asymmetric decarboxylative protonation of cyclic, acyclic, or bicyclic α-aminomalonate 
hemiesters in high yields and enantioselectivities up to 93% (Scheme 21).[117]  This 
methodology offers a general applicability for the synthesis of α-amino acids, but requiring 
stoichiometric base (1 equiv.) and long reaction time (7 d). 
R2
CO2Et
R1
CO2H
OH3C
33 (1.0 equiv.)
acetone, 0 °C, 7 d
R2
R1
OH3C
CO2Et
up to 93% ee  
Scheme 21. Enantioselective decarboxylation catalyzed by cinchona-thiourea. 
 
Hiemstra and co-workers reported that 6'-thiourea-substituted cinchona alkaloid derivative 
34 serves as an effective enantioselective catalyst for addition of nitromethane to carbonyl 
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compounds (the Henry or nitroaldol reaction, Scheme 22).[118]  Replacing the phenolic 
functional group with a thiourea led to an efficient catalyst for the Henry reaction.  High 
asymmetric induction was observed for benzaldehyde and heteroaromatic aldehyde 
derivatives with 10 mol% of 34.  The highly enantioenriched products from the Henry 
reaction can be elaborated to aziridines, β-lactams, and α-alkylcysteines. 
H
O
+ CH3NO2
34 (10 mol%)
THF, –20 °C
OH
NO2
90% yield, 92% ee  
Scheme 22. Cinchona-thiourea for enantioselective Henry reaction. 
 
Ricci and co-workers demonstrated that cinchona-based thiourea 32 catalyzes efficiently 
aza-Henry reaction using nitromethane and a range of aromatic and heteroaromatic differently 
protected imines, giving β-nitroamines in good to excellent yields with up to 94% ee (Scheme 
23).[119] 
N
Ar
PG
+ CH3NO2
32 (20 mol%)
toluene, –24 °C Ar
NO2
NH
PG
up to 95% yield
up to 94% ee  
Scheme 23. Enantioselective aza-Henry reaction. 
 
1.3.2.2.3 Primary amine-thiourea 
N
H
N
H
CH3SPh
NH2
Ph
35
N
N
H
N
HO
t-Bu S
NH2
Ph
R
36a: R = Me
36b: R = H  
Primary amine-containing bifunctional thiourea catalysts have been identified recently for the 
direct addition of carbonyl nucleophiles to nitroalkenes.  Primary amine catalysis is exploited 
in nature by enzymes such as type I aldolases that contain and active-site lysine residue.[120]  
Tsogeoeva and Wei reported the primary amine-thiourea catalyst 35 for the addition of 
ketones to aromatic nitroalkenes (Scheme 24).[121]  In the presence of 35, addition of 
cycloalkanones to β-nitrostyrene generates syn adducts whereas addition of unasymmetric 
acyclic dialkylketone such as methyl ethyl ketone generates anti adducts, both in moderate 
diastereoselectivity and very high enantioselectivity.  Computational studies support a 
mechanism involving nitroalkene activation by dual H-bond donation to a single oxygen atom 
of the nitro group in the transition state.[122] 
Ph
NO2 +
O
35 (15 mol%)
H2O, AcOH
toluene, 23 °C
O
NO2
Ph
82% yield, 4:1 dr, 96% ee  
Scheme 24. Tsogoeva’s primary amine thiourea catalyst. 
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In independent studies, Huang and Jacobsen discovered that primary amine 36a catalyzes 
the addition of ketones to nitroalkenes.  The catalyst displays a strong bias for activation of 
ethyl ketones, allowing highly region- and anti-diastereoselective addition reactions of dialkyl 
ketones to β-alkyl and β-aryl nitroalkenes (Scheme 25).[123]  Racemic α,α-disubstituted 
aldehydes also undergo conjugate addition to nitroalkenes in the presence of the closely 
related primary amine catalyst 36b (Scheme 25).[124]  Nitroalkenes bearing adjacent 
quaternary and tertiary stereocenters can be prepared by this method in high enantioselectivity 
with excellent scope for both the nitroalkene and aldehyde partner.  In all examples of 
primary amine-catalyzed conjugate addition reactions reported, added water and acid was 
observed to increase the rate of catalysis, likely serving to facilitate catalyst turnover by imine 
and enamine hydrolysis. 
Ph
NO2 +
O 36a (10 mol%)
PhCO2H (10 mol%)
toluene, rt
O2N
Me
Ph O
93% yield, 99% ee
O
H
Ph
Me
+ Me NO2
36b (20 mol%)
H2O (5.0 equiv.)
H
NO2
O
MePh
Me
CH2Cl2, 23 °C
54% yield, 28:1 dr, 96% ee  
Scheme 25. Jacobsen’s thiouea primary amine catalysts. 
 
1.3.2.2.4 Secondary amino-thioureas 
 
Yoon and Jacobsen found that the acetamide thiourea 37 is an excellent catalyst in the Henry 
(nitro-Mannich) reaction of N-Boc imines with nitroalkanes, offering the syn adducts with 
high enantio- and diastereoselectivity (up to 97% ee and 16/1 dr) in the presence of Hünig’s 
base (Scheme 26).[125]  In this study, they found that the addition of 4 Å molecular sieves 
improved the reproducibility of the process and provided higher diastereoselectivity in the 
products.  Although the mechanism was not investigated in detail, dual activation of both 
reaction partners can not be excluded. 
Ph
N
Boc
+
NO2 37 (10 mol%)
Hünig's base
4 °C, PhMe
4 Å MS
Ph
NO2
HN
Boc
99%, 7:1 dr, 95% ee
Me N
H
N
H
Me
O
tBu S
NHAc
37
 
Scheme 26. Enantioselective nitro-Mannich reaction. 
 
Recently, Tang and co-workers reported that the combination of thiouea and pyrrolidine in 
a chiral scaffold could result in an efficient bifunctional catalyst 38a for asymmetric Michael 
additions of cyclohexanone to both aryl and alkyl nitroolefins (Scheme 27).[126]  The high 
yield, high diastereoselectivity, and high enantioselectivity were observed in the presence of 
catalyst 38a (20 mol%) under mild reaction conditions.  Simultaneously, Xiao and co-workers 
reported a similar bifunctional pyrrolidine-thiourea catalyst 38b for the direct Michael 
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additions of cyclohexanone to various aromatic nitroolefins, giving the product with excellent 
enantio- and diastereoselectivities (Scheme 27).[127] 
Ph
NO2 +
O
38a (20 mol%)
n-Butyric acid
neat, 0 °C
O
NO2
Ph
93% yield, 24:1 dr, 90% ee
N
H
N
H
CF3
CF3
S
NH 38a
Ph
NO2 +
O
38b (10 mol%)
PhCOOH
n-hexane, 0 °C
O
NO2
Ph
87% yield, 99:1 dr, 96% ee
N
H
N
H
S
NH 38b
 
Scheme 27. Tang’s secondary amino-thiourea for Michael addition. 
 
1.3.2.2.5 Hydroxyl thioureas 
 
Thiourea incorporating additional hydroxyl group also show promise as bifunctional catalysts.  
Ricci and co-workers demonstrated that catalyst 39 bearing both a thiourea and an adjacent 
hydroxyl group promotes asymmetric Friedel-Crafts addition of indoles to nitroalkenes 
(Scheme 28).[128]  The optically active nitroalkane products were converted in a high-yielding 
reaction sequence to tryptamines and tetrahydro-β-carbolines without erosion in ee.  Since 
only unprotected indoles underwent reaction in good enantioselectivity, the authors proposed 
that the role of hydroxyl group may be to activate the nucleophile by accepting a H-bond from 
the indole N-H.  Recently, Sibi and Itoh extended the application of catalyst 39 in asymmetric 
conjugate amine additions (Scheme 29).[129]  Amine addition to crotonate using 30 mol% of 
catalyst 39 is efficient yielding the product in high ee, which provides access to a variety of β-
amino acid derivatives in high selectivity. 
N
H
+ Ph
NO2 39 (20 mol%)
CH2Cl2, –24 °C
 72 h
N
H
Ph
NO2
78% yield, 85% ee
N
H
N
H
S
39
CF3
F3C
OH
 
Scheme 28. Enantioselective Friedel-Crafts addition of indoles. 
N
N
O
Me + BnONH2
39 (30 mol%)
MS 4 Å, F3CC6H5, 0 °C
N
N
O
Me
H OBn
86% yield, 89% ee  
Scheme 29. Enantioselective conjugate amine additions. 
  
Lattanzi demonstrated that enantiopure amino alcohols derived thiourea 40 promotes the 
asymmetric Morita-Baylis-Hillman reaction of 2-cyclohexen-1-one and different aldehydes in 
the presence of triehtylamine under solvent-free conditions, affording the products in good to 
high yields and moderate to high enantioselecivity (Scheme 30).[130]  
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O
+
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H 40 (20 mol%), Et3N
neat, 4 °C
O OH
67% yield, 84% ee
N
H
N
H
CF3
CF3
S
40
H
Ph
Ph
Ph
HO
 
Scheme 30. Asymmetric Morita-Baylis-Hillman reaction. 
 
1.3.2.2.6 Guanidino thiourea 
 
The bisthiourea-guanidinium ion 41 has been identified by Nagasawa and co-workers as an 
enantio- and diastereoselective catalyst for Henry reactions of achiral or chiral α-branched 
aliphatic aldehydes (Scheme 31).[131, 132]  In addition to enantioselective nitromethane 
additions, catalyst 41 promotes highly syn-selective additions of nitroalkanes to functionalized 
aliphatic aldehydes.[133]  Nagasawa and co-workers successfully utilized this reaction in an 
enantioselective synthesis of (4S,5R)-epi-cytoxazone, a type-2 cytokine selective inhibitor.  A 
likely role of the thiourea is as activator of the aldehyde by dual H-bond donation while the 
guanidinium ion pairs with the nitronate nucleophile.  In the presence of 10 mol% (R,R)-
guanidinium thiourea 41, optically active (S)-α-amino and α-alkoxy aldehydes react with 
nitromethane in high anti-diastereoselectivity, enhancing the otherwise moderate facial 
selectivity of the substrates.  Further evidence for the hypothetical guanidine-thiourea 
cooperative reaction mode was obtained by using structural variants of 41.[134]  Drastic 
substituent effects on the guanidinium and chiral spacer moiety suggest a role of 41 as a chiral 
surfactant. 
O
H + CH3NO2
41 (5 mol%)
KI, KOH
toluene-H2O, 0 °C
NO2
OH
91% yield, 92% ee
TBSO
H
O
+
OCH3
NO2
(R,R)-41 (10 mol%)
KI, KOH
toluene-H2O, 0 °C
TBSO
OCH3OH
NO2
O
NH
O
HO
OMe
76% yield, 90:10 dr
95% ee (4S,5R)-epi-cytoxazone
H3C H
O
NBn2
+ CH3NO2
41 (10 mol%)
KI, KOH
toluene-H2O, 0 °C
H3C
NBn2
OH
NO2
70% yield, 99:1 dr
99% ee
H
N
H
N
N
H
N
H
H
N
H
N CF3
CF3
F3C
CF3
S
Ph
N
C18H37 H Cl
S
Ph41
 
Scheme 31. Guanidine thiourea catalyzed Henry reaction. 
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1.3.2.2.7 Imidazole thiourea 
 
The bifunctional organocatalyst 42 bearing a thiourea moiety and an imidazole group on a 
chiral diaminocyclohexane scaffold was demonstrated by Tsogoeva and co-workers for 
asymmetric nitro-Michaeal reaction (Scheme 32).[135]  Mechanism investigation by 
experiments showed that neither the imidazole ring nor the thiourea moiety is able to facilitate 
the Michael addition on their own.  The authors proposed that the reactions are most likely 
promoted in a synergistic manner. 
NO2
+
O 42 (15 mol%)
toluene, rt, 40 h
O2N
O
55% yield, 87% ee
N
H
N
H
S
N42
HN N
 
Scheme 32. Asymmetric Michael addition of acetone to nitrolefins. 
 
1.3.2.2.8 Oxazoline thiourea 
 
Chang and co-workers disclosed that oxazoline-thiourea catalyst 43 promotes aza-Henry 
reactions between N-Boc aryl imines and nitromethane (Scheme 33).[136]  The reactions 
proceeded smoothly giving the products in moderate to high yields with high levels of 
enantioselectivity. 
 
N
Ph
Boc
+ CH3NO2
43 (10 mol%)
THF, rt
HN
Ph
Boc
NO2
CH3
93% yield, 88% ee
N
H
N
H
S
CF3
CF3O
N
H3C
43
 
Scheme 33. Oxazoline-thiourea catalyzed aza-Henry reaction. 
 
1.3.2.2.9 Phosphine thiourea 
 
The phosphine-thiourea 44 was first reported by Shi group as a efficient catalyst for 
asymmetric aza-Morita-Baylis-Hillman reaction of N-sulfonated imines (Scheme 34).[137]  
Moderate to excellent ee and yields of the products were obtained in the presence of 10 mol% 
44.  The authors proposed that 44 acts as a bifunctional organocatalyst in this reaction, in 
which the phosphine served as a nucleophile to initiate the reaction and the thiourea group 
served as a hydrogen-bonding donor to stabilize the in situ generated intermediate. 
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PhCH=NTs +
O 44 (10 mol%), PhCO2H
CH2Cl2, rt, 10 h Ph
TsHN O
97% yield, 91% ee
PPh2 44
N
H
N
H
S
 
Scheme 34. Phosphine-thiourea catalyzed aza-Morita-Baylis-Hillman reaction. 
 
1.3.2.2.10 Sulfinamido urea 
 
Addition of organometallic nucleophiles constitutes an important class of carbon-carbon 
bond-forming reactions, and substantial effort has been dedicated toward the discovery of 
enantioselective reactions of this type.  The application of chiral H-bond donor catalysts to 
this problem is susceptible to several potential problems, including the possible 
incompatibility of organometallic agents with protic functional groups.  Recent investigations 
by Jacobsen group of the addition of allylindium reagents to acylhydrazones demonstrate that 
despite these potential issues, bifunctional catalysis may be useful in this context (Scheme 
35).[138]  The optimal urea catalyst 45 bears a configurationally defined, Lewis basic 
sulfinamide group, which is postulated to activate the incoming allylindium nucleophile 
towards attack.  An X-ray crystallographic analysis of 45 revealed that the sulfinamide N-H 
participates in an H-bond to the C=O of the urea in the solid-state structure.  This interaction 
may serve to increase the Lewis acidity of the urea functionality and rigidify the catalyst 
structure.  Given the well-studied ability of Lewis bases to activate organometallic and related 
reagents,[139] this general catalyst design may prove to have considerable utility for 
enantioselective methodology.  
N
NHBz
Ph
+ Br
In (o)
45 (10 mol%)
toluene, –20 °C Ph
HN
NHBz
89% yield, 92% ee
N
H
N
H HN
O
CF3
F3C
45 S
O
t-Bu  
Scheme 35. Sulfinamido urea catalyzed allylation of hydrazones. 
 
1.3.2.2.11 Amino-hydroxyl thiourea 
 
Recently, Takemoto and co-workers developed a thiourea catalyst 46 bearing an amino-
hydroxyl moiety for enantioselective Petasis reaction of quinolines by activation of 
nucleophilic organoboronic acids (Scheme 36).[140]  In these reactions, catalyst modification 
studies have revealed that both the thiourea and the amino-hydroxyl moieties of the catalyst 
are necessary for reactivity and enantioselectivity.  The authors proposed a dual activation 
mechanism of catalysis.  The reactions with electron-rich boronic acids are more reactive and 
the reaction with electron-withdrawing boronic acid was remarkably ineffective, but high 
degrees of stereocontrol for both reactions were achieved. 
 Chapter 1   Introduction and State-of-the-Art 
23 
N
PhOCOCl
46 (10 mol%)
H2O, NaHCO3, CH2Cl2
+ Ph
B(OH)2
N
CO2Ph
Ph
65% yield, 94% ee
N
H N
N
H
CF3
F3C
CH3HO
S
46
 
Scheme 36. Asymmetric Petasis reaction of quinolines. 
 
1.3.3 Conclusions and Outlook 
 
Recent developments in the area of urea and thiourea-catalyzed reactions have been 
introduced.  Due to their strong hydrogen-bonding properties, they can be used to recognize a 
series of Lewis base functionalities, such as carbonyls, imines, nitros, as well as other 
functionalities and activate them as a general acid catalyst.  In addition, novel urea and 
thiourea derivatives have been demonstrated as an efficient catalyst for a variety of diastereo- 
and enantioselective reactions.  However, the application of these catalysts to asymmetric 
reactions seems to be somewhat limited, owing to the weaker binding interaction.  Dual 
activation strategies by incorporation of an additional functionality to known (thio)urea 
scaffold, not only greatly enhance the reaction rate via simultaneous activation of both the 
electrophile and nucleophile, but also allows greater steric control over the transition states 
and results in promising stereoselective outcome.  However, rational design of multi-
functional thiourea based H-bond donor catalyst is considerably difficult at this stage, since 
detailed mechanistic understanding of this chemistry is not available.  Therefore, many 
techniques, such as kinetic, computation, state-of-the-art spectroscopic methods, 
crystallography, and reverse docking methods, have been brought to explain the action modes 
of thiourea catalysts.   Moreover, mimicry of some enzyme systems involving H-bonding is 
also a powerful strategy in finding new catalysts and new transformations. 
 
1.4 Organocatalyzed transfer hydrogenation with Hantzsch esters as the hydrogen 
source 
 
1.4.1 Introduction 
 
The synthesis of enantiopure products by asymmetric catalysis of organic reactions represents 
one of the most important areas in modern synthetic chemistry.[141]  Among many successful 
asymmetric transformations, asymmetric hydrogenation of unsaturated organic compounds 
such as olefins, carbonyls, and imines, is currently becoming a standard procedure in both 
academia and industrial applications.[142-144]  In the last few decades, all the methods 
developed for the reduction of organic compounds have been dominated by the use of metal 
catalysts surrounded by proper stereodiscriminating chiral ligands in conjunction with 
hydrogen gas,[145, 146] and in the case of transfer hydrogenation, isopropanol or formic acid.[147]  
Today, we are equipped with a plethora of different methods for the enantioselective 
reduction of unsaturated organic compounds, and thus the 2001 Nobel Prize in chemistry was 
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awarded to two prominent scientists in this field.[148, 149]  However, science and industry are 
facing an unprecedented challenge today for achieving environmentally sustainable growth of 
economy.  In the context of chemical synthesis, this challenge has posed stringent and 
compelling demands for green processes and for the developing of cost-effective and 
environmentally-benign solvents, catalysts and reagents.[150]  Recently, a shift of this 
paradigm was made due to the discovery that small organic molecules such as ammonium 
salts and Brønsted acid could catalyze the chemo- and enantioselective reductions using 
Hantzsch dihydropyridine as the hydrogen source.[151-154] 
Biological systems employ nicotinamide adenine dinucleotide (NADH, 47) and flavin 
adenine dinucleotide (FADH2) as cofactors in a diverse array of reduction reactions (Scheme 
37).[155]  A biomimetic approach that involves the utilization of Hantzsch esters 48 as NADH 
mimics and enzyme-like small organic molecules as catalysts was developed recently[151, 152, 
156-166] to realize the highly enantioselective transfer hydrogenation of C=C, C=N, and C=O. 
N
H H
O
OHOH
O
P O
O O
P
O
O O
O
OH OH(P)
N
N
N
N
H2N
O
NH2
47 NADH (NADPH)
Nature's Reduction Cofactor
N
H
R1 R2
48 Hantzsch esters
OO
R3O OR4
H H
48a, R1 = R2 = Me, R3 = R4 = Et
48b, R1 = R2 = Me, R3 = R4 = t-Bu
48c, R1 = Me, R2 = i-Pr, R3 = R4 = Me
48d, R1 = R2 = Me, R3 = Me, R4 = t-Bu
48e, R1 = R2 = Me, R3 = R4 = Me 
48f, R1 = R2 = Me, R3 = R4 = i-Bu
Biomimetic Reduction Agents  
Scheme 37. Naturally occurring hydride-reduction cofactors and Hantzsch esters. 
 
1.4.2 Developments and applications 
 
1.4.2.1 Reductions of C=C bonds 
 
Reduction of the C=C bond of α,β-unsaturated aldehydes represents a formidable challenge in 
organic synthesis as reduction of the carbonyl group often occurs as the side reaction.  By 
using the well-recognized iminium catalysts developed by MacMillan and co-workers 
together with Hantzsch esters, asymmetric transfer hydrogenation of α,β-unsaturated 
aldehydes was independently reported by List and MacMillan and their co-workers.  List et al. 
found in the presence of 10 mol% of imidazolidinone salt 49, treatment of α,β-unsaturated 
aldehydes with Hantzsch ester 48c afforded aldehydes in 77–90% yield with 90–96% ee 
(Scheme 38, eq. 1).  Almost simultaneously, MacMillan and co-workers reported the 
asymmetric reduction of various α,β-unsaturated aldehydes by using another imidazolidinone 
salt 50 as catalyst, developed in their own laboratory, to give the corresponding products in 
good yield and excellent ee (74–95% yield, 90–97% ee (Scheme 38, eq. 2). 
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Ar O
N
H
NO
Ph
49
48c, dioxane, 13 °C, 48 h
Ar O
70-90% yield
90-96% ee
(1)
R1 O
R2
N
H
NO
•TFA
50 (20 mol%)
48a, CH2Cl2, –30 °C, 48 h R
1 O
74-95% yield
90-97% ee
(2)
R2
49 (10 mol%)
•TCA
50  
Scheme 38. Asymmetric transfer hydrogenation of α,β-unsaturated aldehydes. 
 
Interestingly, the geometry of the aldehyde olefin was found to have limited effect on the 
enantioselectivity; both conformations led to the same product enantiomer.  The origin of 
stereoconvergence here is explained by the rapid E-Z isomerisation of the two iminium ions 
prior to the rate determining hydride attack from the dihydopyridine.  Tolerance of the starting 
material with low geometric purity undoubtedly enhances the utility of this hydrogenation 
process.  
A distinct difference between this Hantzsch ester hydrogenation process and that with 
hydrogen gas is the stepwise nucleophilic addition of hydride, which generates a new 
nucleophile and enables the “cascade catalysis” in the presence of an electrophile.  Recently, 
this concept was realized independently by MacMillan[167] and List[158] and their co-workers.  
MacMillan and co-workers developed an enantioselective organo-cascade catalysis by 
combining transfer hydrogenation with Hantzsch esters and halogenation with electrophilic 
sources such as 52 and 53 (Scheme 39).  Remarkably, the authors demonstrated rapid access 
to complex molecular architecture by using two different amine catalysts that can be easily 
modulated to produce the required diastereo- and enantioselective outcome.  The mechanism 
pathway was proposed as a tandem process: the first cycle is a hydride transfer from the 
Hantzsch ester 48b to the iminium intermediate, previously formed by the reaction of α,ß-
unsaturated aldehyde 51 and chiral amine 54, followed by hydrolysis to render an aliphatic 
aldehyde intermediate.  The second one is the fluorination, which takes place by reaction of 
N-fluorobenzenesulfonimide 53 with the enamine formed by previous reaction of the aliphatic 
aldehyde intermediate and the chiral amine 55.  The final hydrolysis gave anti-56 with a 
diastereomeric excess higher than 95% and enantiomeric excess more than 99%. 
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Scheme 39. Organo-cascade catalysis for asymmetric transfer hydrogenation and 
halogenation. 
 
Instead of using electrophilic sources for halogenation, List and co-workers ulitized α,β-
unsaturated ketones as the electrophilic acceptor to realize the asymmetric reductive Michael 
cyclization (Scheme 40).[158]  In the presence of 20% mol of 57 and Hantzsch ester 48a, a 
variety of enal enones underwent the reductive Michael cyclization to afford functionalized 
five- and six-membered rings with excellent diastereo- and enantioselectivities.  The spacers 
used are not limited to substituted benzene rings; the cyclization of aliphatic enal in the 
presence of 57 provided the corresponding product with excellent diastereo- and 
enantioselectivities. 
COR2
OR
1
N
H
NO
Ph
•HCl
57 (20 mol%)
R1
COR2
O
15:1–>50:1 d.r.
86–97% ee
48a, dioxane, rt
86–98% yield
57
 
Scheme 40. Asymmetric reductive Michael cyclization. 
 
Almost simultaneously, the asymmetric reductive Mannich-type reaction, another 
excellent example of cascade reactions, was introduced by Zhao and Cordova (Scheme 
41).[168]  Highly enantioselective direct organocatalytic asymmetric reductive Mannich-type 
reactions can be realized in the presence of 10 mol% 58 and 10 mol% benzoic acid as additive, 
furnishing three contiguous stereocenters in one step.  
R H
O
N
H
Ph
Ph
OTMS
58 (10 mol%)
benzoic acid
(10 mol%)
CHCl3,–20 °C, 63 h
48a R H
O
N
H CO2Et
PMP
+4 °C, 24 h
R CO2Et
HN
PMP
H OR = Ph, 4-MePh,        4-BrPh, 2-Naphthyl
54–70% yield
10:1–50:1 d.r.
95–99% ee  
Scheme 41. Organocatalytic asymmetric reductive Mannich-type reactions. 
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In contrast to use a salt formed by a chiral amine and an achiral acid via iminium 
activation, List and co-workers elegantly developed a method that employs an achiral amine 
and a chiral Brønsted acid catalyst for transfer hydrogenation of α,β-unsaturated aldehydes, 
which was named by them as asymmetric counteranion-directed catalysis (ACDC) (Scheme 
42).  With 20 mol% of 59, α,β-unsaturated aldehydes bearing substituents were reduced to 
their corresponding saturated aldehydes in moderate to good yields with excellent 
enantioselectivities (96–99% ee). 
R O
O
O
P
O
OH
HN O
Ar
Ar
Ar = 2,4,6-(i-Pr)-Ph
48c, dioxane, 50 °C, 24 h R O
59
63–90% yield
96–99% ee
59 (20 mol%) •
 
Scheme 42. Asymmetric transfer hydrogenation of α,β-unsaturated aldehydes by ACDC. 
 
Transfer hydrogenation of α,β-unsaturated ketones were reported independently by List[159] 
and MacMillan[163] and their co-workers.  During the search for an efficient catalyst, however, 
both aforementioned ACDC and chiral iminium catalysts failed to provide satisfying yields or 
enantioselectivities.  Interestingly, ammonium phosphate 60, derived from a chiral phosphoric 
acid and a valine tert-butyl ester, proved effective for this process (Scheme 43, top).  Just 
before the aforementioned work was carried out, Macmillan and co-workers also found 
imindazolidinone salt 61 is an efficient catalyst for this transformation (Scheme 43, bottom). 
O
O
P
O
OH
Ar
Ar
Ar = 2,4,6-(iPr)-Ph
5 mol%
48a, Bu2O,60 °C,48 h
6068–99% yield
70–98% ee
H2N CO2tBu
R
O
n
n = 0, 1, 2
R
O
n
n = 0, 1, 2
•
60 (5 mol%)
 
R
O
n
n = 0, 1, 2
N
H
N
Ph O
O
TCA
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48b, Et2O, 0 °C, 1–25 h R
O
n
n = 0, 1, 266–89% yield
88–98% ee
61
•
 
Scheme 43. Asymmetric transfer hydrogenation of α,β-unsaturated ketones. 
 
Over the past several years, the dominant strategy for enantioselective organocatalytic 
transfer reduction of C=C with Hantzsch esters as hydrogen source has involved activation by 
iminium catalysts, chiral Brønsted acids based on BINOL derived phosphoric acid, as well as 
ACDC discovered by List and co-workers.  Thioureas have played an important role during 
the maturity of organocatalysis and have found a vast variety of applications in synthetic 
transformations, which can catalyzed the reactions through dative hydrogen bonding 
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activation.  However, less is known employing thioureas in transfer hydrogenation of C=C 
with Hantzsch esters as hydrogen source, due to the interaction through hydrogen bonding is 
too moderate to render the transformations occur.  Very recently, during the course of our 
studies on non-conjugate catalysis based on thiourea derivatives mediated through hydrogen 
bonding activation, we demonstrated a biomimetic method in reducing a variety of conjugated 
nitroalkenes to their corresponding saturated nitroalkanes in moderate to good yields.[55]  
Independently, List and co-workers found that the enantioselective reduction of nitroolefins 
can be catalyzed by chiral thiourea derivative 62 designed by Jacobsen et al (Scheme 44).[169] 
R1
NO2
R2
Et N
H
N
H
Et
O
t-Bu S
N
62
48b (1.1 eq)
toluene, 40 °C, 24–48 h
R1
NO2
R2
82–99 yield, 95:5–98:2 e.r.
62 (5 mol%)
 
Scheme 44. Asymmetric transfer hydrogenation of nitroalkenes. 
 
1.4.2.2 Reduction of C=N bonds (imines, quinolines, and pyridines) 
 
Besides the hydrogenation of C=C bonds, Hantzsch esters can also be applied in reduction of 
C=N bonds to their corresponding products.  The first asymmetric example involving the use 
of an achiral Hantzsch ester was reported as early as 1989 by Singh et al..  Prochiral ketimines 
were reduced by Hantzsch ester 48a in the presence of α-amino acid hydrochlorides or chiral 
acids to afford amines with moderate enantioselectivities (up to 63% ee).[170]  Recently, 
Rueping et al. found that a chiral phosphoric acid is an effective catalyst for transfer 
hydrogenation of ketimines.[164]  In the presence of 48a and 20 mol% of 7a, various aryl 
methyl ketimines were converted to the respective amines in 46–91% yield with 70–84% ee 
(Scheme 45, top).  Subsequently, List and co-workers discovered another similar phosphoric 
acid for this transformation by changing the substituents at 3,3′-position to a more sterically 
hindered group.  Good to excellent yields (80–98%) and enantioselectivities (80–93%) were 
attained for a variety of aryl methyl ketimines in the presence of 48a and 1 mol% of 7b 
(Scheme 45, middle).[156]  
Ar
N
PMP 20 mol% 7a
48a, benzene, 60 °C
Ar
HN
PMP
Ar'
O
O
P
O
OH
Ar'
7a. (S) Ar' = 3,5-(CF3)-Ph
7b. (R) Ar' = 2,4,6-(iPr)-Ph
7c. (S) Ar' = SiPh3
Ar
N
PMP 1 mol% 7b
48a, toluene,35 °C
Ar
HN
PMP
46–91% yield, 70–84% ee
80–98% yield, 80–93% ee
R
O
+ H2N-Ar''
10 mol% 7c
48a, 5 Å MS
benzene, 40–50 °C R
HN
Ar''
49–92% yield, 83–96% ee  
Scheme 45. Asymmetric transfer hydrogenation of imines and reductive aminations. 
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Soon after these results, a biomimetic reductive amination was successfully achieved and 
reported by MacMillan and co-workers (Scheme 45, bottom).[171]  The newly designed 
phosphoric acid 7c, which bears two triphenylsilyl groups on the 3- and 3′-positions of the 
binaphthyl scaffold, was found to be optimal for the reductive amination starting from ketone, 
amine and Hantzsch ester 48a.  In the presence of 10 mol% 7c and MS 5 Å, a broad spectrum 
of structurally diverse amines was formed in moderate to excellent yields and 
enantioselectivities.  It is noted that a single-crystal X-ray structure of 7c bound with an imine 
substrate was also obtained, which provided direct insight into the origin of the enantiofacial 
discrimination. 
Inspired by the Hantzsch ester mediated transfer hydrogenation of alkenes and imines, 
Rueping et al. demonstrated that phosphoric 7d could catalyze transfer hydrogenation of 
quinolines, an important class of heteroaromatic compounds.[166]  With Hantzsch ester 48a as 
the hydrogen source, a proposed cascade-hydrogenation process afforded 
tetrahydroquinolines with excellent enantioselectivities of up to > 99% ee in the presence of 2 
mol% of 7d.  This methodology has been applied to the synthesis of several biologically 
active tetrahydroquinoline alkaloids such as (+)-galipinine (63; 91% ee), (+)-cuspareine (64; 
90% ee), and (–)-angustureine (65, 90% ee) (Scheme 46).  This mild reaction conditions, 
operational simplicity, and relative low catalyst loading make this organocatalytic approach 
very attractive for the synthesis of enantio-enriched tetrahydroquinolines. 
O
O
P
O
OH
Ar
Ar
7d Ar = 9-phenanthryl
48a, benzene, 60 °CN R
R = Ar, alkyl, 2-furyl
N
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N
O
O N
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N
(+)-galipinine 91% ee
63 64
(+)-cuspareine 90% ee
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(–)-angustureine 90% ee
7d (2 mol%)
 
Scheme 46. Asymmetric transfer hydrogenation of quinolines. 
 
The development of highly efficient organocatalyst for low catalyst loading still remains 
one of the biggest challenges in practical organocatalysis.  Rueping and his group recently 
extended aforementioned approach to transfer hydrogenation of benzoxazines, benzothiazines, 
and benzoxazinones (Scheme 47).[165]  Remarkably, the catalyst loading can be reduced to 0.1 
mol% (or even 0.01 mol%) without a considerable loss in reactivity and selectivity.  Highly 
enantioselectivities and low catalyst loading render this approach competitive with transition-
metal-catalyzed hydrogenation, which are known to be poisonous by sulphur-containing 
substrates. 
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Scheme 47. Asymmetric transfer hydrogenation of benzoxazines, benzothiazines, and 
bezoxazinones. 
 
With the success of highly enantioselective Brønsted acid catalyzed transfer 
hydrogenation of ketimines, quinolines, and so on, Rueping and co-workers recently explored 
this approach in reduction of pyridines, which today is still represents a great challenge.  After 
evaluation of catalysts and optimization of reaction conditions, they indentified that in the 
presence of 5 mol% 7e and Hantzsch ester 48a as hydride source, the products, 
hexahydroquinolinones and tetrahydropyridines, are isolated in good yields and with excellent 
enantioselectivities (up to 92% ee) (Scheme 48).[172] 
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7e Ar = 9-anthracenyl
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Scheme 48. Asymmetric transfer hydrogenation of pyridines. 
 
Although organocatalytic selected asymmetric reductive amination of ketones to give α-
branched amines has been reported, the reductive amination of α-branched aldehydes via 
dynamic kinetic resolution to give β-branched chiral amines is unexplored.  Recently, List et 
al. successfully realized this concept (Scheme 49).[160]  In the presence of 5 mol% of 7b, a 
series of α-branched aldehydes with different anilines undertook reductive amination to afford 
β-branched chiral amines in 39–96% yield and with 40–98% ee. 
R1
R2
O + H2N-R3
7b (5 mol%)
48d, 5 Å MS
benzene, 6 °C
R1 NHR3
R2
39–96% yield
40–98% ee  
Scheme 49. Asymmetric reductive amination of aldehydes. 
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The direct reductive amination of ketones and aldehydes were recently reported by 
Menche et al.[173-175]  This approach requires catalytic amount of thiourea as hydrogen bond 
donor and 48a as hydrogen source in the presence of 5 Å MS as dehydrating agent.  After 
carefully investigation of their protocol and comparison with our catalyst, we found the 
catalytic effect arised from the unactivated MS instead of their claimed thiourea.  Besides 
questioning their protocols, we presented a practical method for the thiourea-catalyzed 
transfer hydrogenation of aromatic as well as aliphatic aldimines with 48a as hydrogen source 
(Scheme 50).[54] 
N
H
N
H
S
CF3
F3C
CF3
CF3
5
48a, CH2Cl2, rt, 15 hR1 R2
N
R3
R1 R2
N
R3
80–93% yield
5 (1mol%)
 
Scheme 50. Thiourea-catalyzed transfer hydrogenation of aldimines. 
 
1.4.3 Summary and outlook 
 
Transfer hydrogenation of C=C and C=N functionalities can be realized in the presence of 
catalytic amount of organocatalysts such as imidazolidinones, phosphoric acid, ACDC, or 
thioureas and with Hantzsch esters as hydrogen sources.  A variety of enantio-enriched 
organic compounds can be obtained under these protocols.  Compared with the traditional 
reduction by transition metal combined with hydrogen gas or transfer hydrogenation by 
transition metal combined with isopropanol or formic acid, organocatalytic transfer 
hydrogenation mediated with Hantzsch esters as hydrogen sources showed quite superior such 
as mild reaction conditions, operational simplicity, and so on.  All these make this biomimetic 
reductive process very attractive in synthetic chemistry.  On the other hand, problems are still 
confronted with current approaches, such as problematic removal of the oxidized pyridine 
form of Hantzsch ester for industrial-scale and poor atom economy, as only two protons are 
used per molecule.  Thus, efforts toward the easy separation and recycling of Hantzsch esters 
will be highly desirable.  It is reasonable to believe that by overcoming the formidable 
drawbacks, the practical application of this biomimetic approach will be forthcoming. 
 
1.5 Organocatalytic reduction with trichlorosilane 
 
1.5.1 Introduction 
 
Asymmetric hydrogenation, hydroboration, and hydrosilylation are the most frequently used 
catalytic methods for reduction of prochiral ketones and imines.[141]  Although asymmetric 
hydrogenation remains favored by industry in general, it is not free of problems, namely, 
those associated with metal leaching, high pressure, and the cost of the catalyst and its 
regeneration.  Stoichiometric borane reduction, catalyzed by chiral oxazoborolidine, avoids 
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most of these problems and offers high levels of enantioselection,[141] but its cost is 
prohibitive for large-scale industrial application.  The recently developed reduction of C=C 
and C=N, which uses the Hantzsch ester as a stoichiometric reducing agent and chiral 
imidazolidinone or chiral Brønsted acid as organocatalysts is also limited by removal of the 
pyridine form of Hantzsch ester and the cost implications.[151, 152, 156-167, 169, 171, 172]  It is still 
worthwhile to exploit new methods, which can be carried out in industrial scale under mild 
conditions.  One of such reagents may be trichlorosilane (HSiCl3), a commercially available 
and abundant byproduct of the industrial Rochow process,[176] albeit some activators are 
necessary for HSiCl3 to efficiently reduce ketones[177] and imines.[178, 179]  In general, HSiCl3 
is an appealing alternative due to the environmentally and physiologically less toxic qualities.  
The reagent is volatile and can be pumped away under reduced pressure; alternatively, after 
workup with dilute aqueous saturated NaHCO3, HSiCl3 and its byproducts are converted to 
much less-harmful hydroxysilanes. 
In view of its advantages, a variety methodologies have been developed for reduction of 
C=C, C=N and C=O.  The currently most successful methods are based on use of transition 
metal-cetered hydrosilylation,[141] however, recent advance in organocatalytic alternative 
appeals to be very attractive and competitive with traditional methods.  In this perspective, I 
attempt to offer a comprehensive overview of reduction with HSiCl3 as reductant mediated by 
organocatalysts.  Since for the most part it is still less known with precision about the catalytic 
mechanism, the advance in this field will be classified into different parts based on the 
organic molecules developed for the activation of HSiCl3. 
 
1.5.2 Developments and applications 
 
1.5.2.1 HSiCl3-tertiary amine combinations 
 
Prior to 1962, there were only three reports of HSiCl3 additions to olefins catalyzed by tertiary 
amine.[180-182]  Since then a vast majority of applications have been reported.[183]  Organic 
halides, in the presence of HSiCl3-tertiary amines, undergo a variety of transformations 
depending upon the reaction conditions.  One of the most remarkable and useful 
transformations which the trichlorosilane-tertiary amine systems can effect is the removal of a 
carbonyl oxygen from a wide variety of compounds.  Aromatic ketones, aldehydes, acid 
chlorides, acid amides, and aromatic acids all undergo such a reaction, which have termed, 
“reductive silylation”.  Pictorially, the reaction can be represented as the replacement of a 
carbonyl oxygen by the H and SiCl3 moieties of trichlorosilane (Scheme 51).  
R R1
O HSiCl3
R3N R R
1
H SiCl3
 
Scheme 51. “Reductive Silylation” by the combination of HSiCl3 with tertiary amine. 
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It has been amply demonstrated in previous work that the trichlorosilane and tertiary 
amine combination is a powerful reagent for a number of interesting and useful chemical 
transformations.  In an effort to gain insight into this mechanism, Benkeser et al. found 
unexpected results when this approach was applied to carbon-nitrogen double bond.  N-
(benzylidene)aniline was treated with this system yielding the amine rather than cleavage 
product toluene after hydrolysis.[184]  The reaction also proceeded well under reflux conditions 
in acetonitrile (Scheme 52). 
R1 H
N
R2
HSiCl3
CH3CN, refux
KOH
EtOH R1 H
HN
R2
 
Scheme 52. Reduction of aldimines under reflux conditions in acetonitrile. 
 
1.5.2.2 Trichlorosilane-dimethylformamide (HSiCl3-DMF) as an efficient reducing agent 
 
In contrast to “reductive silylation” by the combination of trichlorosilane with tertiary amine, 
Kobayashi and co-workers developed another efficient reducing agent, triclorosilane-
dimethylformamide (HSiCl3-DMF), which is effective for reduction of aldehydes to alcohols, 
imines to amines, and also reductive amination of aldehydes under mild conditions (Scheme 
53).[178]  The reduction of aldehydes proceeded smoothly at 0 °C for 4–6 h with HSiCl3 in 
DMF-dichloromethane to give the corresponding alcohols in high yields.  As for the reduction 
of ketones, a longer reaction time was required, and the secondary alcohols were obtained in 
good to high yields (Scheme 53, eq. 1).  Moreover, the reduction of imines (Scheme 53, eq. 2) 
and reductive amination (Scheme 53, eq. 3) of aldehydes were successfully carried out using 
HSiCl3-DMF (Scheme 53, eq. 2 and 3). 
R1 R2
O HSiCl3
CH2Cl2 : DMF = 4 : 1
0 °C, 4-6 h
R1 R2
OH
(1)
R3 H
N
R4 HSiCl3
CH2Cl2 : DMF = 4 : 1
0 °C, 4 h
R3 H
HN
R4
(2)
R5CHO + R6NH2
1. MgSO4, CH2Cl2
    rt, 1 h
2. HSiCl3,
   CH2Cl2 :DMF = 4 : 1
   0 °C, 4 h
R5 H
HN
R6
(3)
 
Scheme 53. Reductions with HSiCl3-DMF. 
 
1.5.2.3 Reduction of carbonyl compounds with pentacoordinate hydriodosilicates 
 
Sakurai and Kira reported that bis(1,2-benzendiolato)hydridosilicate, prepared from 
trichlorosilane and dilithium catecholate, reduced aldehydes and ketones to afford the 
corresponding alcohols.  Besides catechol (66), 2,2′-dihydroxybiphenyl (67) also provides a 
ligand which produces an effective reducing agent.  However, aliphatic diols such as 1,2-
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ethanediol (68) and pinacol (69) produce reducing agents which are less effective and 
monoalcohols (70, 71) were totally ineffective to reduce ketones under the conditions 
(Scheme 54). 
R1 R2
O
R1 R2
OH
OH
OH
OH
HO
OH
OH
OH
OH
EtOH PhOH
66 67 68 69 70 71
1. 66-71, n-butyllithium, THF
2. HSiCl3
 
Scheme 54. Reduction of carbonyl compounds with pentacoordinate hydrodosilicates. 
 
1.5.2.4 Asymmetric organocatalytic reduction with HSiCl3 
 
Based on the reduction with reducing agent HSiCl3-DMF, Mstsumura and co-workers found 
some kinds of N-formyl cyclic amine derivatives to be effective activators for trichlorosilane 
to reduce ketones.  Namely, a catalytic amount of these activators were sufficient to complete 
the reduction of ketones with trichlorosilane, and the reduction of ketones by trichlorosilane 
with optically active activators gave enantiomerically enriched sec-alcohols in some extent of 
optical yields (up to 51% ee) (Scheme 55).[177] 
R1 R2
O
N X
OH
"activator"
R1 R2
OH
72a-j
a: X = H
b: X = CONHPh
c: X = CONH-1-Naph
d: X = CONHCHPh2
e: X = CONH-n-C6H14
f:  X = CONH-t-Bu
g: X = COOPh
h: X = COOMe
i:  X = COOt-Bu
j:  X = CH2OBn
up to 51% ee
HSiCl3
 
Scheme 55. Asymmetric reduction of ketones with HSiCl3 catalyzed by N-formylated cyclic 
amine derivatives. 
 
In the continuous exploration of the versatility of HSiCl3 activated with N-
formylpyrrolidine derivatives, the Matsumura group found trichlorosilane activated with N-
formylpyrrolidine derivatives to be an effective reagent for chemo- and seteroselective 
reduction of imines (Scheme 56).[179]  The reduction of imines using trichlorosilane activated 
with optically active N-formylproline derivatives gave enantiomerically enriched amines in 
moderate yields with up to 66% ee. 
Ar
N
R
HSiCl3
Ar
HN
R
72b or 72c
CH2Cl2, rt, 24 h
N
OH
CONHPh
N
OH
CONH-1-Naph
72b 72cup to 66% ee  
Scheme 56. Asymmetric reduction of imines with HSiCl3 activated by N-formylpyrrolidine 
derivatives. 
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The work presented by Matsumura group in designing N-formyl pyrrolidine derivatives as 
HSiCl3 activator can be considered as a milestone for the asymmetric reduction of ketones 
and imines using HSiCl3 as reducing agent.  Since then, considerable efforts have been 
devoted to the development of this transformation, and remarkable progress has been made.  
One important breakthrough was achieved by Malkov et al.  They developed a new N-methyl-
L-valine derived Lewis basic organocatalyst 73 for asymmetric reduction of ketimines with 
trichlorosilane to afford the corresponding products with high enantioselectivity (Scheme 
57).[185]  It is noteworthy that the rigid cyclic framework of proline may not always be an 
advantage.  Among the methods designed to enhance enantioselectivity through structural 
variations, chiral relay represents an emerging new strategy where a conformationally flexible 
group, appropriated placed, effectively conveys the chiral information to the reaction 
center.[186, 187] 
Ar
N
Ph
HSiCl3, 73
Toluene, r.t. Ar
HN
Ph
N
H
O
HN
O
73up to 92% ee  
Scheme 57. Asymmetric reduction of ketimines with trichlorosilane catalyzed by 73. 
 
Generally, development of any new catalytic protocol include a delicate balancing of 
various factors, such as catalyst structure and loading, solvent, temperature, etc. Often, even 
minor changes in any of these characteristics can produce a dramatic effect on the 
stereochemical outcome of the reaction.  Recently, Malkov et al. fully investigated the 
structure-reactivity of the reduction of imines with HSiCl3 catalyzed by N-methyl-L-amino 
acid derivatives.[188]  They designed a library of chiral DMF analogues based on the use of 
amino acids as the chiral scaffold, with the α-amino group converted into N-methyl 
formamide moiety and the amino acid carboxyl converted into another amide group, with 
either aromatic or aliphatic substituent adjacent to the nitrogen.  After assessment of a variety 
of prepared N-methyl-L-amino acid in the reduction of ketimines, they draw some conclusions 
as follows: (1) The N-methyl formamide moiety of the catalyst is crucial for the 
enantioselectivity.  (2) The anilide part of the catalyst and the N-aryl substituent of the 
substrate imine are crucial for the enantiodifferentiating process, suggesting arene-arene 
interaction.  (3) The anilide moiety of the catalyst must constitute a secondary amide, with an 
NH group.  (4) The reagent HSiCl3 is apparently activated by the formamide moiety.  (5) The 
nature of the amino acid side chain determines the configuration of the resulting product, 
apparently by controlling the conformation of the transition state. According the experiments, 
key features of the catalyst and the substrate was depicted (Figure 2). 
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Figure 2. Key features of the catalyst and the substrate. 
 
The search for efficient catalysts for highly enantioselective reductions of imines still 
remains a challenging task, due to the difference in reactivity among imines containing 
different nitrogen substituents, the existence of acyclic imines as inseparable mixtures of E/Z 
isomers, and the ease of interconversion between these two isomers in solution.  Recently, 
Sun and co-workers developed the L-pipecolinic acid derived formamides as highly efficient 
and enantioselective Lewis basic organocatalysts for the reduction of N-aryl imines with 
trichlorosilane (Scheme 58).[189]  A broad spectrum of N-aryl imines were reduced to their 
corresponding in high yields (up to 98%) and enantioselectivities (up to 96%). 
 
R
N
R'
74 (10 mol%)
HSiCl3, CH2Cl2, 0 °C R
HN
R'
75–98% yield
87–96% ee
*
N
H
N
O
Ac
O
OH
Ph
Ph
74  
Scheme 58. Asymmetric reduction of ketimines with trichlorosilane catalyzed by 74. 
 
Soon after the aforementioned work, Sun and co-workers reported that L-piperazine-2-
carboxylic derived N-formamide 75 is also highly enantioselective Lewis basic catalysts for 
the reduction of N-aryl imines with trichlorosilane (Scheme 59).[190]  High isolated yields (up 
to 99%) and enantioselectivities (up to 97%) were obtained for a broad range of substrates, 
including aromatic and aliphatic ketimines, particularly those with R2 as relatively bulky alkyl 
groups. 
R1 R2
N
Ph 75 (10 mol%)
HSiCl3, CH2Cl2, –20 °C
63–99% yield
82–97% ee
R1 R2
HN
Ph
N
N
H
N
O
OH
75
SO2(p-tBuPh)
Ph*
 
Scheme 59. Asymmetric reduction of ketimines with trichlorosilane catalyzed by 75. 
 
Several months later in the same year, the Sun group found that easily accessible chiral 
sulfinamide 76 was highly efficient and enantioselective organocatalyst for the reduction of 
 Chapter 1   Introduction and State-of-the-Art 
37 
N-aryl ketimines with triclorosilane (Scheme 60).[191]  In the presence of 20 mol% of 76, a 
broad range of N-aryl ketimines were reduced by trichlorosilane to produce the corresponding 
amines in high yield (up to 98% yield) and enantioselectivity (up to 93% ee). 
76 (20 mol%)
HSiCl3, CH2Cl2, –20 °C
73–98% yield
74–93% ee
R1 R2
N
R3
R1 R2
HN
R3
*
S
N
H
O OH
F76  
Scheme 60. Asymmetric reduction of ketimines with trichlorosilane catalyzed by 76. 
 
After successful development of 74, 75, and 76 as efficient catalyst for the reduction of 
ketimines with trichlorosilane, Sun and his group developed L-proline derived C2-symmetric 
chiral tetraamide 77 as an effective Lewis basic catalyst in the enantioselective reduction of 
ketimines, affording high yields (up to 95%) and moderate to high enantioselectivities (up to 
86% ee) (Scheme 61).[192] 
77 (10 mol%)
HSiCl3, CH2Cl2, 0 °C
74–95% yield
61–86% ee
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Scheme 61. Asymmetric reduction of ketimines with trichlorosilane catalyzed by 77. 
During the course of developing chiral Lewis basic N-formamide as highly effective 
organocatalyst for reductions with trichlorosilane, Sun et al. demonstrated that 78 arising from 
fine-tuning the structure of 74 was a first highly effective catalyst for the asymmetric 
reduction of aromatic and aliphatic ketones as well as aromatic and aliphatic ketimines in 
good to high enantioselectiviy (Scheme 62).[193] 
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Scheme 62. Asymmetric reduction of ketones and ketimines with trichlorosilane catalyzed by 
78. 
 
During the last several years, a variety of Lewis basic organic activators have been 
developed for asymmetric reductions with trichlorosilane.  The noticeable feature in most of 
the activators was that N-formyl substituent was essential for those reductions.  Recently, two 
other types of activators were independently disclosed by Matsumura and Malkov groups.  
Matsumura et al. developed 79 as organic activator in asymmetric reduction of imines to the 
Chapter 1   Introduction and State-of-the-Art 
38 
corresponding amines with trichlorosilane in moderate to good enantioselectivities (Scheme 
63).[194] 
R1 R2
N
Ph
79 (10 mol%)
HSiCl3, CH2Cl2, rt R1 R2
HN
Ph
*
N
N
O
HO Ph
Ph
79  
Scheme 63. Asymmetric reduction of ketimines with trichlorosilane catalyzed by 79. 
 
Simultaneously, Malkov and co-workers developed a new, practical, and efficient 
organocatalyst 80 for the enantioselective reduction of aromatic ketones (up to 94% ee) and 
ketimines (up to 87% ee) using trichlorosilane (Scheme 64).[195]  It is noteworthy that the 
reaction is characterized by an unusual, long-ranging chiral induction. 
R1 R2
O 80 (10 mol%)
HSiCl3, CHCl3, –20 °C R
1 R2
OH
*
R3
N
Ar 80 (10 mol%)
HSiCl3, toluene, –20 °C R2 R3
HN
Ar
*
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85–87% ee
80
35–93% yield
70–94% ee
N N
O Ph
 
Scheme 64. Asymmetric reduction of ketones and ketimines with trichlorosilane catalyzed by 
80. 
 
Recently, one remarkable progress in asymmetric reduction of aryl ketones using 
trichlorosilane was achieved by Matsumura and co-workers.  In the presence of a catalytic 
amount of 83 aryl ketones were reduced to the corresponding alcohols with excellent 
enantioselectivity (up to 99.7% ee) (Scheme 65).[196]  Also, by using this method, they 
succeeded in the preparation of an optically active lactone 84 from keto ester 85 in 93% yield 
with 97% ee.  85 is an important intermediate for a preparation of a wide variety of 
biologically active substance. 
Ar R
O 83 (10 mol%)
HSiCl3, CH2Cl2, rt Ar R
OH
*
CO2Me
O 1. HSiCl3 (3 equiv)    56 (10 mol%)
    CHCl3, rt, 6 h
2. HCl/MeOH
up to 99.7% ee
O
O
84 85
93% yield
97% ee
NHOOC
CHO
83
 
Scheme 65. Asymmetric reduction of aryl ketones with trichlorosilane catalyzed by 83. 
 
The aforementioned reductions using trichlorosilane activated by an organic activator is a 
well-established two-electron transformation, in which a hydride was transferred from 
 Chapter 1   Introduction and State-of-the-Art 
39 
activated trichlorosilane to nucleophiles, such as imines or ketones.  The related free-radical 
reduction remains a potentially valuable one-electron alternative to this reaction.  Enholm et 
al. reported that the reduction of α-hydroxy ketones can be performed with trichlorosilane 
under neutral free radical conditions to anti-1,2-diols in high diastereoselectivities (Scheme 
66).[197]  This reduction provides a stereoselective, mild, one-electron alternative to the 
established two-electron methods that use hydride regents. 
O
R
OH
Ph
HSiCl3
hν, 23 °C
OH
R
OH
Ph
 up to 134 : 1 (syn : anti)  
Scheme 66. Trichlorosilane radical reduction of α-hydroxy ketones. 
 
Recently, Malkov and co-workers continued to refine their valine-derived organocatalysts 
for the asymmetric reduction of N-aryl ketimines with trichlorosilane (Scheme 67).[198]  The 
introduction of bulky groups into the anilide moiety of the catalysts resulted in an increase of 
enantioslectivity not only in the aromatic realm, but also for the nonaromatic imines.  The 
catalyst loading can be reduced to 1 mol%, which is rather uncommon in general.  In addition, 
they enhanced the practicality by fluorous tagging of the catalyst, which allows a very easy 
isolation of the product and an undemanding recovery of the catalyst that can be used in the 
next cycle. 
R1 Me
N
R2
86 (1 mol%)
HSiCl3, toluene, rt R1 Me
HN
R2
up to 95% ee
N
H
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HN
O
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O
C6F13
 
Scheme 67. Asymmetric reduction of ketimines with trichlorosilane catalyzed by 86. 
 
Almost simultaneously, the same group of Malkov et al. developed a new, expedient 
protocol for the synthesis of 1,2-diaryl aziridines that have hot been prepared previously as 
pure enantiomers, in which the reductive amination of α-chloroacetophenone with 
trichlorosilane catalyzed by L-valine-derived formamide 87 is a crucial step (Scheme 68).[199] 
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Scheme 68. Enantioselective synthesis of 1,2-diarylaziridines. 
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1.5.3 Summary 
 
In general, trichlorosilane, employed as the stoichiometric reducing agent for the reduction of 
ketones or imines, serves as a starting material in the silicon industry and is manufactured in 
bulk, so that its price is reduced almost to the level typical for common organic solvents.  
Although trichlorosilane is sensitive to water, the implications are rather modest and the 
reagent can be easily handled by using standard procedures for moisture-sensitive materials 
with minimum precautions (in principle, a CaCl2 drying tube could be used instead of an inert 
atmosphere of nitrogen of argon).  Since toluene was identified as an optimal solvent and the 
workup of the reaction with aqueous NaHCO3 produces innocuous inorganic materials, 
namely NaCl and silica, this protocol represents a relatively low environment risk.  In 
conjunction with the low catalyst loading, all these features suggest that the organocatalyzed 
reductions with HSiCl3 may become an attractive alternative to the established industrial 
technologies for asymmetric reductions. 
 
1.6 Organocatalyzed asymmetric cyanosilylation 
 
1.6.1 Introduction 
 
Cyanohydrins are of synthetic interest as they may be elaborated into a number of key 
functional groups, including α-hydroxyacids, β-hydroxyalcohol, and other valuable building 
blocks.[200, 201]  Hydrogen cyanide (HCN) is the most commonly industrially used reagent for 
cyano transfer to carbonyl compounds.[202]  However, due to its toxicity and difficulty in 
handling, new methods have been developed to substitute HCN with other potentially less 
harmful and yet easily manageable reagents.  Trimethylsilyl cyanide (TMSCN) is widely used 
as a cyanide source with various catalysts.  The use of TMSCN allows the desired 
cyanohydrin to be prepared directly as the corresponding trimethylsilyl ether.  The stability of 
the TMS adduct, conferred by an energetically favourable Si-O bond, prevents the reverse 
cyanation reaction from occurring and hence removes a potential pathway for racemization.  
In 1973, Evans and Sundermeyer and their co-workers are among the first to report the 
addition of TMSCN to aldehydes, ketones, and acid chlorides catalyzed by thermal and Lewis 
acid respectively.[203, 204]  Since then, a multitude of different catalysts has been reported in the 
literature for both the racemic and asymmetric addition of the cyanide to carbonyls.[200, 205, 206]  
Majority of these chiral catalysts are based on metallic Lewis acidic systems containing a 
variety of ligands that enable enantioselective transfer of CN- to carbonyls.  However, in view 
of environmental benign pressures, organocatalysts have received great attention in recent 
years.[12]  This chapter describes the progress in organanocatalytic addition of TMSCN to 
carbonyls, mainly on the addition of aldehydes or ketones, which was ordered mainly in two 
parts: organocatalytic racemic addition of TMSCN to carbonyls and enantioselective addition 
of TMSCN to carbonyls. 
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1.6.2 Synthesis of racemic cyanohydrins with green approaches 
 
1.6.2.1 Organocatalytic racemic addition of TMSCN to carbonyls 
 
Before discussing enantiomerically enriched cyanohydrins, I would like to introduce the area 
by reviewing cyanohydrin synthesis in the absence of chiral control.  This section therefore 
summarizes the preparation of racemic cyanohydrins. 
Generally, in the absence of a catalyst, no reaction is observed between TMSCN and 
carbonyl compounds.  Consequently, a variety of organic activators or promoters have been 
reported for the cyanation of carbonyl compounds with TMSCN.  Element I2, tertiary amines 
and quaternary ammonium salts have been used to catalyze the addition of TMSCN to 
aldehydes and ketones.[207-210]  Interestingly, 1,2- or 1,4-adducts can be manipulated easily in 
the case of α,β-unsaturated ketones under specific conditions.[208, 209]  Plumet et al. have 
reported racemic or diastereoselective cyanosilylation of carbonyl compounds with TMSCN 
using Tetrabutylammonium cyanide or methyltriphenylphosphonium iodide as catalysts.[210-
212]  A series of N-oxides including commercially available N-methylmorpholine N-oxide 
(NMO) and prepared tertiary amine and pyridine N-oxides are reported independently by Kim 
and Feng and their co-workers to be effective promoters for the addition of TMSCN to 
ketones (Scheme 69).[213, 214]  The air-stable phenolic N-oxide 89 exhibited superior catalytic 
effect over 88.  In the presence of 5 mol% of 89, ketones were quantitatively converted into 
corresponding cyanohydrin O-TMS ethers at mild temperature within short reaction time.  
Denmark and Chung conducted a brief survey of effective solvents, catalysts, and kinetics of 
Lewis base catalyzed addition of TMSCN to aldehydes.[215]  Maruoka, Song, and Aoyama 
have reported the use of N-heterocarbenes (NHCs) as effective catalysts for the addition of 
TMSCN to carbonyl compounds.[216-218]  Wilhelm and Blanrue have reported cyanosilylaiton 
of aldehydes with TMSCN using Imidazolium-carbodithionates as catalysts.[219]  Verkade and 
Fetterly have reported the 1,2-addition of trialkylsilylcyanides to aldehydes and ketones in the 
presence of catalytic amounts of non-ionic strong base P(RNCH2CH2)N.[220]  Feng et al. have 
reported catalytic cyanosilylation of ketones using 1,1,3,3-tetramethylguanidine as 
catalyst.[221]  Takemoto et al. have reported thiourea-catalyzed addition of TMSCN and ketene 
silyl acetals to nitrones and aldehydes.[48]  Recently, Olah and co-workers reported the 
cyanosilylaitons in demethylformamide (DMF) using nucleophilic catalysts such as 
carbonates and phosphates.[222]  They found that the CN to carbonyl transfer in DMF can be 
carried out even in the absence of a catalyst.  With the addition of K2CO3 or organic 
phosphate as catalyst, the rate of the reaction has been significantly enhanced. 
R1 R2
O
+ TMSCN
88 or 89
R1 R2
NC OTMS
N
O
O
OH
N
O
88 89  
Scheme 69. N-oxides catalyzed addition of TMSCN to ketones. 
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1.6.2.2 Cyanosilylation of carbonyl compounds through heterogeneous catalysis 
 
The ever-increasing pressure of environmental pollutions has compelled chemists to research 
green chemistry and technology in order to replace currently existing pollution sources with 
clear manufacturing process.  The rational way is to immobilize homogeneous catalysts with 
polymers or to pursue solid catalysts made from mineral materials affording heterogeneous 
catalysis, which is featured in recyclable use of the catalyst and simplified workup. 
In the area of cyanosilylation synthesis, many efforts have been made to realize 
heterogeneous addition of TMSCN to ketones.  Modified mineral materials were firstly 
utilized to catalyze cyanosilylation of ketones.  Solid acidic cation-exchanged 
montmorillonites (Mn+-Mont, Mn+ = Al3+, Fe3+, Sn4+, Ca2+, Ni2+),[223-225]  solid basic calcined 
hydrotalcite (HT, Mg6Al2(OH)16CO3·4H2O), MgAlCO3-HT and hydroxyapatite 
(Ca(PO4)6(OH)2), were employed as heterogeneous catalysts for the reaction in organic 
solvents.[223-226]  Some inorganic metal oxides such as MgO and CaO were also used as 
heterogeneous promotors.[224, 225]  CaF2 can release cyanide from TMSCN as a result of the 
formation of Si-F bond, thus accelerate the addition of TMSCN to ketones.[223]  In fact, all 
basic heterogeneous catalysts could promote this transformation due to the coordination 
between silicon atom of TMSCN and O2– of those catalysts.[227] 
Recently, diamine attached to commercially purchased mesoporous silica MCM-41 
exhibited good catalytic capacity to cynosilylation of ketones as a green catalyst.[228] 
Heterogeneous catalysis has received increasing interest in organic synthesis using 
inorganic salts as catalysts.  Jenner has reported cyanosilylation of ketones with TMSCN 
using LiClO4 or solution of LiBF4 as catalysts.[229]  Later, Saidi reported the use of LiClO4 as 
catalyst for this reaction under solvent-free conditions, however, solvents was required for the 
workup stage.[230]  Recently, Ohkuma et al. reported LiCl as a highly effective catalyst for 
cyanosilylation of aldehydes and ketones to the corresponding silylated cyanohydrins under 
solvent-free conditions.[231]  The turnover frequency (TOF) can reach 28000 at a 
substrate/catalyst (S/C) 50000.  K2CO3 was found as the efficient inorganic salt to catalyze the 
addition of TMSCN to ketones under solvent conditions.[232] 
 
1.6.3 Asymmetric synthesis of cyanohydrins with TMSCN catalyzed by organocatalysts 
 
Since cyanohydrins can serve as precursors to α-hydroxy acids, β-amino alcohols, and other 
valuable chiral building blocks, the catalytic asymmetric cyanation of carbonyl compounds 
ranks among the most important and well-studied reaction classes in asymmetric catalysis.[201]  
Whereas several outstanding catalyst systems have been identified for cyanation of 
aldehydes,[200] ketones present a greater challenge as a substrate class, and only recently have 
effective methods using chiral metal complexes,[200, 233-242] cinchona alkaloids,[243] chiral 
oxazaborolidinium ions,[244] amino acid salts,[245] mono- or bilithium salts of binols,[246-248] 
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and chiral thioureas[93] been devised.  This part mainly covers the recent advancement in 
organocatalytic asymmetric addition of TMSCN to carbonyl compounds. 
 
1.6.3.1 Organocatalytic asymmetric addition of TMSCN to aldehydes 
 
Feng and coworkers developed an asymmetric cyanosilylation of aldehydes catalyzed by 
proline-based chiral N,N’-dioxide (Scheme 70).[249]  In the presence of 2.5 mol% 90, a variety 
of aromatic aldehydes were converted to their corresponding products with good yields in up 
to 73% ee. 
Ar H
O 90 (2.5 mol%)
1.3 equiv TMSCN
CH2Cl2, 80 h, –78 °C
Ar
OTMS
CN
H
57–92% yield
53–73 ee N N
O NH
O O
HN O
90  
Scheme 70. Asymmetric cyanosilylation of aldehydes catalyzed by 90. 
 
Gennari and co-workers reported the use of a diastereomeric mixture of atropisomeric 
thioureas 25 as a bifunctional orgnocatalytic system for enantioselective cyanosilylation of 
aldehydes (Section 1.3.2.2.1).[95] 
Corey and Ryu described a new chiral system based on boron and Ph3PO as a coreactant 
(Scheme 71).[250]  A variety of aldehydes, aromatic and aliphatic, have been transformed into 
cyanohydrins with excellent yield in >90% ee.  In addition, the chiral precursor of the catalyst 
is readily recoverable and the absolute stereochemical course of the reaction is predicted 
clearly by a well precedented mechanism. 
R H
O
91 (0.1 equiv)
Ph3PO (0.2 equiv)
TMSCN, toluene, 0 °C R CN
H OTMS
N B
O
Ar
Ar
H
H
Tf2N
Ar = 3,5-dimethylphenyl
91
 
Scheme 71. Asymmetric cyanosilylation of aldehydes catalyzed by 91. 
 
Kagan and coworkers have reported the use of mono- and dilithium salts binol for 
asymmetric addition of TMSCN to aldehydes (Scheme 72, top).[247, 248]  It should be noted 
that the enantioselectivity and rate of reactions are very substrate specific.  Recently, Ishiahara 
and coworkers have modified this system by introducing a water/alcohol mixture as a 
coactivator (Scheme 72 bottom).[246]  A highly enantioselective cyanation of aromatic 
aldehydes can be obtained using a simple and inexpensive chiral lithium binaphtholate aqua 
or alcohols complexes.  This system is suitable for process chemistry to ensure the practical 
gram-scale cyanohydrin synthesis in minimum solvent. 
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R H
O 92 (1.0 mol%)
TMSCN, ether, –78 °C R
OTMS
CN
OH
OLi
N N
OH LiO t-Bu
t-But-Bu
t-Bu
92
R H
O 93 (1.0 mol%)
TMSCN, ether, –78 °C R
OTMS
CN
93  
R H
O 94 / LiOPri (1–10 mol% each)
TMSCN (1.0 equiv)
toluene, –78 °C, 1 h
R CN
OH
OH
94
OTMS
 
Scheme 72. Asymmetric cyanosilylation of aldehydes catalyzed monolithium salt 92, 93, or 
94. 
 
1.6.3.2 Organocatalytic asymmetric cyanosilylation of ketones 
 
The asymmetric cyanation of ketones has been historically considered as problematic.  There 
is more steric hindrance around the carbonyl group of ketones than of aldehydes, significantly 
decreasing the propensity of the former to undergo cyanation.  Despite this inherent problem, 
the area has received considerable attention as a consequence of the synthetic utility of 
homochiral cyanohydrins of ketones.  This part mainly describes the recent progress in 
organocatalytic systems. 
During the investigation of chiral oxazaborolidium ion as catalyst for asymmetric 
cyanosilylation of aldehydes, Corey and Ryu succeeded to extend this system to 
enantioselective cyanosilylation of methyl ketones (Scheme 73).[244]  After optimizing the 
reaction parameters, in the presence of 10 mol% 95 and MePh2O as acoreactant, a range of 
methyl ketones can be converted to the corresponding cyanosilyl ether with good to high yield 
in high to excellent enantioselectivities.  The absolute stereochemical course of these carbonyl 
addtions can be rationalized in a logical way.  Interestingly, higher enantioselectivities result 
with the more electron-withdrawing groups, presumably considered that these favour early 
transition states and a stronger attractive interaction between the coordinated methyl ketone 
carbonyl and the neighboring π-electron-rich mexyl group of 95.  In contrast, electron-
supplying groups have the opposite effect, leading to stereochemically variable pathways. 
R CH3
O
R CH3
TMSO CN
N B
O
Ar
Ar
H
H
TfO
Ar = 3,5-dimethylphenyl
95
+ TMSCN
95 (0.1 equiv)
MePh2PO (0.11 equiv)
toluene, 25–45 °C
 
Scheme 73. Asymmetric cyanosilylation of ketones catalyzed by 95. 
 
Deng et al. reported the first highly enantioselective cyanosilylation of ketones with 
modified cinchona alkaloids (Scheme 74).[243]  Reasoning that acetal ketones serve not only as 
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a versatile handle for synthetic elaboration of the product, but the acetal group also enhances 
the activity of the ketone toward the nucleophilic enantioselective cyanosilylation, 
cyanosilylation of a series of prepared acetal ketones was investigated with various cinchona 
alkaloid derivatives.  In the presence of 2 mol% of (DHQ)2AQN (96a) in chloroform or 5–10 
mol% of (DHQ)2PHAL (96b) in ethyl acetate, excellent enantioselectivity and yield is 
obtained with acetal ketones bearing a broad range of aryl, alkenyl, and alkyl substituents. In 
addition, both the isolation of product and the recovery of the 96a were achieved in 
quantitative yield using a simple extractive procedure.  These results were duplicated with the 
recovered 96a.  In general, this reaction provides a new, practical, and broadly applicable 
approach toward chiral building blocks bearing quaternary stereocenters.  This is in marked 
contrast to the often highly exothermic, poorly selective reactions normally observed with the 
addition of TMSCN to unactivated ketones.  Choi and coworkers investigated simple 
cinchona alkaloid systems as catalysts for the reaction of TMSCN with acetophenone.  After 
the variation of a number of reaction parameters, including solvent and pressure, a maximum 
of 10% ee was obtained.[251] 
R1
O
OR2
OR2 Catalyst 96a or96b
TMSCN
R1 OR2
OR2
NC OTMS
*
NHHN
OO
N
H
Et
N
OMe
N
MeO
N
Et
(DHQD)2PHAL96b
O O
O O
NN
N N
H H
Et Et
MeO OMe
(DHQ)2AQN 96a  
 
Scheme 74. Asymmetric cyanosilylation of ketones catalyzed by 96a or 96b. 
 
Jacobsen and Fuerst reported a significant new example of thiourea catalysis in the highly 
enantioselective cyanosilylation of ketones and aldehydes with a bifunctional thiourea-amine 
derivative (Section 1.3.2.2.1).[93]   
Much differently from the known enzyme- and transition metal-based methods, Feng and 
coworkers developed a sodium salt of chiral amino acid 97 as catalyst for highly 
enantioselective cyanosilylation of ketones (Scheme 75).[245]  In the presence of 30 mol% of 
97 and add isopropanol, a variety of aromatic ketones were converted to their corresponding 
cyanosilyl ether in excellent yields and enantioselectivities, but only moderate ee values for 
aliphatic and α,β-unsaturated ketones.  Notable features of the reaction are the utilization of 
commercially available and fully recyclable catalysts and employment of simple and 
convenient experiment procedures, which should render the reaction more attractive for 
industry application. 
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R1 R2
O
+ TMSCN
97 (30 mol%)
CF3CH2OH, CH2Cl2
–45 °C
R1 R2
TMSO CN
COONa
NH2
97  
Scheme 75. Asymmetric cyanosilylation of ketones catalyzed by organic salt 97. 
 
1.6.4 Conclusions and outlook 
 
Recent progress in organocatalytic addition of TMSCN to carbonyls was introduced.  
Generally, these organocatalysts include cinchona alkaloids, amino acid salts, mono- or 
bilithium salts of binols, N-oxides, as well as thiourea derivatives.  However, operations of the 
present methods are considerably complicate and there are still less alternatives for efficient 
organocatalytic asymmetric cyanosilylation of ketones, due to steric hindrance around ketones.  
Since enantiomerically enriched cyanohydrins can be elaborated into a number of key 
functional groups, generally applicable and environmentally benign methodologies are still 
highly anticipated. 
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Chapter 2  Research Objectives 
 
 
 
 
As outlined briefly above, thiourea-based catalysts have proven effective in promoting a 
variety of reactions.  However, the development of “privileged” thiourea-based organocatalyst 
with general applications is still formidable.[252] One of the main targets of this present 
doctoral thesis is to develop novel thiourea-based chiral organocatalysts for several 
fundamentally important transformations, such as transfer hydrogenations, cyanosilylation, as 
well as hydrophosphonylation.  First, we design and prepare a series of thiourea-based 
compounds with novel chiral modules via a short and straightforward synthetic route.  
General strategies are based on the following aspects: (1) incorporation of chiral oxazoline 
moieties into known achiral thiourea catalysts;  (2) incorporation of additional Lewis base 
functionality;  (3) preparation of analogues of reported catalysts;  (4) exploration of new 
applications for reported catalysts.  After the potential catalysts’ library is set up, their 
catalytic efficacy will be investigated under optimized reaction conditions. 
The applications of chiral N-formamides as metal-free catalysts have recently added to the 
advances in the field of organocatalysis.  Another important goal of our study is to develop 
novel chiral N-formamide for asymmetric reduction of ketimines using trichlorosilane as the 
hydrogen donor.  Since the detailed mechanisms of these reactions are not available, 
preliminary mechanistic studies will be considered, which involve the interception and 
characterization of reaction intermediates by means of experimental and computational 
methods.  The implication of these mechanistic findings should provide information for 
rational design of novel chiral activators for trichlorosilane. 
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Chapter 3  Organocatalytic Reductions 
 
 
 
General Remarks 
 
The results achieved so far have been published in two papers, and the other unpublished 
attempts are introduced separately. 
 
3.1 Thiourea-Catalyzed Transfer Hydrogenation of Aldimines 
 
Zhiguo Zhang, Peter R. Schreiner* 
 
Synlett 2007, 1455–1457. 
 
Reproduced by permission of the Thieme Chemistry 
 
On the question of some of the published literature protocols, we present a practical method 
for the thiourea-catalyzed reduction of aromatic as well as aliphatic aldimines with a Hantzsch 
ester as the hydrogen source.   
 
3.2 Organocatalytic Biomimetic Reduction of Conjugated Nitroalkenes 
 
Zhiguo Zhang, Peter R. Schreiner* 
 
Synthesis 2007, 2559–2564. 
 
Reproduced by permission of the Thieme Chemistry 
 
A thiourea-catalyzed biomimetic metal- and acid-free reduction of conjugated nitroalkenes to 
the respective nitroalkanes utilizing a Hantzsch ester as the hydrogen source was developed. 
 
3.3 Miscellaneous 
 
The in situ regeneration of Hantzsch ester, development of chiral ammonium salts as potential 
catalysts, as well as search for other hydrogen sources were investigated. 
 
3.4 Trichlorosilane (HSiCl3) – A Cheap and Convenient Reducing Agent 
 
Zhiguo Zhang 
 
Submitted to Synlett Spotlight on Jan. 9, 2008. 
 
An introduction to trichlorosilane was performed.
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3.5 Asymmetric Organocatalyzed Reduction of Ketimines with HSiCl3 (Manuscript in 
preparation) 
 
Various novel chiral N-formamides derived from proline, valine, and pipecolinic acid were 
developed for the asymmetric reductions of ketimines using trichlorosilane as the hydrogen 
donor.  The enantioselectivity up to 68% ee was so far obtained.  The preliminary mechanism 
studies showed quite different features as described in the literature.  Further work will be 
directed to elaborate the mechanism aspects by means of experimental and computational 
methods and develop more efficient catalysts. 
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Abstract: The present letter reports on the thiourea-catalyzed trans-
fer hydrogenation of imines through hydrogen-bonding activation
with Hantzsch 1,4-dihydropyridine as the hydrogen source. A
variety of aromatic as well as aliphatic aldimines can be reduced to
give the respective amines under acid- and metal-free reaction con-
ditions.
Key words: Hantzsch dihydropyridine, hydrogen bonds, organo-
catalysis, thiourea, transfer hydrogenation
The organocatalytic hydrogenation of imines and the re-
ductive amination of carbonyl compounds represent a
contemporary challenge.1 There are many metal-based
approaches to this transformation, and molecular hydro-
gen as the reductant activated by chiral metal complexes
is a powerful method for the preparation of amines,2 even
on industrial scale.3 Transfer hydrogenations using iso-
propyl alcohol or formic acid as sources of hydrogen also
are effective.4 However, expensive and toxic metal ions
were used in most of these transformations, so that the
organocatalytic hydrogenation of imines and reductive
aminations were eagerly anticipated. These include hy-
drosilylations catalyzed by chiral Lewis bases5 and hydro-
gen-transfer reactions catalyzed by chiral phosphoric acid
derivatives in combination with the NADH analogous
Hantzsch ester.6
In the course of our studies on noncovalent organocataly-
sis mediated through hydrogen bonding, we have demon-
strated that thiourea derivatives catalyze Diels–Alder-
reactions,7 acetalizations,8 epoxide openings9 as well as
several other reactions.10 We envisioned that activation of
imines 1 by hydrogen bonding with electron-poor biaryl
thiourea 3 would promote hydrogen transfer from the
Hantzsch ester 2 to generate amine 4 (Scheme 1, eq. 1).
Recent work by Menche et al. on the reductive amination
of ketones11 and aldehydes12 with thiourea (5) itself
(Scheme 1, eq. 2) encouraged us to utilize 3, which has
proven to be generally a more effective catalyst. First, we
attempted to reproduce the findings by the Menche group
and compared the catalytic activity of 3 and 5 (Table 1).
Much to our surprise, the reductive amination of ace-
tophenone (6a) was ineffective (entries 6–8). When the
reaction was carried out using unactivated 5 Å MS as de-
hydrating agent (entry 9), the conversion at 50 °C was
smooth (89%) even without a thiourea catalyst added.
This is in stark contrast to the previous report by Menche
et al. who reported a maximum yield of 5%;11 the reasons
for using unactivated MS is not clear to us but complies
with the data given in the original publications.11,12
Conversely, activated MS gives the product in less than
5% yield in the presence of 10 mol% of 5, while Menche
et al. report 88% yield when using unactivated 5 Å MS. As
a consequence, we conclude that commercially available
5 Å MS contains some water or other relatively volatile
components that could catalyze the reaction as well.
Our attempts at reproducing the published protocol12 for
the reductive amination of aldehydes were equally puz-
zling at first (entries 1–5). We found that benzaldehyde
(6b) could be condensed and reduced to the corresponding
amine 4b without catalyst with 78% yield in 24 hours!
Naturally, we assumed that the auto-oxidation of 6b had
produced sufficient quantities of benzoic acid that could
catalyze the reaction as well. Hence, upon addition of
excess of base (10 mol% NaHCO3), the reaction was com-
pletely suppressed (entry 1). The same reaction in the
presence of 5 gave no product (entry 2). In contrast, over
80% yield of product can be realized within 24 hours with
5 mol% or 10 mol% of 3 (entries 3 and 4). Other substitut-
ed aryl aldehydes gave poor to moderate yields.
Scheme 1 Thiourea-catalyzed transfer hydrogenation
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We therefore turned our attention to the reduction of iso-
lated imines to further clarify the crucial step in the report-
ed reductive amination. These were allowed to react with
reductant 2 under thiourea catalysis (Table 2). While the
ketimine derived from 6a only gave traces of product, the
aldimine 1b produced the corresponding amine even at 1
mol% loading of 3 (entry 8), while 5 again had no catalyt-
ic effect (entries 2 and 5). Loadings as low as 0.1 mol%
are also possible at the expense of longer reaction times
(entry 9).
Using dichloromethane as solvent and 3 (1 mol%) as cat-
alyst we explored the scope of this acid- and metal-free
transfer hydrogenation for the aldimines (Table 3).14 In
general, a variety of aromatic aldimines can be reduced,
including electron-rich, electron-deficient, as well as
ortho-, meta-, and para-substituted aryl aldehydes. In
addition, aliphatic aldimines can also be reduced to give
the respective amines with high yields (entries 10 and 11).
The present paper questions some of the published litera-
ture protocols11,12 on the reductive amination of aldehydes
and ketones. At the same time, we present a practical
method for the thiourea-catalyzed reduction of aromatic
as well as aliphatic aldimines with a Hantzsch ester as the
hydrogen source.
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Table 1 Thiourea-Catalyzed Reductive Amination
Entry R Catalyst 
(mol%)
Temp 
(°C)
Conditions Yield 
(%)a
1 H – r.t. base,b 24 h trace
2 H 5 (10) r.t. base,b 24 h trace
3 H 3 (10) r.t. base,b 24 h 86
4 H 3 (5) r.t. base,b 24 h 84
5 H – 70 5 Å MS,c 24 h 91 (9312)
6 Me – 50 5 Å MS,d 48 h <5
7 Me 5 (10) 50 5 Å MS,d 48 h <5 (8811)
8 Me 3 (10) 50 5 Å MS,d 48 h <5 
9 Me – 50 5 Å MS,c 48 h 89 (<511)
a
 Yield of 4 after column chromatography.
b
 10 mol% of NaHCO3 was added.13
c
 Unactivated (Acros organics, pellets, 4–8 mesh, product number: 
197285000).
d
 Activated.
Ph R
O
+
Ph R
HN
PMP
4
H2N
PMP
6 7
2 (1.5 equiv)
toluene
Table 2 Imine Reduction with Thioureas
Entry R Catalyst 
(mol%)
Conditions Yield 
(%)a
1 Me – toluene, 50 °C, 48 h trace
2 Me 5 (20) toluene, 50 °C, 48 h trace
3 Me 3 (20) toluene, 50 °C, 48 h trace
4 H – CH2Cl2, r.t., 24 h trace
5 H 5 (10) CH2Cl2, r.t., 24 h trace
6 H 3 (10) CH2Cl2, r.t., 15 h 91
7 H 3 (5) CH2Cl2, r.t., 15 h 89
8 H 3 (1) CH2Cl2, r.t., 15 h 89
9 H 3 (0.1) CH2Cl2, r.t., 60 h 87
a
 Yield of 4 after column chromatography.
Ph R
N
Ph
2 (1.1 equiv)
catalyst Ph R
HN
Ph
41
Table 3 Thiourea-Catalyzed Reduction of Aldimines
Entry R Yield (%)a
1 Ph 89
2 4-MeC6H4 92
3 4-O2NC6H4 91
4 4-BrC6H4 93
5 3-HOC6H4 86
6 4-FC6H4 84
7 3-ClC6H4 90
8 2,6-Cl2C6H3 86
9 3-MeOC6H4 84
10 i-Bu 80
11 c-Hex 87
a
 Yield of pure 4 after column chromatography.
R H
N
Ph
1
R H
HN
Ph
4
CH2Cl2, r.t., 15 h
3 (1.0 mol%), 2 (1.1 equiv)
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In a typical experiment the aldimine 1 (1.0 mmol), thiourea 
3 (1 mol%) and Hantzsch dihydropyridine 2 (1.1 equiv) were 
suspended in anhyd CH2Cl2 (5 mL) in a flask. The resulting 
mixture was allowed to stir at r.t. for 15 h. The solvent was 
removed under reduced pressure and the residue was 
purified by column chromatography on silica gel using 
mixtures of PE and Et2O to afford the pure corresponding 
amine 4. All compounds were fully characterized on the 
basis of IR, 1H NMR, 13C NMR and HRMS.
Compound 4a: light yellow oil. IR (film): 3418, 1699, 1602, 
1505, 1179, 1064 cm–1. 1H NMR (400 MHz, CDCl3): 
d = 4.20 (s, 2 H), 6.50–6.52 (d, 2 H, J = 8.71 Hz), 6.59–6.63 
(t, 1 H, J = 7.41 Hz), 7.04–7.09 (t, 2 H, J = 7.40 Hz), 7.14–
7.27 (m, 5 H). 13C NMR (100 MHz, CDCl3): d = 48.2, 112.8, 
117.5, 127.1, 127.4, 128.5, 129.2, 139.4, 148.1. HRMS: m/z 
calcd for C13H13N: 183.10425; found: 183.10347.
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Abstract: A thiourea-catalyzed biomimetic reduction of conjugat-
ed nitroalkenes has been developed. Various aromatic and aliphatic
conjugated nitroalkenes can be reduced to give the respective ni-
troalkanes with good yields under mild conditions. This protocol is
not only practical, but may also provide insight into the mechanisms
of redox transformations in biological systems. 
Key words: biomimetic reduction, Hantzsch ester, hydrogen bond-
ing, nitroalkenes, thiourea
Aliphatic nitroalkanes are valuable building blocks and
intermediates in organic synthesis as well as in carbohy-
drate chemistry.1 They are very useful tools for carbon–
carbon bond formation or carbon skeleton elongation be-
cause the high electron-withdrawing power of the nitro
group stabilizes a-carbanions and enables their reactions
with electrophiles under mild conditions. Moreover, the
nitro group itself can be transformed into other function-
alities such as, amongst others, carbonyl, amino, oxime,
and hydrogen moieties.2 The preparation and subsequent
reduction of conjugated nitroalkenes has been widely ac-
cepted as a straightforward route to nitroalkanes, thus,
there are quite a number of reducing reagents and reduc-
tion methodologies employed in this transformation.3
Commonly used reductants include borohydride deriva-
tives, metal hydrides, and metal halides. However, the se-
lective reduction of the conjugated double bond is rather
difficult because nitro-group reduction often takes place
simultaneously.4 Though sodium borohydride primarily
furnishes the corresponding nitroalkanes, these reactions
are often accompanied by the formation of polymeric side
products through Michael addition of the nitronate inter-
mediate to the starting nitroalkene.5 Zinc borohydride is
reported to be an efficient reagent with which to convert
nitroalkenes smoothly into the corresponding nitroal-
kanes.6 Metal-catalyzed hydrogenations and transfer hy-
drogenation are also very effective, however, due to the
difficulties in handling or the toxicity of metal ions, new
efficient and environmentally friendly methods remain
desirable.7
In contrast to the chemical conversions described above,
biological redox transformations using reduced nicotin-
amide adenine dinucleotide (NADH) as a coenzyme to re-
duce unsaturated functionalities, proceeds smoothly
under very mild conditions. The ease with which such re-
actions takes place has been a stimulus for the develop-
ment of a wide range of NADH models for a variety of
reductions.8 Among these, Hantzsch esters are one of the
most widely investigated biomimetic reductants because
they are inexpensive, stable and readily available.9 Recent
advances in organocatalysis have shown considerable
promise for employing Hantzsch esters as the hydrogen
source in asymmetric reductions as well as reductive am-
inations;10 however, there is no organocatalytic method
for the reduction of conjugated nitroalkenes.11
Developments in biological and enzymatic catalysis have
shown that isolated enzymes from baker’s yeast or Old
Yellow Enzyme (OYE), which was termed as nitroalkene
reductase, can efficiently catalyze the NADPH-linked re-
duction of nitro-olefins. The crystal structure of OYE re-
vealed that several amino acid residues around the active
site of the enzyme affect catalysis and ligand binding.
With a systematic study of the OYE-catalyzed reduction
of nitrocyclohexene, a catalytic mechanism was proposed
in which the nitrocyclohexene was activated by nitro-ox-
ygen hydrogen bonds to His-191 and Asn-194 (Figure 1,
A).12 A hydride is then transferred to the b-position from
the reduced flavin which, ultimately, originated from
NADPH. The product is finally formed through proton
transfer from the Tyr-196 hydroxyl to the a-position.12 
Figure 1 Thiourea-catalyzed biomimetic reduction of nitroalkenes.
(A) Key interactions between the enzyme (OYE) and nitrocyclohex-
ene (Protein Databank ID code 1OYB); (B) model of the thiourea-ca-
talyzed biomimetic reduction of conjugated nitroalkenes.
This excellent study inspired us to mimic the procedure in
preparative chemistry with an organocatalyst functioning
as the ‘reductase’ and an NADPH analog such as a
Hantzsch ester. During our efforts at developing noncova-
lent organocatalysis mediated through hydrogen bond-
ing,13 we recently found that thiourea 3 catalyzes the
transfer hydrogenation of aldimines with Hantzsch ester 2
as the hydrogen source, at low catalyst loadings
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(Scheme 1).14 We were hopeful that it would be possible
to extend this procedure to other electron-deficient a,b-
unsaturated conjugated olefins such as nitroalkenes
(Figure 1, B). Here we report the first thiourea-catalyzed
biomimetic reduction of conjugated nitroalkenes through
hydrogen-bonding activation.
Scheme 1 Thiourea-catalyzed transfer hydrogenation of aldimi-
nes.14
We first examined some representative electron-with-
drawing, conjugated olefins such as nitrostyrene (5a), cin-
namaldehyde (5b), 2-cyclohexenone (5c) and chalcone
(5d) with the protocol described in Table 1. Only nitrosty-
rene could be reduced at 10 mol% loading of 3; a decrease
in the catalyst loading resulted in somewhat reduced
yields (Table 1). The rationale behind this effective reduc-
tion may be that the nitro group, as the most electron-
withdrawing substituent known,15 forms strong hydrogen-
bonding interactions between the nitro group and 3 and is
thus very effective in lowering the LUMO energy of the
olefin and thus accelerating the reaction.
We then evaluated solvent effects on the reduction of ni-
trostyrene (Table 2). Reductions in non-polar media such
as benzene and toluene, as well as halogenated solvents,
proceeded smoothly. Performing the reaction in more po-
lar media led to sluggish reactions and considerably di-
minished yields. Surprisingly, a moderate yield was also
obtained in the protic solvent methanol (entry 9). In order
to further clarify this unusual phenomenon, the reaction
was repeated in methanol without the addition of catalyst
3; complete consumption of 5a was observed and, in ad-
dition to the expected nitroalkane, the Michael addition
product was also obtained (entry 10).
Using dichloromethane as solvent and 3 (10 mol%) as cat-
alyst, we studied the general applicability of this proce-
dure for reducing various nitroalkenes (Table 3). All
aromatic nitroalkenes were smoothly reduced in good
yields and varying the substituents had no marked effect
on the outcome of this reaction. As expected, the reduc-
tions of electron-rich nitrostyrenes took longer and afford-
ed the product in lower yield. Aliphatic nitroalkenes (5q
and 5r) were reduced to the corresponding nitroalkane in
very good yield. Only the reduction of nitrocyclohexene
gave the nitroalkane in poor yield even at 20 mol% load-
R H
N
Ph
N
H
EtO OEt
O O
N
H
N
H
S
CF
3
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C
CF
3
CF
3
R H
HN
Ph
(1.1 equiv)
(1 mol%)
CH
2
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2
, r.t., 15 h
80–93%
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2
3
Table 1 Substrate Screening for Thiourea-Catalyzed Reductions
Substrate Catalyst 
(mol%)
Product Yield (%)a
5a
– 6a 0
5a 3 (10) 6a 87
5a 3 (5) 6a 75
5b
3 (10) 6b 0
5c
3 (10) 6c 0
5d
3 (10) 6d 0
a
 Yield of product after column chromatography.
(1.1 equiv)
(10 mol%)
toluene, 50 °C, 48 h
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Table 2 Solvent Effects on the Reduction of Nitrostyrene
Entry Solvent Yield (%)a
1 toluene 78
2 benzene 84
3 CH2Cl2 88
4 CHCl3 76
5 THF 39
6 1,4-dioxane 30
7 MeCN 39
8 DMF 31
9 MeOH 52
10 MeOH 45b
a
 Yield of product after column chromatography.
b
 The reaction was carried out in the absence of catalyst 3.
NO
2
NO
2
2 (1.1 equiv)
3 (10% mol)
50 °C, 24 h
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ing. Reduction of the nitro group and polymerization of
the olefins did not occur in any case.
In summary, we have developed a thiourea-catalyzed bio-
mimetic metal- and acid-free reduction of conjugated ni-
troalkenes to the respective nitroalkanes utilizing a
Hantzsch ester as the hydrogen source. A variety of aro-
matic and aliphatic conjugated nitroalkenes can be re-
duced to the respective nitroalkanes with good yields
under mild conditions. This protocol is not only practical,
but may also provide insights into transformations
through hydrogen-bond activation in biological systems.
The extension of this protocol to an asymmetric reduction
of disubstituted or trisubstituted nitroalkenes, using chiral
thiourea derivatives, is under investigation.
Unless otherwise noted, all materials were obtained from commer-
cial suppliers and were used without further purification. Solvents
for chromatography were of technical grade and were distilled prior
to use. Solvents used in the reactions were reagent grade and were
distilled from the indicated drying agents: toluene (P2O5), CH2Cl2
(P2O5), benzene (Na), Et2O (Na), MeCN (P2O5), 1,4-dioxane (Na),
DMF (CaH2), CHCl3 (P2O5), THF (Na). For TLC, silica gel coated
aluminum plates (Merck, silica gel 60 F254) were used and chro-
matograms were visualized by irradiation with UV light at 254 nm.
Column chromatography was performed using J. T. Baker silica gel
(particle size 0.063–0.200 mm). Solvent mixtures are understood as
volume/volume. 1H NMR and 13C NMR spectra were recorded on a
Bruker AM 400 spectrometer at 298 K in 5 mm NMR tubes. The
chemical shifts (d values) were obtained in CDCl3 solutions unless
otherwise noted and referenced to residual CHCl3 (1H NMR: d =
7.25 ppm, 13C NMR: d = 77.2 ppm). Data are presented as follows:
chemical shift, multiplicity, coupling constant in Hertz (Hz), inte-
gration. IR spectra were reported in terms of frequency (cm–1) and
intensity of absorption (s = strong, m = medium, w = weak).
HRMS were recorded on a Thermo Finnigan MAT 95. GC-MS
analyses were carried out with a Quadrupole-MS HP MSD 5971
(EI) and HP 5890A gas chromatograph equipped with a J & W Sci-
entific fused silica GC column (30 m × 0.250 mm, 0.25 micron DB-
5MS stationary phase: 5% phenyl and 95% methyl silicone) using
Table 3 Biomimetic Reduction of Various Nitroalkenes
Nitroalkene Product Yield (%)a
5e
6e 80
5f
6f 72
5g
6g 85
5h
6h 79
5i
6i 75
5j
6j 71
5k
6k 82
5l
6l 89
5m
6m 80
5n
6n 71
5o
6o 93
R
NO
2
R
NO
2
2 (1.1 equiv)
3 (10 mol%)
CH
2
Cl
2
, reflux, 24 h5 6
NO
2
Me
NO
2
MeO
NO
2
OMe
NO
2
Br
NO
2
HO
NO
2
HO
OMe
NO
2
Cl
Cl
NO
2
Cl
Cl
NO
2
MeO
OBz
NO
2
OMe
MeO
O
NO
2
5p
6p 37
b
47b,c
5q
6q 82
5r
6r 87
a
 Yield of product after column chromatography.
b
 A mixture of 5p and 6p was isolated; yield was determined by 1H 
NMR spectroscopy.
c
 20 mol% of 3 was used.
Table 3 Biomimetic Reduction of Various Nitroalkenes (continued)
Nitroalkene Product Yield (%)a
R
NO
2
R
NO
2
2 (1.1 equiv)
3 (10 mol%)
CH
2
Cl
2
, reflux, 24 h5 6
NO
2
NO
2
NO
2
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He as carrier gas; T-program standard 60–250 °C (15 °C/min heat-
ing rate), injector and transfer line 250 °C.
Preparation of Nitro Alcohols; General Procedure
To a solution of the aldehyde (45.4 mmol) and nitromethane (2.5
mL, 46.2 mmol) in EtOH (10 mL) cooled to 0 °C, was added aq
NaOH (10 M, 4.54 mL, 45.4 mmol) through a plastic syringe, drop-
wise, under vigorous stirring (necessary to prevent the formation of
a solid mass). After 10 min, the reaction mixture became white and
solidified. AcOH (2.6 mL, 45.4 mmol) and subsequently H2O (20
mL) was added and the aqueous phase was extracted with Et2O
(2 × 500 mL). The combined organic phase was washed with H2O
(5 × 300 mL) until the pH of the washings was about 6. After drying
over MgSO4, filtration and concentration in vacuo, the nitro alcohol
was obtained and used without further purification. 
1-Nitro-2-cyclohexyl-2-ethanol
Colorless oil. 
1H NMR (400 MHz, CDCl3): d = 0.88–1.18 (m, 5 H), 1.28–1.37 (m,
1 H), 1.50–1.56 (m, 2 H), 1.63–1.71 (m, 2 H), 2.65 (br, 1 H, OH),
3.92–3.98 (m, 1 H), 4.25–4.37 (m, 2 H). 
13C NMR (100 MHz, CDCl3): d = 25.76, 25.88, 26.09, 27.97, 28.81,
41.45, 72.91, 79.38. 
MS: m/z (%) = 112, 94, 83, 68, 55 (100).
1-Nitro-3-methyl-2-butanol
Yellow oil. 
1H NMR (400 MHz, CDCl3): d = 0.91 (m, 6 H), 1.72 (m, 1 H), 3.16
(br, 1 H, OH), 4.04 (m, 1 H), 4.32–4.45 (m, 2 H). 
13C NMR (100 MHz, CDCl3): d = 17.4, 18.3, 31.7, 73.5, 79.4. 
MS: m/z (%) = 91, 90, 86, 73, 69 (100), 62, 55.
Preparation of Aliphatic Nitroalkenes (5q and 5r);16 Typical 
Procedure
To a solution of 1-nitro-2-cyclohexyl-2-ethanol (5.06 g, 29.2 mmol)
in CH2Cl2 (60 mL), cooled to 0 °C, were added successively TFAA
(4.34 mL, 30.7 mmol) then, dropwise, Et3N (8.56 mL, 61.4 mmol).
The reaction mixture was allowed to warm to r.t. and stirred for 1 h.
CH2Cl2 (40 mL) was added and the organic phase was washed suc-
cessively with H2O (20 mL), sat. aq NH4Cl (20 mL) and brine (20
mL) then dried over MgSO4. After filtration and concentration in
vacuo, the product was distilled under reduced pressure.
5q
Yellow oil. 
1H NMR (400 MHz, CDCl3): d = 1.06–1.78 (m, 10 H), 2.19 (m,
1 H), 3.09 (m, 1 H), 6.86 (d, J = 13.6 Hz, 1 H), 7.15 (m, 1 H). 
13C NMR (100 MHz, CDCl3): d = 25.4, 25.6, 31.4, 37.5, 138.3,
147.4. 
MS: m/z (%) = 138, 97, 81, 79, 69, 57, 55 (100).
5r
Yellow oil. 
1H NMR (400 MHz, CDCl3): d = 1.14 (d, J = 6.79 Hz, 6 H), 2.58
(m, 1 H), 6.94 (m, 1 H), 7.22–7.28 (m, 1 H). 
13C NMR (100 MHz, CDCl3): d = 21.0, 28.3, 138.1, 148.5. 
MS: m/z (%) = 100, 67, 57 (100), 53, 51.
Biomimetic Reduction of Nitroalkenes; General Procedure
Nitroalkene (1.0 mmol), thiourea 3 (10 mol%) and Hantzsch ester
(2; 1.1 equiv) were suspended in anhyd CH2Cl2 (5 mL) and the re-
sulting mixture was allowed to reflux for 24 h. The solvent was re-
moved under reduced pressure and the residue was purified by
column chromatography on silica gel to afford the pure correspond-
ing nitroalkanes. The yields are given in Table 3. 1H NMR data for
known compounds were identical to those in the literature: 6a,11e
6f,11e 6e,17 6g,11e 6i,18 6l,19 6m,5b 6o,11e 6p,20 and 6q.21 The 13C
NMR, IR, and MS data are given below. All new compounds or
those that have not been well-described in the literature were fully
characterized on the basis of IR, 1H NMR, 13C NMR, and HRMS.
6a
Colorless oil. 
IR (film): 3031, 1551, 1455, 1379, 1083, 769, 752 cm–1. 
13C NMR (100 MHz, CDCl3): d = 33.4, 76.3, 127.4, 128.6, 129.2,
135.7. 
HRMS: m/z calcd for C8H9NO2: 151.06278; found: 151.06220. 
6e
Colorless oil. 
IR (film): 3025, 2923, 1905, 1551, 1517, 1433, 1379, 1181, 1115,
811 cm–1. 
1H NMR (400 MHz, CDCl3): d = 2.24 (s, 3 H), 3.19 (t, J = 7.39 Hz,
2 H), 4.49 (t, J = 7.39 Hz, 2 H), 7.03 (dd, J1 = 8.17 Hz, J2 = 10.31
Hz, 4 H). 
13C NMR (100 MHz, CDCl3): d = 21.1, 33.1, 76.5, 128.5, 129.6,
132.6, 137.1. 
MS: m/z (%) = 165, 118 (100), 103, 91, 77, 65.
6f
Colorless oil. 
IR (film): 3007, 2959, 2937, 2838, 1612, 1551, 1514, 1434, 1379,
1250, 1180, 866, 827 cm–1. 
13C NMR (100 MHz, CDCl3): d = 32.7, 55.3, 76.6, 114.4, 127.6,
129.6, 158.9. 
HRMS: m/z calcd for C8H11NO3: 181.07389; found: 181.07319.
6g
Colorless oil. 
IR (film): 2941, 2839, 1603, 1589, 1551, 1465, 1380, 1120, 1031,
756 cm–1. 
13C NMR (100 MHz, CDCl3): d = 29.2, 55.3, 74.7, 110.4, 120.8,
123.9, 128.9, 130.7, 157.5. 
HRMS: m/z calcd for C8H11NO3: 181.07389; found: 181.07288.
6h
Colorless solid. 
IR (KBr): 3029, 2974, 2957, 2911, 1719, 1565, 1488, 1425, 1336,
1295, 1009, 979, 803, 771 cm–1. 
1H NMR (400 MHz, CDCl3): d = 3.19 (t, J = 7.20 Hz, 2 H), 4.51 (t,
J = 7.20 Hz, 2 H), 7.01 (d, J = 8.43 Hz, 2 H), 7.37 (d, J = 8.43 Hz,
2 H). 
13C NMR (100 MHz, CDCl3): d = 32.75, 75.90, 121.44, 130.31,
132.08, 134.66. 
HRMS: m/z calcd for C8H8BrNO2: 228.97384; found: 228.97034.
6i
Colorless oil. 
IR (film):  3424, 2984, 1552, 1516, 1445, 1107, 772 cm–1. 
1H NMR (400 MHz, CDCl3): d= 3.13 (t, J = 7.41 Hz, 2 H), 4.47 (t,
J = 7.41 Hz, 2 H), 6.70 (d, J = 8.42 Hz, 2 H), 6.94 (d, J = 8.42 Hz,
2 H). 
13C NMR (100 MHz, CDCl3): d = 32.7, 76.6, 116, 130, 155.6. 
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MS: m/z (%) = 167, 120 (100), 103, 91, 77, 65, 51.
6j
Colorless oil. 
IR (film): 3505, 2941, 1613, 1551, 1517, 1453, 1433, 1033 cm–1. 
1H NMR (400 MHz, CDCl3): d = 3.17 (t, J = 7.31 Hz, 2 H), 3.80 (s,
3 H), 4.50 (t, J = 7.31 Hz, 2 H), 5.52 (br, 1 H, OH), 6.62 (m, 2 H),
6.78 (d, J = 7.96 Hz, 1 H). 
13C NMR (100 MHz, CDCl3): d = 33.3, 55.9, 76.7, 111.1, 114.8,
121.3, 127.4, 145.0, 146.7. 
HRMS: m/z calcd for C9H11NO4: 197.06826; found: 197.06995.
6k
Colorless oil. 
IR (film): 3084, 2920, 1437, 1380, 1088, 1025, 779 cm–1. 
1H NMR (400 MHz, CDCl3): d = 3.59–3.63 (m, 2 H), 4.47–4.51 (m,
2 H), 7.08–7.13 (t, J = 8.04 Hz, 2 H), 7.25–7.27 (d, J = 8.04 Hz,
2 H). 
13C NMR (100 MHz, CDCl3): d = 29.0, 72.0, 128.6, 129.4, 131.4,
135.8. 
HRMS: m/z calcd for C8H7Cl2NO2: 218.98483; found: 218.98395.
6l
Colorless oil. 
IR (film): 2977, 2929, 1557, 1279, 865, 772, 566 cm–1. 
1H NMR (400 MHz, CDCl3): d = 3.17 (t, J = 7.19 Hz, 2 H), 4.52 (t,
J = 7.19 Hz, 2 H), 6.96 (m, 1 H), 7.22 (m, 1 H), 7.28 (m, 1 H). 
13C NMR (100 MHz, CDCl3): d = 32.2, 75.5, 123.0, 128.0, 130.5,
130.8, 135.9. 
HRMS: m/z calcd for C8H7Cl2NO2: 218.98483; found: 218.98395.
6m
Yellow solid. 
IR (KBr): 3345, 3038, 2936, 1664, 1590, 1516, 1380, 1349, 1010,
808 cm–1. 
1H NMR (400 MHz, CDCl3): d = 3.13 (t, J = 7.32 Hz, 2 H), 3.77 (s,
3 H), 4.43 (t, J = 7.32 Hz, 2 H), 5.04 (s, 2 H), 6.66 (m, 2 H), 6.75–
6.77 (d, J = 8.00 Hz, 1 H), 7.17–7.35 (m, 5 H). 
13C NMR (100 MHz, CDCl3): d = 32.9, 56.0, 71.2, 76.4, 112.1,
114.6, 121.4, 127.4, 127.9, 128.1, 128.5, 136.7, 148.2, 149.0. 
HRMS: m/z calcd for C16H17NO4: 287.11521; found: 287.11575.
6n
Colorless oil. 
IR (film): 2941, 2838, 1588, 1551, 1484, 1278, 1083, 1007, 750
cm–1. 
1H NMR (400 MHz, CDCl3): d = 3.22 (t, J = 7.45 Hz, 2 H), 3.77 (s,
3 H), 3.79 (s, 3 H), 4.52 (t, J = 7.45 Hz, 2 H), 6.68 (m, 1 H), 6.78
(m, 1 H), 6.91 (t, J = 7.98 Hz, 1 H). 
13C NMR (100 MHz, CDCl3): d = 28.7, 55.7, 60.7, 75.2, 110.0,
119.3, 124.3, 129.2, 147.3, 152.7.
HRMS: m/z calcd for C10H13NO4: 211.08391; found: 211.08459.
6o
Yellow oil. 
IR (film): 2921, 1724, 1555, 1507, 1378, 1281, 1145, 741 cm–1. 
13C NMR (100 MHz, CDCl3): d = 26.0, 73.4, 107.4, 110.1, 143.8,
149.4. 
MS: m/z (%) = 141, 94 (100), 83, 65, 55.
6p
Colorless oil; ratio 6p/5p = 4:5.
IR (film): 2802, 2669, 1713, 1468, 1431, 1268, 1243, 1223, 1194,
1160 cm–1. 
13C NMR (100 MHz, CDCl3): d = 23.8, 24.6, 30.8, 84.6. 
MS: m/z (%) = 84, 83, 81, 77, 67, 65, 55 (100).
6q
Colorless oil. 
IR (film): 2926, 2854, 1554, 1449, 1385 cm–1. 
1H NMR (400 MHz, CDCl3): d = 0.84–0.93 (m, 2 H), 1.06–1.18 (m,
4 H), 1.57–1.66 (m, 5 H), 1.84 (q, J = 7.11 Hz, 2 H), 4.34 (t,
J = 7.30 Hz, 2 H). 
13C NMR (100 MHz, CDCl3): d = 25.9, 26.2, 32.7, 34.6, 34.9, 73.8. 
MS: m/z (%) = 138, 122, 111, 109, 99, 94, 81, 79, 67, 55 (100).
6r
Colorless oil. 
IR (film): 2964, 2875, 1785, 1555, 1470, 1382, 1279, 1135 cm–1. 
1H NMR (400 MHz, CDCl3): d = 0.89 (d, J = 6.63 Hz, 6 H), 1.58–
1.66 (m, 1 H), 1.85 (q, J = 7.27 Hz, 2 H), 4.34 (t, J = 7.39 Hz, 2 H). 
13C NMR (100 MHz, CDCl3): d = 22.0, 25.6, 36.0, 74.3. 
MS: m/z (%) = 71, 69, 67, 62, 59, 55 (100).
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3.3 Miscellaneous 
 
3.3.1 Hydrogen sources 
 
Transfer hydrogenation using stable organic hydrogen donors is an attractive alternative in 
view of operational simplicity, as well as possible high overall cost performance.  Although 
such reductions has emerged as a convenient method for asymmetric transition metal-
catalyzed saturation of C=C, C=O, as well as C=N linkages, the hydrogen sources for 
organocatalytic reduction are quite limited.  The problematic removal of oxidized pyridine 
forms of Hantzsch esters prompt us to investigate other alternative hydrogen sources for 
thiourea catalyzed reduction.  In this investigation, we selected as the model reaction the 
reduction of aldimine in the presence of thiourea catalyst 5.  First hydrogen donor was 
focused on a 5:2 formic acid-triethylamine azeotropic mixture (TEAF),[253] which has proven 
to be a useful source of hydrogen.[254-256]  Owing to its solubility in organic solvent and 
decomposition to hydrogen and carbon dioxide during the reaction, TEAF, in contrast to other 
hydrogen donors, was applied to our test reaction (Scheme 1).  Whatever we tried different 
reaction parameters such as solvents, temperatures, as well as catalyst loadings, unfortunately 
no transformation was observed. 
Ph H
N
Ph
HCO2H–(C2H5)3N (5:2)
5
Ph H
HN
Ph
N
H
N
H
S
CF3
F3C
CF3
CF3
5  
Scheme 1. Investigation of TEAF as hydrogen donor for thiourea catalyzed reduction of 
imine. 
 
3.3.2 Biomimetic reductive amination 
 
The reductive amination of α-keto acid or the sodium salt in the presence of two isolated 
enzymes, namely a leucine dehydrogenase and a formate dehydrogenase, is regarded to be 
one the most efficient routes for preparation of enantiomerically pure amino acid.[257, 258]  The 
reaction concept is shown in Scheme 2.  
CO2
FDH
(formate
 dehydrogenase)
HCO2
NADH + H H3C CO2Na
CH3
H3C
O
H3C CO2Na
CH3
H3C
NH2
LeuDH
(leucine 
dehydrogenase)
NH4
L-neopentylglycine
NAD
 
Scheme 2. General reductive amination concept. 
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The reductive amination step under consumption of the cofactor NADH is catalyzed by a 
leucine dehydrogenase, forming the desired L-neopentylglycine as well as oxidized cofactor 
form, NAD+.  This oxidized cofactor form, NAD+, is subsequently reduced under formation 
of NADH by means of a formate dehydrogenase-catalyzed oxidation of formate.  This 
enzymatic reaction has already proven its technical feasibility on large scale.  Since its 
operation is not familiar to most of synthetic chemists and the need for isolated, costly 
enzymes as well as the requirement for significant amounts of the expensive cofactor NAD+, 
we wonder if it is possible to mimic this process in synthetic scale by using thiourea as 
functional enzymes and oxidized pyridine form of Hantzsch ester as NAD+ (Scheme 3).  
N
H
N
H
S
CF3
F3C
CF3
CF3
5
COOH
O
+ HCOONH4+
5 (10 mol%)
100 (1.5 equiv)
COOH
NH2
N
EtO2C CO2Et
100  
Scheme 3. Biomimetic reductive amination. 
 
Experimental details: 
 
To a mixture of phenylpyruvic acid (32.8 mg, 0.2 mmol), 100 (75.4 mg, 0.3 mmol), and 5  
(10.0 mg, 10 mmol%) in 2 mL CH2Cl2 was added ammonium formate (37.8 mg, 0.6 mmol).  
The resulting mixture was stirred at room temperature and was monitored by TLC.  No 
reaction was determined.  Although we further investigated the reaction under different 
conditions such as temperature, solvents and catalyst loadings, no transformation was 
observed.  The proposal was still under investigation. 
 
3.3.3 Regeneration of Hantzsch ester 
 
The problematic removal of oxidized form of Hantzsch ester and poor atom economy prompt 
us to investigate the in situ regeneration of Hantzsch ester using an inexpensive and easily 
handling co-reductant.  Theoretical calculation by Prof. Peter R. Schreiner has revealed that 
the oxidized form of Hantzsch ester can be potentially reduced with 1,4-cyclohexadiene 
(Scheme 4).  
N
+
N
+
ΔHR = +38.3 kcal mol–1
N
+
N
+
ΔHR = –5.0 kcal mol–1EtO2C CO2Et
–145.0 –155.0
EtO2C CO2Et
–5.9 +17.0 +27.4 +22.0 ΔHf (AM1)
+22.0 ΔHf (AM1)+17.0  
Scheme 4. Chemical calculation of the energy. 
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Experimental Section 
 
N
H
48a
OO
EtO OEt
H H
+
2.5 equiv acids
toluene, 50°CN
OO
EtO OEt
+
2 equiv
100  
entry acid yield 
1 CH3COOH - 
2 HCl - 
3 CF3COOH - 
4 H3PO4 - 
5 P-TSA - 
6 CSA - 
7 HClO4 - 
8 HBF4 - 
 
Under argon atmosphere, acid was added to a mixture of 100 (25.1 mg, 0.1 mmol) and 1,4-
cyclohexadiene (16 mg, 0.2 mmol) in 0.5 mL toluene.  The resulting mixture was stirred at 50 
°C and monitored by TLC and GC-MS, no reaction was observed under activation of different 
acids. 
 
3.3.4 Asymmetric ammonium salt catalyzed transfer hydrogenation of quinoline 
 
Asymmetric counteranion-directed catalysis (ACDC), described by List and co-workers, has 
emerged as an effective strategy for asymmetric transfer hydrogenation of α,β-unsaturated 
aldehydes and ketones.[159, 259]  Despite high conversion and enantioselectivity, however, the 
need for costly preparation of BINOL-derived phosphoric acid is a disadvantage.  We turned 
our attention to prepare chiral ammonium salts, formed from commercially abundant quinine 
and acids, as catalysts for transfer hydrogenation of 2-phenylquinoline.  Some of the formed 
ammonium salts do catalyze the transfer hydrogenation of 2-phenylquinoline, albeit no 
enantioselectivities (entries 2, 3, and 7). 
N 20 mol% cat
CH2Cl2, r. t.
N
H101 102
48a (2.4 equiv)
 
Entry Quinine Acids Ratioa Yield (%) ee (%)b 
1 H3PO4 1:1 0 - 
2 p-toluenesulfonic acid 1:1 100 1.2 
3 L-(+)-tartaric acid 1:1 80 0 
4 L-(+)-tartaric acid 2:1 trace - 
5 L-(+)-lactic acid 1:1 trace - 
6 TFA 1:1 trace - 
7 
 
N
MeO
HO N
 
(1S)-(+)-CSA 1:1 100 0 
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a The ratio represents quinine to the corresponding acids, general procedure for the 
preparation of organic salts is: acids was added to the solution of quinine in CH2Cl2, after 
stirring overnight, the solvent was evaporated under reduced pressure to provide the product, 
which was used as catalyst in the hydrogenation of quinoline.  b Determined by chiral HPLC. 
 
Experimental section 
 
Reactions were performed with 2-phenylquinoline (20.5 mg, 0.1 mmol, 1.0 equiv.), Hantzsch 
ester (60.79 mg, 0.24 mmol) in CH2Cl2 (2 mL) using 20 mol% of formed organic salts (0.02 
mmol, 0.2 equiv.) at room temperature. The reaction was monitored with GC-MS, GC and 
TLC. 
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Introduction 
Trichlorosilane (HSiCl3) is a cheap, stable, and commer-
cially available reagent, which has been widely used as a 
stoichiometric reductant.  In general, activators are nec-
essary for HSiCl3 to reduce efficiently C=C, C=O, C=N, 
and P=O functionalities.  The currently most successful 
methodologies are based on transition metal-centered 
catalyzed hydrosilylation, however, recent advances in 
the field of organocatalysis have also provided a series of 
small organic molecules as efficient alternative catalysts 
for asymmetric reductions of ketones or imines with 
HSiCl3. In this paper, reductions using HSiCl3 are sum-
marized.   
A number of methods are available for the preparation of 
trichlorosilane in the laboratory, for example, by the 
reaction of dry HCl gas with silicon1 or with metallic 
silicides.2  The title compound is also an abundant by-
product of the industrial Rochow process.3 
2 Si + 6 HCl 2 HSiCl3 + 2 H2  
 
Abstracts 
(A)  Trichlorosilane has been often used together with 
tertiary amines to reduce carbonyl groups of aromatic 
aldehydes, ketones, acids, amides, acid chlorides, and 
anhydrides to give the corresponding benzylic trichloro-
silane.  This transformation was termed a “reductive 
silylation” through replacement of a carbonyl oxygen 
with H and SiCl3.4  This method provides a new way to 
form silicon-carbon bonds, and the benzylic trichlorosi-
lane products can be can be further transformed to tolue-
nes by base treatment. 
C6H5CC6H5
O
HSiCl3
(C3H7)3N
KOH
C2H5OH
(C6H5)2CH2
C6H5CO2H
HSiCl3
(C3H7)3N, CH3CN
KOH
aq. C2H5OH
C6H5CH3
 
 
(B)   Reduction of isocyanates with HSiCl3 gives the 
corresponding isocyanides in high yield under mild con-
ditions.5  This provides a relatively simple method for 
the synthesis of vinyl isocyanides from alkenes.6 
AgOCN, I2
ether, rt
NCO
I
HSiCl3, i-Pr2NEt
CH2Cl2, 0 °C
55%, 2 steps
NC
I
t-BuOK, THF
–78 °C to rt
95%
NC
 
 
(C) Highly diastereoselective reduction of α-hydroxyl 
ketones can be achieved using HSiCl3 as the reductant 
under neutral free-radical conditions.7  This reduction 
provides a diastereoselective, mild, one-electron alterna-
tive to the established two-electron methods that employ 
hydride reagents.   
O
R
OH
Ph
HSiCl3
hν, 23 °C
OH
R
OH
Ph
 up to 134 : 1 (anti : syn)  
 
(D) The catalytic enantioselective reduction of aryl ke-
tones by HSiCl3 gives the corresponding alcohols with 
excellent enantioselectivity in the presence of catalytic 
amounts of N-formyl-α′-(2,4,6-triethylphenyl)-L-proline 
as the activator.8 
Ar R
O cat (10 mol%)
HSiCl3
CH2Cl2, rt
Ar R
OH
*
up to 99.7% ee
NHOOC
CHO
cat  
 
(E) Asymmetric reduction of ketimines with trichlorosi-
lane can be catalyzed by a new N-methyl-L-valine de-
rived Lewis basic organocatalyst, affording the respec-
tive secondary amines with high enantioselectivity.9 
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Ar
N
Ph
Toluene, r.t.
Ar
HN
Ph
N
H
O
HN
O
catup to 92% ee
HSiCl3
cat (10 mol%)
 
PPh2
Ar
O
HSiCl3
NEt3, toluene, 120 °C
PPh2
Ar
 
  
(F) The N-methylvaline derived Lewis basic formamide 
catalyzed reductive amination of α-chloroketones is a 
key step in the enantioslective synthesis of 1,2-
diarylaziridines that had not been prepared previously as 
pure enantiomers.10  This provides an efficient and envi-
ronmentally friendly methodology for the preparation of 
enantiopure aziridines. 
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(H) Trichlorosilane is an often-used reducing agent for 
converting phosphine oxides to phosphines, which play 
an extremely important role as ligands in homogeneous 
catalysis.10 
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3.5  Asymmetric Organocatalyzed Reduction of Ketimines with HSiCl3 
 
 
 
Introduction 
 
Asymmetric hydrogenation, hydroboration, and hydrosilylation are the most frequently used 
catalytic methods for reduction of prochiral ketones and imines.[141] Although asymmetric 
hydrogenation remains favored by industry in general, it is not free of problems, namely, 
those associated with metal leaching, high pressure, and the cost of the catalyst and its 
regeneration.  Stoichiometric borane reduction, catalyzed by chiral oxazoborolidine, avoids 
most of these problems and offers high levels of enantioselection,[141] but its cost is 
prohibitive for large-scale industrial application.  The recently developed reduction of C=C 
and C=N, which uses the Hantzsch ester as a stoichiometric reducing agent and chiral 
imidazolidinone or chiral Brønsted acid as organocatalysts is also limited by removal of the 
pyridine form of Hantzsch ester and the cost implications.[151, 152, 156-167, 169, 171, 172]  It is still 
worthwhile to exploit new methods, which can be carried out in industrial scale under mild 
conditions.  One of such alternative developments may be asymmetric reductions with 
trichlorosilane (HSiCl3), a cheap and commercial available reagents, albeit some activators 
are necessary for promoting HSiCl3 to efficiently reduce unsaturated functionalities.  The 
currently most successful methods are based on the use of transition metal-centered 
hydrosilylation,[141] however, recent advances in organocatalysis appeal to be very attractive 
and competitive with traditional methods.  The first asymmetric organocatalytic reduction of 
ketimines using trichlorosilane was reported by Matsumura and co-workers in 2001.[179]  
During the past few years, various chiral activators have been studied and reported by several 
laboratories (Scheme 1).[185, 188-191, 194, 195]  Representative organocatalysts for this 
transformation are listed in Scheme 1.  This part describes our studies on this subject. 
N
OH
CONH-1-Naph
N
H
O
HN
O
N
H
N
O
Ac
O
OH
Ph
Ph
N
N
H
N
O
OH
SO2(p-tBuPh)
Ph
72c 73 74 75  
S
N
H
O OH
F
N N
O PhN
N
O
HO Ph
Ph N
H
O
HN
O
tBu
tBu
76 8079 87  
Scheme 1. Some examples of chiral organic activators. 
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Initial design of catalysts 
 
Our search for chiral organic activators for trichlorosilane was initially based on the following 
general strategies: (1) N-formyl proline is used as basic chiral modular, with the carboxyl 
converted into amide group by incorporation of aliphatic amino compounds in various 
molecular sizes;  (2) N-formyl proline derived diastereomeric activators involving more than 
one chiral centers;  (3) extension of amino acids from proline to valine or pipecolinic acid 
scaffold;  (4) introduction of N-formyl proline to an axially C1-symmetric scaffold;  (5) it was 
also intended to prepare 1,3-dicarbonyl N-formamide as potentially “six ring” activators;  (6) 
two reported catalysts were prepared for comparison.  On the basis of these considerations, a 
series of compounds (103–120) were designed and prepared as reservoir for potential 
trichlorosilane activators (Scheme 2). 
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Scheme 2. Synthesized compounds. 
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Synthesis 
 
The synthesis of proline-derived formamides started with the formylation of proline in the 
presence of acetyl anhydride and formic acid, which afforded N-formyl proline in 90% yield.  
The carbonyl of the latter derivative was then converted into a series of secondary amides by 
reaction with respective primary amines, employing 1-hydoxy-benzhotriazole hydrate (HOBt) 
and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) as coupling 
reagents (Scheme 3).  This method is applicable to all primary aliphatic amines, namely 
compounds 103–113.  The same strategy was also employed for the synthesis of L-pipecolinic 
acid derived N-formamide 114 and proved to be equally efficient as for proline.  
N
H
COOH HCOOH, Ac2O
N
COOH
O
H
RNH2
HOBt, EDCl N
O
H
R
O
103–113  
Scheme 3. Catalyst synthesis. 
 
The synthesis of 118 commenced with conversion of Boc-protected L-proline 119 to active 
anhydride, which generated in situ from 119 and methyl chloroformate and then reacted with 
axially (R)-(+)-1,1′-Bi(2-naphthyl)amine (BINAM, 120) to give product 121 (64%).  Boc-
deprotection with TFA followed by formylation with a mixed anhydride, generated in situ 
from formic acid and acetic anhydride, to produce the desired axially C1-symmetric activator 
118 (Scheme 4).  
NH2
NH2
N
COOH 1. MeOCOCl, TEA,     THF, 0 °C, 1 h
O
O 2.
rt, 16 h, reflux, 3 h
H
N
H
N
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O
N
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O
1. CF3COOH, rt, 1 h
2. HCO2H, Ac2O, rt
H
N
H
N
O
O
N
N
HO
O
H
118121119
120
 
Scheme 4. Catalyst preparation. 
 
The synthesis of 116, started with the conversion of (R)-2-methoxyphenyl acetic acid 122 
to acid chloride with oxalyl chloride in the presence of catalytic amount DMF, followed by 
reaction with N-methylformamide (Scheme 5).  The phenyl alanine derived formamide 117 
prepared through the same manner failed to produce the corresponding product, due to serious 
side reactions.  An alternative method for conversion of Fmoc-protective L-phenyl alanine 
123 to acid chloride 124 was carried out with SOCl2, followed by reaction with N-
methylformamide, giving the desired product, albeit in low yield (Scheme 6). 
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COOH
OCH3 1. (COCl)2, DMF, CH2Cl2
2. HNCH3CHO, Pyridine
OCH3
O
N O
H116122  
Scheme 5. Catalyst synthesis.    
COOH
NHFmoc
1. SOCl2, CH2Cl2, reflux
2. HNCH3CHO, Pyridine
CH2Cl2
NHFmoc
N
O
H
O
117123  
Scheme 6. Catalyst synthesis. 
 
The synthesis of 115 commenced with N-
methylation of the BOC-protected L-valine 
125 with MeI in the presence of NaH, 
which afforded the BOC-protected N-
methyl valine 126.  The latter was then 
converted to 127 through the reaction of 1-
aminoadmantane with the mixed anhydride, 
generated in situ from 126 and methyl 
chloroformate.  BOC-deprotection with 
TFA was followed by formylation with 
formic acid and acetic anhydride to 
produce 115 (Scheme 7).  The known 
compounds 73 and 76 were prepared 
according to the literature reported.[185, 260] 
Scheme 7. Catalyst synthesis. 
 
Asymmetric reduction of ketimines with HSiCl3 
 
A typical reaction is performed firstly by the reduction of ketimine 98 (derived from 
acetophenone and aniline) with HSiCl3 in CH2Cl2 at 0 °C in the presence of L-proline-derived 
catalyst 104 (10 mol%), affording the corresponding amine in high yield with 67% ee (Table 
1, entry 1).  We next examined the influence of other reaction parameters on the reaction 
outcome.  Interestingly, when the reaction was run at –18 °C and room temperature, both the 
ee values of product 99 decreased to 45% ee and 58% respectively (entry 2 and 3), and the 
yields was almost unchanged.  Toluene was found to afford the same level of 
enantioselectivity as dichloromethane at –18 °C (Table 1, entry 4).  The lower 
enantioselectivities obtained in Et2O and THF clearly indicate that the reaction requires 
nonpolar solvents (Table 2, entries 5 and 6).  The reaction in CHCl3 also shows inferiority 
(Table 3, entry 7).  No enantioselectivity was observed when the reaction was run in DMF 
(Table 4, entry 8). 
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Table 1. Solvent and Temperature Survey in the Reduction of Imin-1 with Trichlorosilane in 
the presence of 104 (10 mol%). 
Ph
N
Ph HSiCl3 (2.0 equiv)
104 (0.1 equiv)
CH2Cl2, 0 °C
Ph
HN
Ph
*
98 99  
 
entry temperature solvent yield (%) ee (%) 
1 0 °C CH2Cl2 82 67 
2 -18 °C CH2Cl2 80 45 
3 rt  CH2Cl2 80 58 
4 -18 °C toluene 78 45 
5 -18 °C Et2O 75 33 
6 -18 °C THF 79 31 
7 0 °C CHCl3 81 60 
8 0 °C DMF 85 0 
 
We then investigated the role of the amide functionality in the catalyst by running the 
reaction in CH2Cl2 at 0 °C, using the designed compounds as catalysts at 10 mol% loading 
(Table 2).  In general, reduction of imin-1 with HSiCl3 using different synthesized compounds 
as catalysts except 116 and 117, gives the corresponding product in good to high yields.  
Variation of the molecular size of the amide functionality in catalysts had a dramatic effect on 
the stereochemical outcome.  The enantioselectivites increased when the substituents changed 
from cyclohexane to diamantane (Table 2, entries 1–3), however, catalyst 107 with 1-amino 
triamantane was found to be slightly less efficient, affording the product in lower yield with 
65% ee (Table 2, entry 5), indicating the importance of steric interaction between the amide 
functionality and substrate for the reaction outcome.  Catalysts involving one more chiral 
centers proved to be generally inefficient in achieving higher enantioselectivities.  The 
conformation of α-position in proline is crucial for the absolute configuration of the 
corresponding product (Table 2, entries 8 and 9, 10 and 11).  “Six ring” activators 1,3-
dicarbonyl formamides 116 and 117 proved to be sluggish catalysts, which suggest that the 
proposed simultaneous coordination of two carbonyls with one silyl group may be not correct 
(Table 2, entries 17 and 18).  Interestingly, catalyst 114 derived from L-pipecolinic acid and 
1-amino admantane gives the product in racemic form (Table 2, entry 12).  According to the 
literature reported, N-formamide catalysts derived from L-pipecolinic acid exhibited 
significantly higher reactivity and selectivity than its congener derived from L-proline.[190]  
This unexpected phenomenon prompted me to investigate the optical purity of L-pipecolinic 
acid, which is exactly the same optical activity as reported.  The search for more proofs is still 
in progress, which may help in gaining insight into the mechanism.  In addition, the reaction 
for the reduction of imines using reported catalysts 73 and 76 can be repeated (Table 2, entries 
14 and 15). 
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Table 2.  Catalyst Screening of Reduction of 98 with Trichlorosilane.a 
Ph
N
Ph HSiCl3 (2.0 equiv)
Cat (0.1 equiv)
CH2Cl2, 0 °C
Ph
HN
Ph
*
98 99  
entry catalysts solvent yield (%)b ee (%)c configd 
1 103 CH2Cl2 79 42 R 
2 104 CH2Cl2 85 67 R 
3 105 CH2Cl2 81 68 R 
4 106 CH2Cl2 78 60 R 
5 107 CH2Cl2 52 65 R 
6 108 CH2Cl2 87 65 R 
7 109 CH2Cl2 83 61 R 
8 110 CH2Cl2 78 28 R 
9 111 CH2Cl2 78 45 S 
10 112 CH2Cl2 70 30 R 
11 113 CH2Cl2 76 15 S 
12 114 CH2Cl2 80 0 - 
13 115 CH2Cl2 89 54 R 
14 76 CH2Cl2 82 86 S 
15 73 CH2Cl2 91 95 S 
16 118 CH2Cl2 82 30 S 
17 116 CH2Cl2 43 0 - 
18 117 CH2Cl2 39 0 - 
a The reaction was carried out on a 0.2 mmol scale with 10 mol% loading of catalysts and 2 
equivalent of HSiCl3 in CH2Cl2 at 0 °C.  b Yield of isolated product.  c Determined by chiral 
GC analysis and HPLC.  d Absolute configuration was referred to literature.[185] reported. 
 
Structure features 
 
1H-NMR spectroscopy shows that all the N-formamide catalysts are mixtures of trans- and 
cis-isomers (Scheme 8). We found that the value of Ktrans/cis, as determined by 1H-NMR 
spectroscopy, is actually >1 in CDCl3.  Two main factors may be considered to be 
determinant of the preference of the N-formyl group in trans-conformation.[261]  
Hyperconjugative delocalization of a nonbonding pair of electrons (n) from the formyl 
oxygen to the C–O bond is the most well-known factor in stabilizing molecular conformation.  
The intramolecular hydrogen bonding between amide and N-formyl oxygen can not be ruled 
out.  Analysis of the ROESY NMR gives further information about the conformations (Fig. 1).  
Correlation between formyl-H and C5-CH2 represents the existence of trans isomer, while the 
correlation between formyl-H and C2-CH means the cis isomer. 
N
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HN R
N
O
O
HN R
H
Ktrans Kcis
Ktrans/cis
 
Scheme 8. Catalyst conformations. 
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Fig. 1. ROESY spectrum of compound 105. 
 
Mechanistic consideration 
 
The reduction of imin-1 with HSiCl3 in the presence of catalysts 104, 114, and 115 afforded 
99 in high yield with 67% ee, 0, and 53% ee respectively, and the product catalyzed by 104 
had opposite configuration to that catalyzed by 115, even the configuration of the catalyst was 
identical.  Interestingly, no ee was observed with catalyst 116.  These results suggest that the 
enantiodifferentiation steps for proline-, pipecolinic acid-, and valine-derived catalyst are 
different. 
Since no mechanism details on this reaction were known at this stage, which provides 
difficulties in rational design and development of efficient catalysts.  Malkov and co-workers 
proposed a possible mechanism based on their empirical experience.[188]  However, the 
inferiorities of catalysts 116 and 117 revealed for the first time that the assumption of 
coordination of two amide groups with HSiCl3 as donors may not be correct.  An intensive 
study on the mechanism was performed by means of experimental and computer methods 
(note: the part of chemical calculation was being performed by Dr. Parham Rooshenas).  To 
probe the mechanism for this reaction, a “six ring” transition state was firstly proposed, in 
which DMF was regarded as proton transporter and HSiCl3 as proton donor (Figure 1).  The 
reduction of 98 was performed as before in the presence d1-DMF as catalyst.  No deuterated 
product 99 was determined either in 1H-NMR or GC-MS.  It indicates that this type of “six 
ring” transition state may be ruled out. 
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Figure 2. Proposed “six ring” proton transporter. 
 
The chemical calculation by Dr. Parham Rooshenas so far proposed a “seven ring” 
transition state using N-methyl formamide as stoichiometric catalyst (Figure 3).  The imine 
was stabilized and reduced by a hypercovalent silicate formed between catalyst and HSiCl3.  
More proofs are still needed to confirm this hypothesis, such as kinetic and NMR studies. 
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Figure 3. Proposed transition state by chemical computation. 
 
In addition, in the 1H-NMR spectrum of a 1:2 mixture of catalyst 104 and HSiCl3, shift of 
~0.1 ppm to downfield was only observed for the corresponding signal of the formamide 
proton in cis conformation, no formamide proton shift was found for trans conformation, 
suggesting that cis conformation of proline-derived catalysts may play a crucial role in 
promoting the reduction with HSiCl3 (Fig. 4).  All these features observed do show that the 
proposed transition state in literature should be improved.  Further efforts will focus on 
elaboration of the mechanism and development of more efficient catalysts. 
 
5.56.06.57.07.58.08.5 ppm
104
 
 
5.56.06.57.07.58.08.5 ppm
104+HSiCl3 (1:2)
 
Fig. 4. Determination of reaction intermediate by 1H NMR. 
Chapter 3   Organocatalytic Reductions 
 
75 
Summary and outlook 
 
We have designed a series of novel chiral organocatalysts derived from proline, valine, and 
pipecolinic acid for asymmetric reduction of ketimine with HSiCl3 to afford the 
corresponding secondary amine.  The enantioselectivity up to 68% ee was observed in the 
presence of catalyst 105 formed by N-formyl-L-proline and 1-aminodiamantane.  Variety in 
catalyst structures clearly demonstrated determinant role of amino acids scaffold for the 
action mode in enantiodifferentional step.  The preliminary mechanism studies showed quite 
different feature as in the literature.  Further work will be directed to elaborate the mechanism 
aspects and develop more efficient catalysts. 
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Chapter 4 Development of Thiourea-Catalyzed Cyanosilylation 
 
 
Introduction 
 
Cyanohydrins are of synthetic interest as they may be elaborated into a number of key 
functional groups, including α-hydroxyacids, β-hydroxyalcohol, and other valuable building 
blocks.[200, 201]  Hydrogen cyanide (HCN) is the most commonly industrially used reagent for 
cyano transfer to carbonyl compounds.[202]  However, due to its toxicity and difficulty in 
handling, new methods have been developed to substitute HCN with other potentially less 
harmful and yet easily manageable reagents.   
Trimethylsilyl cyanide (TMSCN) is widely used as a cyanide source with various catalysts.  
The use of TMSCN allows the desired cyanohydrin to be prepared directly as the 
corresponding trimethylsilyl ether.  The stability of the TMS adduct, conferred by an 
energetically favourable Si-O bond, prevents the reverse cyanation reaction from occurring 
and hence removes a potential pathway for racemization.  In 1973, Evans and Sundermeyer 
and their co-workers are among the first to report the addition of TMSCN to aldehydes, 
ketones, and acid chlorides catalyzed by thermal and Lewis acid respectively.[203, 204]  Since 
then, a multitude of different catalysts has been reported in the literature for both the racemic 
and asymmetric addition of the cyanide to carbonyls.[200, 205, 206]   
Generally, in the absence of a catalyst, no reaction is observed between TMSCN and 
carbonyl compounds.  Consequently, a variety of activators or promoters have been reported 
for the cyanation of carbonyl compounds with TMSCN including Lewis acids, Lewis bases, 
peptides and enzymes.  In recent years, Shibasaki and co-workers developed Lewis acid-
Lewis base bifunctional catalysts for the enantioselective addition of TMSCN to 
aldehydes.[262]  However, in view of environmental benign pressures, organocatalysts and 
heterogeneous catalysts have received great attention in recent years.[12]  Among of them, 
Jacobsen and Fuerst reported a significant new example of thiourea catalysis in the highly 
enantioselective cyanosilylation of ketones and aldehydes with a bifunctional thiourea-amine 
derivative.[93]  Ishihara and co-workers reported chiral lithium binaphtholate was efficient 
catalyst for the asymmetric addition of TMSCN to aldehydes.[246]  All of these developments 
have significantly advanced the frontier of enantioselective cyanohydrin synthesis. 
In view of our continuing interest in the use of thiourea derivatives for asymmetric 
transformations, we undertook the development of bifunctional catalysts bearing thiourea 
moieties and lithium phenolate in one chiral modular molecule.  Herein, we described the first 
example of chiral thiourea bearing oxygen anion as bifunctional catalyst for asymmetric 
cyanosilylation of ketones.  
 
 
 
Chapter 4   Development of Thiourea-Catalyzed Cyanosilylation 
 
77 
Results and discussion 
 
Catalyst design and synthesis 
 
As we started the program on thiourea catalyzed asymmetric cyanosilylation in 2004, there 
was only one report on nucleophilic addition of TMSCN to nitrones catalyzed by thiourea 5 in 
Takemoto group (Scheme 1).[48] 
N
O
TMSCN (5 eq)
5 (0.5 eq), CH2Cl2
–78 °C
HCl
MeOH N CN
OH NH
N
H
CF3
CF3
CF3
F3C
S
5
 
Scheme 1. Thiourea-catalyzed nucleophilic addition of TMSCN to nitrone. 
 
Besides this application, thiourea 5 has also proven to be an active Lewis acid-like catalyst 
in promoting Diels-Alder reaction through cooperative hydrogen bonding interaction with 
unsaturated 1,3-diketones (Scheme 2).[41, 45, 263]   
                       
O
i-Pr
O
N N
CF3
F3C
CF3
CF3
S
H H
5
                           
        Scheme 2a. Proposed system                                 Scheme 2b. Computed system 
 
Inspired by the general ability for activation of a series of functionalities by thiourea 
derivatives via a double hydrogen bonding “clamp”, we set out to design second-generation 
chiral thiourea derivatives for asymmetric cyanosilylations, in which chiral oxazoline moieties 
are used as stereogenic center and placed much close to the binding site.  On the basis of this 
strategy, various oxazoline based thiourea derivatives 128 were prepared in a straightforward 
route (Scheme 3).   
NH2
CN
ZnCl2, PhCl
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H2N OH
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NH2
O N
F3C
F3C
NH2
CSCl2, THF, Et3N
-15°C
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H
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CF3
O N
R1 = H, 3,5-di-CF3,
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132 133
128R2
R1
R1
R2
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Scheme 3. Synthetic routes to oxazoline thiourea organocatalysts. 
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The oxazoline derivatives 131 can conveniently be synthesized through zinc-catalyzed 
condensation of 2-aminobenzonitrile or 4,6-ditrifluromethyl-2-aminobenzonitrile 129 with 
chiral amino alcohols 130 that are readily accessible form the respective (natural) amino 
acid.[264]  Coupling compounds 131 with isothiocyanato-3,5-ditrifluoromethylbenzene gives 
the desired products 128 in considerably yields.  For purification of the intermediates and 
final products please refer to the experimental section.  As we had proposed, one of the 
thiourea N–H hydrogens resonates at much lower field in the NMR spectrum (>12.5 ppm), 
indicating the desired hydrogen-bond interaction between N–H hydrogen and lone pair 
electron of nitrogen in oxazoline ring.   
In order to increase the N–H hydrogen donor properties, electron deficient 4,6-
ditrifluoromethyl-2-aminobenzonitrile 134 was prepared by a known method (Scheme 4).  
Treating 1-nitro-3,5-ditrifluoromethylbenzene with EtO2CCH2CN, KOH, as well as KCN in 
DMF followed by aqueous workup affords the crude product, which was further purified by 
column chromatography with chloroform as eluent.[265]  For details refer to experimental 
section. 
NO2F3C
CF3
+ EtO2CCH2CN
KOH, KCN
DMF
NH2F3C
CF3
CN
134  
Scheme 4. Synthesis of 4,6-ditrifluoromethyl-2-aminobenzenonitrile. 
 
Chiral amino alcohols were obtained through reduction of natural amino acid with NaBH4-
I2 mixture in THF as reported in literature,[266] in the exception of (S)-2-amino-propanol using 
LiAlH4 as reductant.[267]  Although 3,5-ditrifluoromethylbenzylisothiocyanate is commercially 
available, a modified method was carried out in our group by dropwise addition of  the cold 
and diluted solution of 3,5-bifluoromethylaniline CSCl2 at about –15 °C.  All newly 
oxazoline-based thiourea derivatives are listed in Table 1. 
 
Table 1. List of oxazoline-based thiourea derivatives 128.[a] 
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[a] For experimental details, please refer to the experimental section. 
 
In a first set of experiments, catalytic efficiency of these novel thiourea derivatives was 
tested in the addition of TMSCN to benzaldehyde, the results are depicted in Scheme 5. 
H
O
+ TMSCN
cat. (10 mol%)
CH2Cl2, rt, 24 h
H
TMSO CN
with 5: 76% yield
with128a–128i: 0  
Scheme 5: Cyanosilylation of benzaldehyde. 
 
These results showed that the designed novel thiourea derivatives displayed no catalytic 
activity in promotion of the addition of TMSCN to benzaldehyde.  In comparison, good yield 
can be obtained with thiourea 5 as catalyst.  Presumably the hydrogen-bond interaction 
between thiourea N–H hydrogen and lone pair electron of nitrogen in oxazoline ring 
dramatically decrease the binding ability of thiourea derivatives.  In addition, it was also 
revealed that the bidentate hydrogen bond binding is requisite for thiourea’s catalytic effect. 
The presence of basic functionalities for thourea-based catalysts is desirable for many 
reactions because they may synergistically activate both nucleophile and electrophile at an 
appropriate arrangement of transition state, giving rise to enantioselective outcome.  It should 
be noted that these basic sites should be placed in a way so that they can not effectively 
compete with the electrophile for binding to the thiourea clamp.  Our strategy involves the 
preparation of 4-N,N-dimehylaminopyridine (DMAP) based thiourea 135a, 135b, and 2,6-
diaminopyridine based thiourea 136.  The synthesis of these thiourea derivatives is shown in 
Scheme 6. 
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Scheme 6. Synthesis of 135a, 135b, and 136. 
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NH2N NH2
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CF3
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NH2N NH
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CF3
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Scheme 6. Synthesis of 135a, 135b, and 136. 
 
The synthesis of 135 started with bromination of DMAP, followed by amination under the 
homogeneous aminating conditions of KNH2 in NH3 (l), affording a mixture of 2-amino-4-
dimethylaminopyridine and 3-amino-4-dimethylaminopyridine.  The major product 2-amino-
4-dimethylaminopyridine was refluxed with isothiocyanate in ethanol to give the desired 
product 135a and 135b respectively.  The preparation of 136 was achieved by refluxing 2,6-
diaminopyridine with equimolar isothiocyanate 133.  135a, 135b, and 136 were tested as 
catalyst for the cyanosilylation of benzaldehyde with TMSCN in CH2Cl2 at room temperature.  
With a catalyst loading of 10 mol%, no conversion was observed within 24 h.  After we 
optimized other reaction parameters such as catalyst loading, temperature, and solvents, no 
conversion was detected, either.  A possible reason for this unexpected result may be the low 
nucleophilicity of aromatic amine functionalities or less of synergetic effect due to steric 
arrangement of amino- and thiourea-functionalities.  Both 135a and 135b were also tested in 
acylation of alcohol as acyl-transfer catalysts, but no conversion was determined (Scheme 7).  
The only catalytic effect of 135a was found in Michael addition of thiophenol to 2-
cyclohexenone (Scheme 8).  With a catalyst loading of 10 mol% of 135a, the product was 
obtained in 78% yield and 15% ee at room temperature.  After lowering the reaction 
temperature to –40 °C, no increase in enantiomeric excess was obtained. 
OH
Ph
+ Ac2O
cat (10 mol%)
CHCl3, NEt3
OAc
Ph
with DMAP: 100% yield
with 135a:        0
 
 
Scheme 7. Acylation of alcohol. 
O
+
SH 135a (10 mol%)
toluene, rt
O
S*
78% yield
15% ee
 
Scheme 8. Michael addition. 
 
Preparation of Jacobsen’s catalyst analogue. 
 
Jacobsen and co-workers have developed a series of urea- and thiourea-containing Schiff-base 
catalysts for various types of asymmetric reactions such as Strecker, Mannich, 
hydrophosphonylation, nitro-Mannich, and acyl-Pictet-Spengler reactions.[26]  Ishihara and co-
workers reported chiral lithium binaphtholate was efficient catalyst for the asymmetric 
addition of TMSCN to aldehydes.[246]  In accordance with these previous reports, we 
envisioned that catalyst 137b and 137c developed by Jacobsen group may serve as a 
bifunctional catalysts for cyanosilylation, when it was used in combination with a base 
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cocatalyst.  In addition, we also prepared a Jacobsen’s catalyst analogue 137a by exchanging 
the tertiary amide with more electron deficient thioureas (Scheme 9).  First we tried to prepare 
137a by reacting (R,R)-1,2-diaminocyclohexane with equimolar of isothiocyanate 133 
followed by addition of equimolar of 3,5-di-tert-butyl-2-hydroxybenzaldehyde or in contrary 
sequence, but both methods afforded only symmetric products such as bis-thiourea or bis-
Schiff base instead of the desired product.  We then protected one amino group with 
hydrochloride and then coupled with isothiocyanate 133, affording the crude intermediate 138, 
which can be further purified by column chromatography.  Treating 138 with K2CO3 solution, 
followed by refluxing with 3,5-di-tert-butyl-2-hydroxybenzaldehyde give product 137a in 
excellent yield.  For experimental details, please refer to experimental section. 
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Scheme 9. Synthesis of Jacobsen’s catalysts and analogue. 
 
Survey of efficient catalyst systems 
 
The asymmetric cyanation of ketones has been historically considered as problematic. Initial 
catalyst screening revealed that none of these chiral thiourea derivatives tested alone can 
catalyze the addition of TMSCN to acetophenone.  In light of these molecular scaffolds 
bearing phenol moiety, we envisioned that metal phenolate complex may promote the 
cyanation of ketone through Si-O bonding activation.  Therefore, systematic study was 
performed using 137a, 137b, and 137c as chiral scaffold and variable metalli bases as 
additives.  These results were shown in Table 2.  Interestingly, using Jacobsen’s catalysts 
137b and 137c in combination with various metalli bases, the product can be obtained in 
excellent yield with no enantioselectivity (Table 2, entries 2, 3, 5, 6, 8, 9).  Amongst others, 
with 137a and LiOH as catalytic system, product with ee up to 36% was obtained in high 
yield (Table 2, entry 4).  Ph3PO has been used by Ryu and Corey to convert TMSCN to a 
more reactive reactive cyanide donor, Ph3P(OTMS)(N=C:), in chiral oxazaborolidinium 
catalyzed cyanosilylation of adehydes and ketones.[244, 250]  Inspired by the previous reports, 
we applied Ph3PO as co-catalysts along with chiral thiourea derivatives for the cyanosilylaiton 
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of ketones.  After the reaction was run at room temperature for 60 h, no conversion was 
observed (Table 2, entries 15–17). 
 
Table 2. Survey of catalytic systems on the asymmetric addition of TMSCN to 
acetophenone.a 
 
Ph CH3
O
+ TMSCN Cocatalysts (20 mol%)
Ph CH3
TMSO CN
Catalyst (20 mol%)
CH2Cl2, rt  
a The reaction was carried out on a 0.1 mmol scale with 20 mol% catalyst 4.11, 20 mol % 
cocatalyst and 1.2 eq TMSCN at room temperature.  b Yield of isolated product.  c Determined 
by chiral GC analysis.  d 10 mol% of catalysts and cocatalysts were used. 
 
Survey of n-BuLi as catalyst 
 
Although the combination of n-BuLi and thiourea derivatives showed appreciable catalytic 
activity, there was no asymmetric induction, presumably the catalytic effect is ascribed from 
the metal specie.  n-BuLi alone was then assessed as catalyst at 10 mol% loading and it is 
interesting of note that the quantitative conversion of acetophenone was observed with TLC 
and GC-MS.  To our knowledge, there is so far no report on n-BuLi catalyzed cyanosilylation.  
Two possible catalytic cycles were proposed, one mechanism cycle is that n-BuLi itself acts 
as nucleophilic catalyst, that is, the formed TMSCN and n-BuLi complex serves as active 
Entry Catalyst Cocatalyst T 
(℃) 
Time 
(h) 
Conversionb 
(%) 
ee(%)c 
1 137q n-BuLi r.t 15 100 0 
2d 137b n-BuLi r.t 15 100 0 
3d 137c n-BuLi r.t 15 100 0 
4 137a LiOH r.t 15 80 36 
5d 137b LiOH r.t 15 100 0 
6d 137c LiOH r.t 15 100 0 
7 137a LiOPri –20 °C 15 97 11 
8d 137c LiOPri –20 °C 15 94 0 
8 137a LiOH·H2O –20 °C 15 21 0 
9d 137c LiOH·H2O –20 °C 15 79 4 
10 137a KOH r.t 60 trace - 
11 137a NaOH r.t 60 9 0 
12 137a CaH r.t 60 63 6 
13 137a NaH r.t 60 32 7 
14 137a NaOMe r.t 60 35 7 
15d 137a Ph3PO r.t 60 0 - 
16d 137b Ph3PO r.t 60 0 - 
17d 137c Ph3PO r.t 60 0 - 
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species and cyano transfer to acetophenone led to the lithium salt, which then reacted with 
trimethyl-n-butylsilane affording the corresponding product (Figure 1).  However, the 
regeneration of n-BuLi through the reaction of lithium salt with silane under common 
conditions is forbidden due to the high energy consumption.  Thus, another catalytic cycle 
was proposed as Figure 2, the lithium enolate salt arising from the reaction of acetophenone 
with n-BuLi works as the active catalyst, which activates TMSCN and thus promote cyano 
transfer to acetophenone giving the corresponding product and regenerating the active 
catalytic specie.  The latter appears more plausible but needs to be verified by further 
investigation. 
 
Si
Bun
CN
Li
Ph
O
Ph
NC OLi
+ Bun
Ph
NC OSiMe3
Me3SiCN
n-BuLi
–Me3Si
  
Figure 1. Proposed catalytic cycle 1.    
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Figure 2. Proposed catalytic cycle 2. 
 
Summary 
 
Despite the low reactivity of chiral thiourea derivatives alone for cyanosilylation of ketones, it 
was revealed for the first time that one molecular bearing a thiourea functionality and 
phenolate in a chiral scaffold can act as a bifunctional organocatalyst for cyanosilylation of 
ketones, yielding the product with up to 36% ee.  In addition, n-BuLi was found to be an 
effective catalyst for the cyanosilylation of ketones.  Moreover, plausible mechanism is also 
proposed for cyanosilylation of ketone catalyzed by n-BuLi based on empirical experiment.   
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Introduction 
 
Optically active α-amino phosphonic acids serve as isosteric or bio-isosteric analogues of the 
corresponding amino acids, in which the planar and less bulky carboxylic acid group is 
replaced by a tetrahedral phosphoric acid functionality.  α-Amino phosphonic acids and short 
peptides bearing the functionalities display interesting biological and biochemical properties 
giving rise to antibacterial and antifungal agents, a wide range of proteolytic enzyme 
inhibitors, and haptens for catalytic antibodies.[268-271]  Therefore, this class of compounds has 
received considerable attention and resulted in intense efforts directed towards the 
development of suitable synthetic methodologies for their preparation.  The addition of 
phosphites to imines (hydrophosphonylation) is probably the most general and direct 
approach to α-amino phosphonates.  Generally, these transformation can be promoted by an 
alkali metal alkoxide or acids.[272, 273]  NaOEt has been mainly used for this purpose since the 
pioneering work of Pudovik[274] and Lewis acids such as SnCl2, SnCl4, and BF3•Et2O have 
also found to be effective.[275]  However, satisfactory yields can not be achieved using these 
reagents or catalysts.  Although the yields can be strongly improved in the catalysis of ZnCl2 
or MgBr2, one-pot operation with a carbonyl compound, amine, and dialkyl phosphite can not 
be carried out because the presence of amines and water can decompose or deactivate these 
Lewis acids.[276]  After the first one-pot synthesis of α-amino phosphonates in the presence of 
lanthanide triflates/MgSO4,[277] a variety of reagents or catalysts involving InCl3[278], 
In(OTf)3[279], TaCl5/SiO2[280], ZrCl4[281], GaI3[282], BiCl3[283], LiClO4[284], SmI2[285], 
Na2CaP2O7[286], YbCl3[287], Mg(ClO4)2[288, 289]and surface mediated reactions on Al2O3[290, 291] 
have been developed for this transformation.  In view of today’s environmental consciousness, 
there is still a need to develop efficient, practically potential and environmentally benign 
methodologies.  Ionic liquid turned to be promising medium for such three-component 
couplings.[292, 293]  Recent advances in organocatalysis have so far provided alternatives for 
enantioselective preparation of α-amino phosphonates.[57, 294, 295]  Ranu and co-workers 
reported a simple one-pot three-component synthesis of α-aminophosphonates through 
condensation of carbonyl compound, amine, and diethylphosphite at 75–80 °C under neat 
conditions without any solvent and catalyst.[296] 
We took these ideas together and set out to investigate this one-pot transformation 
focusing mainly on two aspects: 1) could this transformation be catalyzed by some other 
novel thiourea derivatives? 2) is this type of transformation autocatalytic reaction?  Herein, 
we disclose that the reaction of aldehydes, amines, and diethyl phosphate proceeds smoothly 
under solvent- and catalyst-free conditions without heating affording the corresponding α-
aminophosphonates at high yields.  In addition, some key elements for rate acceleration were 
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also demonstrated through dynamic study on reaction procedure, which may provide insights 
into the reaction mechanism.  In most cases, phosphonates have been used as P-nucleophiles.   
 
Results and Discussions 
 
Inspired by the successful application of thiourea Schiff-base derivatives as organocatalysts 
for hydrophosphonylation of imines, we envisioned that electron-poor thiourea derivatives 
developed in our group may promote the nucleophilic addition of phosphites to imines 
mediated through hydrogen bonding activation.  To test our proposal, representative reaction 
was performed between imines (139a or 139b) and diethyl phosphite in the presence of 
thiourea derivatives 5, 128d, or 137a (10 mol%) in THF at room temperature (Scheme 1).  
Surprisingly, the control reaction proceeded even faster than the one in the presence of 
thiourea derivatives, though poor conversions were observed in all reactions (<10%).  After 
optimization of reaction conditions, it was found that the reaction proceeds smoothly to afford 
the corresponding α-amino phosphate 140a in high yield (89%) under neat conditions without 
solvent and catalysts.  The completion of this reaction can be easily determined by 
visualization as the reaction mixture is solidified.   The product can be purified through 
recrystallization from mixture of ethyl acetate and hexane according to the procedure 
reported.[296]  This avoids use of large quantities of volatile solvents usually required for 
work-up and purification in many existing procedures.  On the other hand, no catalyst used in 
this process make easier waste disposal.   
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Cat. (10 mol%)
THF, rt Ph P
HN
R
O
EtO OEt
140139a: R = Ph
139b: R = Boc < 10% yield  
Scheme 1. Thiourea-catalyzed hydrophosphonylation. 
 
These results led us to pose the question of whether the product itself is the catalyst for 
this reaction, namely autocatalysis.  If the autocatalysis is true, the graph for these reactions 
should be a sigmoid curve, that is, the rate of reaction increases progressively as the amount 
of catalysts increases and it again slows down as the reactant concentrations decreases.  We 
first initiate a dynamic study monitored by GC using n-dodecane as internal standard.  
Unfortunately, it is difficult to measure the ratio between reactants and n-dodecane, since n-
dodecane is insoluble in the reaction mixture.  As we know, the reaction sparingly proceeds in 
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the solvents without the addition of catalysts.  We then run this reaction parallel using the 
solution of n-dodecane in EtOAc as external standard to quench the reaction at specific time 
and monitored by GC. These results are depicted as graph 1.  The reaction procedure has 
mainly two stages.  The reaction rates increased dramatically from 30 min to 60 min and from 
180 min to 250 min respectively. The reaction was reversible as the product will decompose 
to reactants at extending the reaction time after 5 h.  In addition, it was also found that the 
amount of diethyl phosphite influences the reaction rate since the reaction proceeded 
dramatically faster with a small excess of diethylphosphite (6 h) than substoichiometric 
diethyl phosphite (15 h).  
 
Graph 1. Dynamic study on the reaction procedure between benzylideneaniline 139a and 
diethyl phosphite. 
 
Although the reaction between benzylideneaniline and diethyl phosphate did not show 
automatic effect, we turned our attention to another reactant N-Boc-imine (139b).  The origin 
of the homochirality of biomolecules (e.g., amino acids and carbohydrates) is still puzzling.  It 
is still not clear how these generally small enantiomeric excesses could have been amplified 
under prebiotic conditions.  As an analogue to amino acids, α-phosphoric acids cause our 
attention to be investigated for help to explain this interesting phenomenon.  An initial 
experiment was carried out to prepare 140b at different enantiomeric excesses by known 
method (Scheme 2) and then employ 140b as catalyst for the addition of diethylphosphite to 
N-Boc-Imine 139b.  Independent of the addition amount of product 140b, the isolated 
products were almost the same amount and the ee were varied with the addition amount of 
enantiomeric enriched product.  It was demonstrated that the product 140b has probably no 
influence on the outcome of this reaction.  These results were recorded in Table 1. 
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Xylenes, -20 °C
140b
85% ee  
Scheme 1. Preparation of enantiomeric enriched 140b. 
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Table 1. Investigation of autocatalysis. 
P
HN
Boc
O
OEt
OEt
H
N
Boc
139b
+ HP(O)(OEt)2
xylenes, -20 °C
140b
140b
 
 
Conversiona* (%) entry Catalyst loading 
(mol%) 18 h 40 h 
yield (%)b ee (%)c 
1 30 35 64 3 60 
2 20 52 93 6 56 
3 10 45 63 21 28 
4 1 62 72 27 11 
a Conversion was determined by GC (n-dodecane as internal standard). b Yield after 
subtraction of the initially added product catalyst. c Enantioselectivities was determined by 
chiral HPLC (Chiralpak AD-H). * Only rough value because of the instability of the educt.  
 
From a synthetic point of view, we wonder that imines, generated in situ from aldehydes 
and amines, may immediately react with phosphites to afford α-amino phosphonates in one-
pot way under neat conditions without solvent and catalysis.  The reaction of benzaldehyde, 
aniline, and diethyl phosphite took place smoothly affording the desired α-amino 
phosphonates in 83% yield after 6 h at room temperature under neat conditions.  A wide 
variety of structurally diverse aldehydes and amines were subjected to this procedure and 
converted into the corresponding α-amino phosphonates in high to excellent yields.  The 
results are summarized in Table 2.  This procedure is equally effective for conversion of 
open-chain, heterocyclic, cyclic and aromatic aldehydes.  The presence of electron-
withdrawing or electron-donating substituents on the aromatic ring did not show obvious 
influence on the course of the reaction. 
 
Table 2. One-pot synthesis of α-amino phosphonates under neat conditions. 
R H
O
+ + HOP(OEt)2
rt, neat
P
HN
Ph
OEt
OEt
O
R1
PhNH2
 
entry R time (h) yield (%)a 
1 Ph 6 89 
2 4-NO2Ph 4 86 
3 4-BrPh 6 82 
4 4-OHPh 6 78 
a yield of isolated product. 
 
In general, three-component reaction of aldehydes, amines, and diethylphosphite 
proceeded smoothly to afford the corresponding α-amino phosphonates under neat conditions 
without the involvement of any catalyst and solvent.  The present procedure provides a very 
simple, efficient, and cost-effective methodology.  Systematic dynamic study and 
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enantioselective reaction using product itself as additive have clearly excluded the possible 
autocatalysis.  In addition, diethylphosphite was found to play important role in the 
acceleration of reaction rate, though the real features of diethylphosphite are still needed to be 
investigated.  
 
General experimental procedure 
 
A mixture of aldehyde, amine, and diethyl phosphite was stirred at room temperature under 
neat conditions.  After completion of the reaction as indicated by TLC and GC-MS, the solid 
ones were recrystallized from mixture of ethyl acetate and hexane (4:1) and the liquid 
products were isolated by direct distillation under reduced pressure.  All the products are 
known compounds and the characterizations of these compounds are identical with the 
literature reports. 
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As introduced in this thesis, a series of novel chiral thiourea derivatives were firstly designed 
and synthesized, and their potential applications as organocatalysts were investigated in 
several fundamentally important transformations, such as transfer hydrogenation of imines, 
biomimetic reduction of nitroolefins, cyanosilylation of ketones, as well as 
hydrophosphonylation of imines.  
Inspired by the general activation ability of thiourea derivatives via a double hydrogen 
bonding “clamp”, one class of chiral thiourea derivatives were designed by incorporation of 
chiral oxazoline moieties closely into the binding site.  On the basis of this strategy, various 
oxazoline based thiourea derivatives were prepared in a short and straightforward route 
(Scheme 1).  Unfortunately, no catalytic effects were observed in all test reactions, 
presumably due to the competitive intramolecular hydrogen-bond interaction.   
NH2
CN
ZnCl2, PhCl
36 h, reflux
H2N OH
R2
NH2
O N
F3C
F3C
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F3C
F3C
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N
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CF3
CF3
O N
R1 = H, 3,5-di-CF3,
R2 = H, methyl, i-propyl, 
2-butyl, t-butyl, benzyl
129
130
131
132 133
128R2
R1
R1
R2
R1
 
Scheme 1. Synthesis of oxazoline-based thiourea derivatives. 
 
The presence of basic functionalities for thiourea-based catalysts is desirable for many 
reactions because they may synergistically activate both nucleophile and electrophile at an 
appropriate arrangement of transition state, giving rise to enantioselective outcome.  Our 
strategy involves the preparation of DMAP based thiourea 135a, 135b, and 2,6-
diaminopyridine based thiourea 136.  The catalytic effect was only found in Michael addition 
of thiophenol to 2-cyclohexenone.  With a catalyst loading of 10 mol% of 135a, the product 
was obtained with 15% ee.   
N
N
N
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N
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135a     
N
N
N
H
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N
H
135b     
NH2N NH
N
H
S
CF3
CF3
136  
Scheme 2. Bifunctional thiourea derivatives. 
 
Besides the preparation of Jacobsen’s catalysts 137b and 137c, we also prepared a 
Jacobsen’s catalyst analogue 137a by exchanging the tertiary amide with more electron 
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deficient thioureas (Scheme 3).  It was revealed for the first time that one molecular bearing a 
thiourea functionality and phenolate in one chiral scaffold can act as a bifunctional 
organocatalyst for cyanosilylation of ketones, yielding the product with up to 36% ee.  In 
addition, n-BuLi was found to be an efficient substoichiometric initiator for the 
cyanosilylation of ketones. 
N
H N
N
H
S
CF3
F3C
HO
t-Bu t-Bu
137a
N
H
N
O
S
N
H N
137b
HO
t-Bu t-Bu
N
H
N
O
N
H
S
N
137c
 
Scheme 3.  
 
Thiourea-catalyzed transfer hydrogenations with Hantzsch ester as the hydrogen source 
were reported.  On the question of some of the published literature protocols, we present a 
practical method for the thiourea-catalyzed reduction of aromatic as well as aliphatic 
aldimines with a Hantzsch ester as the hydrogen source.  The loadings of catalyst 5 as low as 
0.1 mol% is sufficient for this transformation. 
A thiourea-catalyzed biomimetic reduction of conjugated nitroalkenes has been developed.  
Various aromatic and aliphatic conjugated nitroalkenes can be reduced to give the respective 
nitroalkanes with good yields under mild conditions.  This protocol is not only practical, but 
may also provide insight into the mechanisms of redox transformations in biological systems. 
In addition, some other efforts concerned with the in situ regeneration of Hantzsch ester, 
development of chiral ammonium salts as potential catalysts, as well as search for other 
hydrogen sources were also investigated. 
Since the newly designed thiourea-based catalysts were generally inefficient for the 
promotion of reduction with trichlorosilane, various novel chiral N-formamides derived from 
proline, valine, and pipecolinic acid were developed for the asymmetric reductions of 
ketimines using trichlorosilane as the hydrogen donor.  The enantioselectivity up to 68% ee 
was so far obtained.  The preliminary mechanism studies showed quite different feature as 
described in the literature.  Further work will be directed to elaborate the mechanism aspects 
by means of experimental and computational methods and develop more efficient catalysts. 
Thiourea-catalyzed addition of diethyl phosphite to imines was also investigated.  
Generally, no catalytic effects were observed for our designed thiourea derivatives.  In 
contrast, three-component reaction of aldehydes, amines, and diethylphosphite proceeded 
smoothly to afford the corresponding α-amino phosphonates under neat conditions without 
the involvement of any catalyst and solvent.  Dynamic study and enantioselective evaluation 
with product itself as additive have clearly excluded the possibility of autocatalysis.   In 
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addition, diethylphosphite was found to play an important role in the reaction rate, though the 
real features of diethylphosphite are still needed to be investigated. 
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7.1 Chemicals and solvents 
 
Chemicals 
 
Unless otherwise noted, chemicals were purchased from commercial suppliers (Acros, 
Aldrich, Fluka, Lancaster, or Merck) and were used without further purification.  
2,6-diaminopyridine and p-anisidine were purified by sublimation.  1-aminodiamantane 
and 4-aminodiamantane were prepared by Dipl.-Chem. Hartmut Schwertfeger.  1-
Aminotriadmantane was prepared by Anika Merz. 
 
Solvents 
 
Solvents for chromatography, recrystallization, and reaction workup were of technical grade 
and were distilled prior to use.  Dry Solvents were prepared in the following manner: 
 
Table I. Preparation of dry solvents 
 
entry solvent dry conditions 
1 THF predried with KOH and then distilled over 
sodium/benzophenone suspension under argon 
2 CH2Cl2 
predried with CaCl2 and then distilled over phosphorous 
pentoxide under argon 
3 toluene predried with CaCl2 and then distilled over phosphorous 
pentoxide under argon 
4 benzene distilled over sodium/benzophenone suspension under argon 
5 diethyl ether predried with CaCl2 and distilled over 
sodium/benzophenone suspension under argon 
6 CHCl3 distilled over phosphorus pentoxide under argon 
7 DMF distilled from calcium hydride under argon and stored over 4 
Å MS 
8 1,4-dioxane predried with KOH and then distilled from 
sodium/benzophenone suspension under argon 
9 CH3OH 
predried with sodium and distilled over magnesium under 
argon and stored over 4 Å MS 
10 xylenes predried with CaCl2 and then distilled over phosphorus 
pentoxide 
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General procedures 
 
All reactions involving air sensitive chemical were performed under an argon atmosphere.  
Glassware was heated in vacuo with heating gun or in oven and subsequently purged with 
argon.  Plastic syringes with steel cannulae were used to transfer air and moisture sensitive 
liquids.  Column chromatography was conducted using J. T. Baker silica gel (particle size 
0.063–0.200 mm), or for flash chromatography, Merck silica gel 60 (particle size 0.040–0.063 
mm).  Solvent mixtures are understood as volume/volume.  For thin-layer chromatography 
(TLC), silica gel plates coated aluminium plates (Merck, silica gel 60 F254) were used and 
chromatograms were visualized by iodine or irradiation with UV light at 254 nm.   
 
7.2 Instrumentation and methods 
 
NMR spectroscopy 
 
Proton nuclear magnetic resonance (1H NMR) spectra and carbon nuclear magnetic resonance 
(13C NMR) were recorded on a Bruker AM 400, 200, or 600 spectrometer at 298 K in 5 mm 
NMR tubes.  The chemical shifts (δ values) were obtained in deuterated solutions unless 
otherwise noted and referenced to respective solvent or TMS residual signals.  Data are 
presented as follows: chemical shift, integration, multiplicity (br = broad, s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, cm = complex multiplet) and coupling constant 
in Hertz (Hz). 
 
IR spectroscopy 
 
Infrared (IR) spectra were obtained using a Bruker IFS25 or IFS48 spectrometer.  The 
measurements were carried out on a film between two plates of KBr for liquids and KBr 
pressing for solids.  Data are represented in terms of frequency of absorption     (cm–1) and 
intensity of absorption (s = strong, m = medium, w = weak).  
 
GC-MS  
 
GC-MS analyses were carried out with a Quadrupol-MS HP MSD 5971 (EI) detector and HP 
5890A gas chromatograph equipped with a J & W scientific fused silica GC column (30 m × 
0.250 mm, 0.25 micron DB-5MS stationary phase: 5% phenyl and 95% methyl silicone) using 
He as carrier gas; T-program standard 60–250 °C (15 °C/min heating rate), injector and 
transfer line 250 °C. 
 
HRMS 
 
High resolution mass spectroscopy (HRMS) was recorded on a Thermo Finnigan MAT 95 
sectorfield spectrometer.  
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Elemental analysis 
 
Elemental analyses were performed on a Carlo Erba 1106 CHN analyzer. 
 
Optical rotations 
 
Optical rotations were measured using a 5 mL cell with a 1 dm path length on a Jasco P-2000 
digital polarimeter. 
 
Melting points 
 
Melting points were measured on a Bunsen burner melting point apparatus and were not 
corrected. 
 
Chiral HPLC  
 
Chiral high performance liquid chromatography (HPLC) analyses were performed on a 
Dionex machine using Diacel Chiralcel OD-H, Chirapak IA, IB, or Nucleocell Delta column. 
2-phenyl-1,2,3,4-tetrahydroquinoline (102): Nucleocell Delta, 254 nm, hexane/isopropanol 
60:40, flow rate 1.0 mL/min, tR1 = 6.64 min, tR2 = 8.38 min. 
N1-(1-phenylethyl)aniline (99): Chiracel OD-H, 254 nm, hexane/isopropanol 99:1, flow rate 
1 mL/min, tR1 = 11.7 min, tR2 = 14.5 min; Chirapak IB, 254 nm, hexane/isopropanol 98:2, 
flow rate 0.7 mL/min, tR1 = 9.7 min, tR2 = 10.9 min 
N1-(1-phenylethyl)-4-methoxyaniline: Chirapak IB, 254 nm, hexane/isopropanol 98:2, flow 
rate 0.6 mL/min, tR1 = 14.9 min, tR2 = 16.2 min 
tert-butyl(diethoxyphosphoryl)(phenyl)methylcarbamate (140b): Chirapak IA, 254 nm, 
hexane/isopropanol 98:5, flow rate 1.0 mL/min, tR1 = 14.4 min, tR2 = 17.0 min 
N1-benzyl-N1-cyano(phenyl)methylacetamide: Chiralpak IA, 254 nm, hexane/isopropanol 
80:20, flow rate 0.7 mL/min, tR1 = 10.05 min, tR2 = 12.62 min 
 
Chiral GC 
 
Chiral gas chromatography (GC) analyses were performed on a Hewlett-Packard 5890 gas 
chromatography using a Hydrodex-β-6-TBDM, Chiraldex G-TA column, or Lipodex E. 
N1-(1-phenylethyl)aniline (99): Hydrodex-β-6-TBDM, 130–175 °C, 1 °C/min, tR1 = 38.13 
min, tR2 = 38.46 min 
2-phenyl-2-(trimethylsilyloxy)acetonitrile: Hydrodex-β-6-TBDM, 100–150 °C, 2 °C/min, 
tR1 = 19.78 min, tR2 = 20.07 min 
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2-phenyl-2-(trimethylsilyloxy)acetonitrile: Hydrodex-β-6-TBDM, 100–170 °C, 2 °C/min, 
tR1 = 14.34 min, tR2 = 14.63 min 
3-phenylsulfanyl-1-cyclohexanone: Hydrodex-β-6-TBDM, 180 °C, isothermal 30 min, tR1 = 
25.54 min, tR2 = 25.15 min 
2-nitropropyl)benzene: Chiraldex G-TA, 100–180 °C, 5 °C/min, tR1 = 12.77 min, tR2 = 13.12 
min 
(1-nitropropane-2-yl)benzene: Chiraldex G-TA, 100–180 °C, 5 °C/min, tR1 = 13.62 min, tR2 
= 13.96 min 
 
7.3 Synthesis of N-formamides 
 
7.3.1 General Procedure for the preparation of N-formyl amino acids. 
 
N-formyl-L-proline[261]  
L-proline (4.0 g, 34.8 mmol) was dissolved in 98% formic acid (50 mL) and the 
resulting solution was cooled to 0 °C.  The cooled solution was added to a 
mixture of acetic anhydride (40 mL, 436 mmol) in 98% formic acid (50 mL) at 0 
°C.  The resulting solution was allowed to warm to room temperature overnight.  The solvent 
was then removed under reduced pressure.  The residue was purified by flash column 
chromatography (30 g silica gel, 10% v/v methanol in chloroform).  Fractions containing N-
formyl-L-proline were pooled, and the solvent was removed under reduced pressure to yield 
compound 1 (4.5 g, 90%) as a clear oil.  1H NMR (400 MHz, CDCl3): δ 8.26 (s, 1 H, COOH), 
8.22 (s, 0.6 H, CHO), 8.18 (s, 0.4 H, CHO), 4.45–4.42 (m, 1 H), 3.63–3.77 (m, 1 H), 3.45 (t, J 
= 7.22 Hz, 1 H), 2.29–2.20 (m, 2 H), 1.87–2.08 (m, 2 H).  13C NMR (100 MHz, CDCl3): δ = 
173.7, 173.6, 163.2, 162.2, 58.9, 56.6, 46.8, 44.1, 29.4, 29.0, 23.6, 22.5. 
 
N-formyl-D-proline[297]   
D-proline (600 mg, 5.21 mmol) was dissolved in 85% formic acid (11 mL) and 
cooled to 0°C.  Acetic anhydride (3.6 mL) was added and the resulting mixture 
was stirred at room temperature for 2 h.  Ice cold water (4.2 mL) was then added 
and the solvent was removed under reduced pressure.  The residue pale yellow oil was 
purified by flash column chromatography (10% v/v methanol in chloroform) to give 
compound 2 (663.9 mg, 89%) as a colorless oil.  1H NMR (400 MHz, CDCl3): δ 8.54 (s, 1 H), 
8.21 (s, 0.6 H), 8.18 (s, 0.4 H), 4.35–4.40 (m, 1 H), 3.56–3.64 (m, 1 H), 3.46 (apparent triplet, 
J = 7.22 Hz, 1 H), 2.14–2.25 (m, 1 H), 1.83–2.06 (m, 3 H).  13C NMR (100 MHz, CDCl3): δ 
= 174.2, 173.8, 163.2, 167.2, 59.2, 57.0, 47.0, 44.3, 29.3, 23.9, 22.8. 
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N-formyl-L-pipecolinic acid[298]   
Acetic anhydride (0.662 mL, 7.0 mmol) was added dropwise to a stirred and 
cooled (0~5 °C) solution of L-pipecolinic acid (129.2 mg, 1.0 mmol) in 1.0 mL 
of 98% formic acid.  Stirring was continued for 1 h at room temperature.  Water 
(0.8 mL) was added and the solution was evaporated to dryness to give 125 mg of crude 
product as yellow oil, which was purified by flash column chromatography (10% v/v 
methanol in chloroform) to yield the product 3 (97 mg, 62%) as a colorless oil. 
   
7.3.2 Synthesis of known catalysts 73 and 76 
 
(R)-N-(2-hydroxybenzyl)-tert-butanesulfinamide (76)[260]  
To a stirred solution of (R)-(+)-2-methyl-2-propanesulfinamide (121.2 mg, 
1.0 mmol) in dry toluene (5 mL) at 45 °C was added anhydrous KHSO4 (272 
mg, 2.0 mmol) and salicylaldehyde (213 µl, 2.0 mmol).  After 24 h, the 
reaction mixture was filtered and concentrated in high vacuum to afford sulfimine as white 
yellow solid 224 mg.  The solid was dissolved in THF (10 mL), and NaBH4 (57 mg, 1.5 mmol) 
was added.  Once the addition was completed, the mixture became yellow and was stirred for 
additional 2 h at 0 °C.  The solution turned colorless before saturated aqueous NH4Cl, was 
added to quench the reaction.  The resulting mixture was extracted with CH2Cl2 (3 × 10 mL).  
The combined organic layers were dried over Na2SO4, filtered, and concentrated to give crude 
product as a colorless oil (260 mg), which was purified by flash column chromatography on 
silica gel (2 : 1 (v/v) hexane/ ethyl acetate) to yield 76 (156 mg, 69%) as a white solid.  The 
resulting solid was recrystallized with ethyl acetate/hexanes to afford highly pure 76 as a 
needle crystal.  [α]20D = -86.8 (c = 0.45, EtOAc); 1H NMR (400 MHz, CDCl3): δ 8.64 (s, 1 H), 
7.03–7.06 (m, 2 H), 6.70–6.80 (m, 2 H), 4.25–4.30 (m, 2 H), 4.08–4.14 (m, 1 H), 1.17 (s, 9 
H) . 13C NMR (100 MHz, CDCl3): δ = 155.7, 129.6, 129.5, 124.0, 119.6, 116.4, 56.2, 46.9, 
22.6. 
 
(S)-2-(tert-Butoxycarbonyl-methyl-amino)-3-methyl-butyric Acid (126) 
Sodium hydride (60% dispersion in mineral oil; 3.0 g, 138 mmol) was added in 
small portions to a stirred solution of (S)-2-tert-butoxycarbonylamino-3-methyl-
butyric acid (125) (3.0 g, 13.8 mmol) and iodomethane (19.6 g, 138 mmol) in 
anhydrous THF (60 mL) at 0 °C.  The mixture was allowed to stir at room 
temperature for 24 h under an argon atmosphere.  The reaction was then quenched with water 
(15 mL), ethyl acetate (10 mL) and evaporated in vacuo.  The residue was diluted in water 
(300 mL) and washed with ethyl acetate (150 mL).  The aqueous solution was acidified to pH 
3.5 with a solution of 5% citric acid and extracted with ethyl acetate (200 mL).  The extract 
was washed with brine (100 mL), dried over anhydrous MgSO4, and evaporated in vacuo to 
give the compound 126 as a yellow oil, which was used in the following step without further 
purification. 
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(S)-N-(3,5-Dimethylphenyl)-2-(tert-butoxycarbonyl-methyl-amino)-3-methyl-butyric 
Amide. 
Methylchloroformate (0.55 mL, 7.15 mL) was added dropwise to a stirred 
solution of 125 (1.40 g, 6.05 mmol) and triethylamine (1.0 mL, 7.15 mmol) 
in anhydrous THF (30 mL) at 0 °C under an argon atmosphere and the 
mixture was stirred at that temperature for 2 h.  The precipitation was 
removed by filtration in vacuo and the filtrate was added dropwise to a solution of 3,5-
dimethylaniline (1.06 mL, 8.5 mmol) and triethylamine (1.0 mL, 7.15 mmol) in anhydrous 
THF (30 mL) at 0 °C.  The mixture was allowed to stir at room temperature overnight under 
an argon atmosphere and the solvent was then removed under reduced pressure.  The residue 
was purified using flash column chromatography on silica gel with a hexane-ethyl acetate (4 : 
1) to afford the compound (958 mg) as a yellow oil. 
 
(S)-N-(3,5-Dimethylphenyl)-2-(formyl-methyl-amino)-3-methyl-butyric Amide (73). 
The BOC derivative (344 mg, 1.03 mmol) was dissolved in trifluoroacetic acid 
(2.0 mL) at room temperature.  After 1 h, the reaction mixture was evaporated 
in vacuo, the residue was dissolved in 98% formic acid (1.5 mL) and the 
resulting solution was cooled to 0 °C.  Acetic anhydride (0.68 mL, 7.21 mmol) 
was added dropwise and the mixture was allowed to stir at room temperature overnight.  The 
solvent was then removed by reduced pressure.  Purification using column chromatography 
on silica gel with a hexanes-ethyl acetate mixture (1 : 1) afforded the compound 73 (175 mg) 
as a colorless oil.  
 
7.3.3 General precedure for the formation of N-formamides 
 
N2-(1-adamantyl)-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (104) 
Triethylamine (1.12 mL, 8.02 mmol) was added dropwise to a cooled (0 °C) 
solution of N-formyl-L-proline (760 mg, 5.35 mmol) in dry 
dichloromethane (50 mL).  1-Aminoadmantane (970.4 mg, 6.4 mmol) was 
added, followed by 1-hydoxy-benzhotriazole hydrate (HOBt; 1.07 g, 6.96 mmol) and 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI; 1.33 g, 6.96 mmol).  The 
mixture was stirred at 0 °C for 1 h, and then at room temperature for 20 h.  The mixture was 
diluted with ethyl acetate (250 mL) and washed successively with water (100 mL), cold 0.5 M 
HCl (2 × 100 mL), saturated NaHCO3 (2 × 100 mL), and brine (100 mL) and dried over 
MgSO4, filtered and evaporated to afford crude product 884 mg as a yellow oil, which was 
purified by column chromatography on silica gel with a chloroform-methanol mixture (20 : 1) 
to give 104 (585 mg, 39.7%) as a white solid.  IR (KBr): 3306, 2906, 2849, 1684, 1639, 1539, 
1384, 612 cm–1.  1H NMR (400 MHz, CDCl3, cis and trans forms): δ 8.24 (s, 1 H, CHO), 
6.68 and 5.53 (2 × s, br, 1 H, NH), 4.34–4.37 and 4.17–4.20 (2 × q, J = 3.75, 1 H), 3.40–3.61 
(m, 2 H), 2.36–2.43 (m, 0.7 H), 1.77–2.16 (m, 13.3 H), 1.62 (m, 6 H).  13C NMR (100 MHz, 
N
O
HN
O
O
N
H
HN
O
O
N
H
N
O
OH
Chapter 7    Experimental Section 
98 
CDCl3): δ = 170.3, 169.1, 162.3, 162.1, 61.6, 58.5, 56.4, 56.2, 46.9, 44.4, 41.5, 41.3, 39.3, 
39.1, 38.9, 38.85, 38.8, 38.7, 38.6, 38.1, 37.8, 37.4, 37.3, 37.2, 37.0, 36.8.  HRMS: m/z calcd 
for C16H24N2O2: 276.18323; found: 276.18317.  Elemental anal.: calcd (%) for C16H24N2O2 
(276.38): C 69.53, H 8.75, N 10.13; found: C 69.50, H 8.74, N 10.24.  
 
N2-pentacyclo[7.3.1.14,12.02,7.06,11]tetradec-1-yl-1-formyltetrahydro-1H-2-
pyrrolecarboxamide (105) 
The general procedure described above was performed on 0.50 mmol 
scale, using 1.0 equivalent of 1-aminodiadmantane.  After workup, the 
crude product was purified by column chromatography on silica gel with 
a chloroform-methanol mixture (15 : 1) to give 105 (116 mg, 71%) as a white solid, mp = 191 
°C.  IR (KBr): 3311, 2899, 2852, 1676, 1640, 1534, 1395, 629 cm–1.  1H NMR (400 MHz, 
CDCl3, cis and trans forms): δ 8.24 (s, 1 H, CHO), 6.70 and 5.56 (2 × s, br, 1 H, NH), 4.38–
4.41 and 4.20–4.22 (2 × m, 1 H), 3.43–3.58 (m, 2 H), 2.39–2.43 (m, 0.8 H), 1.38–2.18 (m, 22 
H).  13C NMR (100 MHz, CDCl3): δ = 170.0, 168.9, 162.2, 162.1, 61.4, 58.5, 52.3, 51.9, 46.9, 
44.3, 44.3, 41.5, 41.4, 30.5, 29.4, 29.36, 26.9, 24.2, 22.9.  HRMS: m/z calcd for C20H28N2O2: 
328.21453; found: 328.21329.  Elemental anal.: calcd (%) for C20H28N2O2 (328.46): C 73.14, 
H 8.59, N 8.53; found: C 72.03, H 8.42, N 8.36.  
 
N2-cyclohexyl-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (103)  
The general procedure described above was performed on 0.50 mmol scale, 
using 1.2 equivalents of cyclohexylamine.  After workup, the crude product 
was purified by column chromatography on silica gel with a chloroform-
methanol mixture (15 : 1) to give 103 (75 mg, 7%) as a white solid.  IR 
(KBr): 3288, 2985, 2933, 2852, 1668, 1646, 1554, 1373, 691 cm–1.  1H NMR (400 MHz, 
CDCl3, cis and trans forms): δ 8.27 (s, 1 H, CHO), 6.89 and 5.84 (2 × s, br, 1 H, NH), 4.41–
4.44 and 4.29–4.32 (2 × quinlets, J = 3.83, 1 H), 3.63–3.79 (m, 1 H), 3.43–3.61 (m, 2 H) 
2.43–2.50 (m, 0.8 H), 1.05–2.24 (m, 15 H).  13C NMR (100 MHz, CDCl3): δ = 170.2, 169.2, 
162.3, 162.2, 61.0, 58.0, 48.5, 48.3, 46.9, 44.4, 33.1, 33.0, 32.8, 32.7, 30.4, 26.9, 25.5, 25.4, 
24.8, 24.6, 24.2, 22.8.  HRMS: m/z calcd for C12H20N2O2: 224.15193; found: 224.15179.  
Elemental anal.: calcd (%) for C12H20N2O2 (224.30): C 64.26, H 8.99, N 12.49; found: C 
64.21, H 8.93, N 12.52. 
 
N2-[(1R)-1-phenylethyl]-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (108) 
The general procedure described above was performed on 0.50 mmol scale, 
using 1.2 equivalents of (R)-1-methyl-benzylamine.  After evaporation of 
the solvent, the residue was directly purified by column chromatography 
on silica gel with a chloroform-methanol mixture (20 : 1) to give 108 (96 
mg, 78%) as a white solid, mp = 103 °C.  IR (KBr): 3284, 2982, 2966, 1649, 1528, 1376, 768, 
706, 544 cm–1.  1H NMR (400 MHz, CDCl3, cis and trans forms): δ 8.23 and 8.22 (2 ×s, 1 H, 
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CHO), 7.40 and 6.21 (2 × d, J = 6.6, 1 H, NH), 7.14–7.29 (m, 5 H), 5.04–5.11 and 4.94–5.01 
(2 × m, 1 H), 4.46–4.49 and 4.28–4.31 (2 × dd, J = 7.7 and 3.6, 1 H), 3.46–3.56 (m, 1 H), 
3.34–3.42 (m, 1 H),  2.42–2.50 (m, 0.8 H), 1.70–2.12 (m, 3.5 H), 1.63 (s, 0.7 H), 1.43 and 
1.40 (2 × d, J = 7.37, 3 H).  13C NMR (100 MHz, CDCl3): δ = 170.3, 169.1, 162.4, 162.3, 
143.5, 142.6, 128.8, 128.6, 127.6, 127.0, 125.9, 125.8, 61.0, 57.9, 49.2, 48.9, 46.9, 44.4, 30.4, 
26.7, 24.1, 22.9, 22.7, 21.5.  HRMS: m/z calcd for C14H18N2O2: 246.13628; found: 246.13662.  
Elemental anal.: calcd (%) for C14H18N2O2 (246.31): C 68.27, H 7.37, N 11.37; found: C 
67.08, H 7.39, N 11.37. 
 
N2-[(1R)-1-(2-naphthyl)ethyl]-(2S)-1-formyltetrahydro-1H-2-pyrrole-carboxamide (109) 
The general procedure described above was performed on 0.50 mmol 
scale, using 1.2 equivalents of (R)-1-methyl-2-naphthylethylamine.  After 
evaporation of the solvent, the residue was directly purified by column 
chromatography on silica gel with a chloroform-methanol mixture (20 : 1) 
to give 109 (120 mg, 81%) as a white solid.  IR (KBr): 3313, 2972, 1673, 
1642, 1534, 1398, 752 cm–1.  1H NMR (400 MHz, CDCl3, cis and trans forms): δ 8.24 and 
8.21 (2 ×s, 1 H, CHO), 7.72–7.76 (m, 3 H), 7.64 (s, 1 H), 7.50 and 6.31 (2 × d, J = 8.0, 1 H, 
NH), 7.28–7.44 (m, 3 H), 5.24 and 5.13 (2 × m, 1 H), 4.50 and 4.30 (2 × dd, J = 7.7 and 3.6, J 
= 8.2 and 3.3, 1 H), 3.44–3.53 (m, 1 H), 3.33–3.40 (m, 1 H),  1.62–2.16 (m, 4 H), 1.51 and 
1.48 (2 × d, J = 7.0, 3 H).  13C NMR (100 MHz, CDCl3): δ = 170.4, 169.2, 162.4, 162.3, 
140.9, 139.9, 133.4, 133.3, 132.8, 132.6, 128.8, 128.4, 128.0, 127.9, 127.7, 127.6, 126.4, 
126.1, 126.08, 125.7, 124.6, 124.45, 124.43, 124.3, 61.0, 58.0, 49.4, 49.0, 46.9, 44.4, 30.4, 
29.7, 26.7, 24.2, 22.9, 22.6, 21.4.  HRMS: m/z calcd for C18H20N2O2: 296.15193; found: 
296.15029.  Elemental anal.: calcd (%) for C18H20N2O2 (296.37): C 72.95, H 6.80, N 9.45; 
found: C 72.68, H 6.77, N 9.45. 
 
N2-(1-adamantyl)-(2S)-1-formylhexahydro-2-pyridinecarboxamide (114)  
The general procedure described above was performed with 0.62 mmol of 
N-formyl-L-pipecolinic acid and 1.2 equivalents of 1-aminoadmantane.  
After workup, the crude product was purified by column chromatography 
on silica gel with a chloroform-methanol mixture (15 : 1) to give 114 (145 
mg, 81 %) as a white solid, mp = 123 °C.  IR (KBr): 3418, 2911, 2850, 1690, 1667, 1653, 
1503, 1410, 549 cm–1.  1H NMR (400 MHz, CDCl3, cis and trans forms): δ 8.01 (s, 1 H, 
CHO), 5.61 and 5.52 (2 × s, br, 1 H, NH), 4.8 and 4.01 (2 × d, J = 5.6, 1 H), 4.31 and 3.46 (2 
× dd, J = 13.3 and 3.0, 1 H), 3.16 and 2.63 (2 × td, J = 13.0 and 3.0, 1 H), 2.43 and 2.2 (2 × m, 
1 H), 2.00 (s, 3 H), 1.60–1.92 (m, 16 H), 1.27–1.5 (m, 2 H).  13C NMR (100 MHz, CDCl3): δ 
= 168.8, 168.0, 162.4, 162.3, 58.1, 53.4, 52.4, 51.9, 51.3, 44.3, 41.6, 41.5, 41.3, 38.6, 36.3, 
36.2, 36.1, 29.6, 29.5, 29.3, 29.2, 26.8, 25.7, 25.1, 24.5, 21.2, 20.9.  HRMS: m/z calcd for 
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C17H26N2O2: 290.19888; found: 290.19754.  Elemental anal.: calcd (%) for C17H26N2O2 
(290.41): C 70.31, H 9.02, N 9.65; found: C 68.67, H 9.04, N 9.22.  
 
N2-pentacyclo[7.3.1.14,12.02,7.06,11]tetradec-4-yl-1-formyltetrahydro-1H-2-pyrrole-
carboxamide (106) 
The general procedure described above was performed on 0.50 mmol 
scale, using 1.0 equivalent of 4-aminodiadmantane.  After workup, the 
crude product was purified by column chromatography on silica gel 
with a chloroform-methanol mixture (20 : 1) to give 106 (108 mg, 66%) as a white solid.  The 
resulting product was purified again with column chromatography on silica gel with hexane-
ethyl acetate mixture (2 : 1) to obtain highly pure product (98 mg, 60%) as a white solid, mp 
= 214 °C.  IR (KBr): 3439, 3303, 2884, 2849, 1682, 1638, 1536, 1461, 1348, 1232, 1051, 630 
cm–1.  1H NMR (400 MHz, CDCl3, cis and trans forms): δ 8.22 (s, 1 H, CHO), 6.65 and 5.49 
(2 × s, br, 1 H, NH), 4.33 and 4.16 (2 × dd, J = 7.8 and 3.9, 1 H), 3.37–3.59 (m, 2 H), 2.34–
2.41 (m, 0.8 H), 1.65–2.14 (m, 22 H).  13C NMR (100 MHz, CDCl3): δ = 170.4, 169.2, 162.2, 
162.1, 61.4, 58.5, 51.2, 50.7, 46.9, 44.3, 42.0, 41.9, 38.5, 38.4, 37.3, 37.2, 36.4, 36.3, 30.4, 
26.8, 25.6, 25.4, 24.1, 22.8.  HRMS: m/z calcd for C20H28N2O2: 328.21453; found: 328.21512.  
Elemental anal.: calcd (%) for C20H28N2O2 (328.46): C 73.14, H 8.59, N 8.53; found: C 
72.79, H 8.64, N 8.26. 
 
N2-heptacyclo[7.7.1.13,15.01,12.02,7.04,13.06,11]octadec-9-yl-1-formyltetrahydro-1H-2-
pyrrolecarboxamide (107) 
The general procedure described above was performed on 0.50 mmol 
scale, using 1.0 equivalent of 4-aminotiadmantane.  After workup, the 
crude product was purified by column chromatography on silica gel 
with a chloroform-methanol mixture (20 : 1) to give 107 (164 mg) as a 
colorless oil.  The resulting product was purified again with column chromatography on silica 
gel with hexane-ethyl acetate mixture (2 : 1) to obtain highly pure product (121 mg, 64%) as a 
white solid, mp = 191 °C.  IR (KBr): 3453, 3290, 3051, 2968, 2873, 1679, 1643, 1540, 1425, 
1387, 1333, 1264, 1232, 1221, 1196, 1083, 1058, 1025, 992, 782, 647, 509, 457 cm–1.  1H 
NMR (400 MHz, CDCl3, cis and trans forms): δ 8.20 (s, 1 H, CHO), 6.67 and 5.50 (2 × s, br, 
1 H, NH), 4.33 and 4.16 (2 × dd, J = 8.0 and 4.2, 1 H), 3.37–3.58 (m, 2 H), 2.35–2.42 (m, 0.8 
H), 1.75–2.14 (m, 10 H) 1.56–1.63 (m, 10 H), 1.49 (s, 2 H), 1.37 (s, 2 H), 1.24 (s, 2 H).  13C 
NMR (100 MHz, CDCl3): δ = 170.4, 169.2, 162.3, 162.1, 61.4, 58.5, 52.3, 51.9, 48.7, 48.6, 
46.9, 45.75, 45.74, 45.64, 45.62, 44.8, 44.7, 44.3, 41.9, 41.8, 41.7, 39.1, 39.0, 38.0, 37.8, 37.7, 
37.6, 37.4, 37.3, 34.9, 34.8, 34.7, 34.6, 34.1, 34.0, 30.5, 27.25, 27.18, 26.8, 24.2, 22.9.  
HRMS: m/z calcd for C24H32N2O2: 380.24638; found: 380.24370.  Elemental anal.: calcd (%) 
for C24H32N2O2 (380.53): C 75.75, H 8.48, N 8.26; found: C 73.59, H 8.27, N 7.04. 
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Benzyl (2S)-2-[(2S)-1-formyltetrahydro-1H-2-pyrrolylcarboxamido]-3-methyl-butanoate 
(110) 
The general procedure described above was performed on 1.0 mmol 
scale, using 1.0 equivalent of L-valine benzyl ester hydrochloride and 
4.3 equivalents of triethylamine.  After workup, the crude product 
was purified by column chromatography on silica gel with a 
chloroform-methanol mixture (15 : 1) to give 110 (232 mg, 67%) as a colorless oil.  IR (KBr): 
3305, 3064, 2966, 2878, 1740, 1661, 1540, 1383, 1193, 751, 700 cm–1.  1H NMR (400 MHz, 
CDCl3, cis and trans forms): δ 8.25 and 8.21 (2 × s, 1 H, CHO), 7.24–7.38 (m, 6 H), 5.03–
5.15 (m, 2 H),  4.41–4.54 (m, 2 H), 3.42–3.60 (m, 2 H), 2.39 and 2.13 (2× m, 2 H), 1.78–2.04 
(m, 3 H), 0.75–0.85 (m, 6 H).  13C NMR (100 MHz, CDCl3): δ = 171.5, 171.4, 171.2, 170.3, 
162.1, 162.0, 135.5, 135.1, 128.8, 128.7, 128.6, 128.57, 128.5, 128.4, 128.3, 127.0, 125.1, 
120.2, 109.4, 85.1, 67.3, 66.9, 60.8, 57.8, 57.6, 57.1, 46.9, 44.3, 31.1, 31.0, 30.5, 27.0, 24.2, 
22.9, 19.1, 19.08, 17.6, 17.5.  HRMS: m/z calcd for C18H24N2O4: 332.17306; found: 
332.17052.  Elemental anal.: calcd (%) for C18H24N2O4 (332.40): C 65.05, H 7.28, N 8.43; 
found: C 62.92, H 7.09, N 9.02.  
 
Benzyl (2S)-2-[(2R)-1-formyltetrahydro-1H-2-pyrrolylcarboxamido]-3-methyl-butanoate 
(111) 
The general procedure described above was performed with 1.0 
equivalent of N-formyl-D-Proline, 1.0 equivalent of L-valine benzyl 
ester hydrochloride and 4.3 equivalents of triethylamine.  After 
workup, the crude product was purified by column chromatography 
on silica gel with a chloroform-methanol mixture (15 : 1) to give 111 (76 mg, 23%) as a 
colorless oil.  IR (Film): 3294, 3034, 2965, 2877, 1740, 1661, 15391382, 670 cm–1.  1H NMR 
(400 MHz, CDCl3, cis and trans forms): δ 8.21 and 8.13 (2 × s, 1 H, CHO), 7.45 and 6.38 (2× 
d, J = 9.2, 1 H, NH), 7.26 (m, 5 H), 4.97–5.15 (m, 2 H),  4.50 (m, 1 H), 4.34 and 4.43 (m, 1 
H), 3.44 and 3.31 (2 × m, 2 H), 2.14 and 2.40 (2× m, 2.7 H), 1.72–1.94 (m, 3.3 H), 0.75–0.89 
(m, 6 H).  13C NMR (100 MHz, CDCl3): δ = 171.5, 171.4, 171.3, 171.2, 171.1, 170.3, 162.3, 
162.0, 135.5, 135.4, 135.0, 128.6, 128.5, 128.4, 128.3, 128.27, 128.24, 128.19, 128.17, 124.9, 
120.0, 109.3, 85.0, 67.1, 66.7, 66.6, 60.6, 59.2, 57.5, 57.4, 57.3,. 57.0, 48.0, 46.6, 44.2, 30.8, 
30.6, 30.5, 26.8, 26.7, 24.8, 23.9, 22.7, 22.2, 19.0, 17.44, 17.39.  HRMS: m/z calcd for 
C18H24N2O4: 332.17306; found: 332.17072.  Elemental anal.: calcd (%) for C18H24N2O4 
(332.40): C 65.05, H 7.28, N 8.43; found: C 64.89, H 7.28, N 8.71.  
 
N2-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-dioxan-4-yl]-(2S)-1-formyltetrahydro-1H-2-
pyrrolecarboxamide (112) 
The general procedure described above was performed on 0.5 mmol scale, 
using 1.0 equivalent of (4S,5R)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-amine.  
After workup, the crude product was purified by column chromatography 
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on silica gel with a chloroform-methanol mixture (20 : 1) to give 112 (78 mg, 47%) as a white 
solid.  IR (KBr): 3253, 2984, 2873, 1676, 1651, 1552, 1378, 1204, 1076, 700 cm–1.  1H NMR 
(400 MHz, CDCl3, cis and trans forms): δ 8.20 and 7.76 (2 × s, 1 H, CHO), 7.37 and 6.36 (2 
× d, J = 8.8, 1 H, NH), 7.15–7.32 (m, 5 H), 5.17 and 5.10 (2× s, 1 H), 3.96–4.22 (m, 3 H), 
3.78 and 3.75 (2 × s, 1 H), 3.37–3.49 (m, 2 H), 1.62–2.00 (m, 4 H), 1.46–1.51 (m, 6 H).  13C 
NMR (100 MHz, CDCl3): δ = 170.8, 169.9, 162.0, 161.9, 138.6, 138.1, 128.4, 128.3, 128.1, 
127.8, 127.5, 125.7, 125.2, 125.1, 99.6, 99.5, 77.4, 77.1, 76.7, 72.2, 71.6, 64.6, 64.4, 64.3, 
60.4, 57.5, 47.4, 47.3, 46.7, 45.5, 44.2, 30.4, 29.8, 29.6, 23.9, 22.7, 18.6, 18.5.  HRMS: m/z 
calcd for C18H24N2O4: 332.17306; found: 331.16577 (M+–1).  Elemental anal.: calcd (%) for 
C18H24N2O4 (332.40): C 65.05, H 7.28, N 8.43; found: C 64.51, H 7.07, N 8.13.  
 
N2-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-dioxan-4-yl]-(2R)-1-formyltetrahydro-1H-2-
pyrrolecarboxamide (113) 
The general procedure described above was performed with 0.5 mmol of 
N-formyl-D-proline and 1.0 equivalent of (4S,5R)-2,2-dimethyl-4-phenyl-
1,3-dioxan-5-amine.  After workup, the crude product was purified by 
column chromatography on silica gel with a chloroform-methanol mixture 
(20 : 1) to give 113 (78 mg, 47%) as a white solid.  IR (KBr): 3253, 2984, 2873, 1676, 1651, 
1552, 1378, 1204, 1076, 700 cm–1.  1H NMR (400 MHz, CDCl3, cis and trans forms): δ 8.04 
and 8.02 (2 × s, 1 H, CHO), 7.70 and 6.38 (2 × d, J = 9.2, 1 H, NH), 7.14–7.29 (m, 5 H), 5.18 
and 5.10 (2 × s, 1 H), 4.49 and 4.40 (2 × d, J = 7.7, 1 H), 4.04–4.22 (m, 2 H), 3.77–3.85 (m, 1 
H), 3.35 and 3.25 (2 × m, 1 H), 3.06 and 2.87 (2 × m, 1 H), 2.21 (m, 0.7 H), 1.46–1.97 (m, 10 
H).  13C NMR (100 MHz, CDCl3): δ = 170.7, 170.4, 169.6, 162.1, 162.0, 139.1, 138.9, 138.3, 
128.4, 128.3, 127.7, 127.1, 127.0, 125.5, 125.4, 125.2, 124.9, 124.8, 99.7, 99.5, 71.6, 71.3, 
71.1, 64.6, 64.4, 64.1, 62.2, 60.7, 59.0, 57.2, 47.6, 47.4, 47.2, 47.0, 46.8, 46.5, 46.1, 45.5, 44.1, 
31.6, 30.0, 29.7, 29.6, 26.2, 26.0, 24.5, 23.5, 22.3, 22.0, 18.6, 18.5.  HRMS: m/z calcd for 
C18H24N2O4: 332.17306; found: 331.16303 (M+–1).  Elemental anal.: calcd (%) for 
C18H24N2O4 (332.40): C 65.05, H 7.28, N 8.43; found: C 64.76, H 7.29, N 8.28.  
 
N1-(1-adamantyl)-(2S)-3-methyl-2-methylformamidobutanamide (115) 
Triethylamine (0.4 mL, 3.0 mmol) was added dropwise to a cooled (0 °C) 
solution of 126 (462.6 mg, 2.0 mmol) in dry dichloromethane (20 mL).  1-
aminoadmantane (302.4 mg, 2.0 mmol) was added, followed by 1-hydoxy-
benzhotriazole hydrate (HOBt; 468 mg, ca. 2.6 mmol) and 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI; 500 mg, 2.6 mmol).  The 
mixture was stirred at 0 °C for 1 h, and then at room temperature for 20 h.  The mixture was 
diluted with ethyl acetate (100 mL) and washed successively with water (40 mL), cold 0.5 M 
HCl (2 × 40 mL), saturated NaHCO3 (2 × 40 mL), and brine (40 mL) and dried over MgSO4, 
filtered and evaporated to afford crude product (750 mg), which was purified by column 
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chromatography on silica gel with a hexane-ethyl acetate mixture (6 : 1) to give 127 (585 mg, 
80 %) as a colorless oil.  
127 (364.5 mg, 1.0 mmol) was then treated with 20% (v/v) trifluoroacetic acid in CH2Cl2 
(10 mL).  After stirring for 1 h at room temperature, the solution was concentrated under 
reduced pressure to give a TFA salt as an oil, which was dissolved in 98% formic acid (1.5 
mL).  The solution was cooled down to 0 °C, acetic anhydride (0.68 mL, 7.21 mmol) was 
added dropwise at the same temperature.  The resulting mixture was allowed to stir at room 
temperature overnight, and then evaporated to dryness.  The residue was purified by column 
chromatography on silica gel with a hexane-ethyl acetate mixture (2 : 1) to give 115 (121 mg, 
41%) as a colorless oil.  IR (KBr): 3525, 3457, 3279, 2966, 2908, 2850, 1672, 1650, 1562, 
1063 cm–11.  1H NMR (400 MHz, CDCl3, cis and trans forms): δ 8.05 and 8.03 (2 × s, 1 H, 
CHO), 5.70 and 5.39 (2 × s, 1 H, NH), 4.08 and 3.13 (2 × d, J = 11.3, 1 H), 2.89 and 2.82 (2 × 
s, 3 H),  2.19–2.32 (m, 1 H), 1.98 (s, 3 H), 1.90 (s, 6 H), 1.59 (s, 6 H), 0.90 (d, J = 6.6, 3 H), 
0.76 (d, J = 6.8, 3 H).  13C NMR (100 MHz, CDCl3): δ = 168.1, 167.8, 163.6, 163.1, 69.2, 
62.4, 53.4, 52.5, 52.1, 41.4, 41.38, 36.3, 36.2, 31.2, 29.5, 29.4, 29.2, 27.2, 26.7, 25.3, 19.7, 
19.4, 18.9, 18.5.  HRMS: m/z calcd for C17H28N2O2: 292.21453; found: 292.21292.  
Elemental anal.: calcd (%) for C17H28N2O2 (292.42): C 69.83, H 9.65, N 9.58; found: C 
69.16, H 9.79, N 9.70.  
 
 (R)-N-formyl-N-methyl-2-phenylpropanamide (116) 
To (R)-2-methoxyphenyl acetic acid (122) (166.2 mg, 1.0 mmol) and 1 drop 
DMF in anhydrous CH2Cl2 (3 mL) was added dropwise oxalyl chloride (186.1 
µl, 2.2 mmol).  The resulting solution was stirred for 2 h at room temperature.  
After removal of the solvent and excess oxalyl chloride under reduced 
pressure, the residue was dissolved in anhydrous CH2Cl2 (2 mL) and cooled to –5 °C under 
ice-salt bath.  Anhydrous pyridine (97.7 µl, 1.2 mmol) was dropwise added, followed by 
dropwise addition of a solution of N-methylformamide (64.3 µl, 1.1 mmol) in anhydrous 
CH2Cl2 (2 mL).  The reaction was allowed to stir at room temperature for 2 h.  The solvent 
was then removed in vacuo, and the residue was purified by column chromatography on silica 
gel with hexane-ethyl acetate mixture (3 : 1) to afford the product 116 (115 mg, 56%) as a 
colorless oil.  IR (Film): 3386, 2994, 2940, 2830, 1726, 1675, 1283, 1075, 700 cm–1.  1H 
NMR (400 MHz, CDCl3): δ 9.27 (s, 1 H, CHO), 7.26–7.35 (m, 5 H) 5.17 (s, 1 H), 3.43 (s, 3 
H), 3.03 (s, 3 H).  13C NMR (100 MHz, CDCl3): δ = 172.7, 163.4, 134.7, 129.1, 129.0, 126.2, 
85.0, 58.0, 26.6.  HRMS: m/z calcd for C11H13NO3: 207.08899; found: 207.08919.  
Elemental anal.: calcd (%) for C11H13NO3 (207.22): C 63.76, H 6.32, N 6.76; found: C 63.34, 
H 6.33, N 6.58. 
  
(S)-(9H-fluoren-9-yl)methyl 1-(N-methylformamido)-1-oxo-3-phenylpropane-2-
ylcarbamate (117) 
OCH3
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Under an argon atmosphere, SOCl2 (0.729 mL, 10.0 mmol) was added to a 
suspension of Fmoc-Phe-OH (123) (387.4 mg, 1.0 mmol) in anhydrous 
CH2Cl2 (5 mL).  The resulting mixture was refluxed for 2 h and the solvent 
was then removed under reduced pressure.  The residue was reevaporated 3 
times with addition of CH2Cl2 to give white solid.  The white solid was dissolved in 
anhydrous CH2Cl2 (2 mL) and another hexane was added to cause precipitations, which was 
filtered and washed with hexane several times, dried in desiccator under vacuo to give the 
corresponding chloride as white solid. 
Fmoc-Phe-OH chloride (276 mg, 0.68 mmol) was dissolved in anhydrous CH2Cl2 (2 mL) 
and cooled to 0 °C, followed by the addition of pyridine (66 µl, 0.82 mmol).  To the resulted 
solution was dropwise added a solution of N-methylformamide (43.7 µl, 0.75 mmol) in 
anhydrous CH2Cl2 (2 mL).  The reaction was allowed to stir at room temperature overnight. 
The mixture was diluted with ethyl acetate (25 mL), washed with water (10 mL), cold 0.5 M 
HCl (2 × 10 mL), saturated aqueous NaHCO3 (2 × 10 mL), brine (10 mL), dried over MgSO4, 
filtered and evaporated to give crude product as an oil, which was purified by column 
chromatography on silica gel with hexane-ethyl acetate mixture (3 : 1) to afford the product 
117 (52 mg, 17.8%) as a white solid.  IR (KBr): 3346, 1694, 1665, 1533, 760, 742, 701 cm–1.  
1H NMR (400 MHz, CDCl3, cis and trans forms): δ 9.00 and 8.55 (2 × s, 1 H, CHO), 7.04–
7.71 (m, 16 H) 5.02 (m, 1 H), 4.29–4.39 (m, 2 H), 3.01 (d, J = 7.1, 2 H), 2.94 (s, 3 H).  13C 
NMR (100 MHz, CDCl3): δ = 161.6, 155.6, 143.4, 143.3, 140.6, 136.3, 129.0, 127.9, 127.2, 
126.6, 126.3, 124.8, 124.7, 119.4, 67.2, 54.1, 47.1, 39.7, 27.1.  HRMS: m/z calcd for 
C26H24N2O4: 428.17306; found: 428.17208.  Elemental anal.: calcd (%) for C26H24N2O4 
(428.49): C 72.88, H 5.64, N 6.54; found: C 68.61, H 5.01, N 5.57. 
 
Synthesis of N2-(R)-(1-2-[(2S)-1-formyltetrahydro-1H-2-pyrrolylcarboxamido]-1-
naphthyl-2-naphthyl)-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (118) 
To a solution of Boc-L-proline (119) (344.4 mg, 1.6 mmol) and 
TEA (223.2, 1.6 mmol) in anhydrous THF (8.0 mL) was added 
dropwise methyl chloroformate (123.6 µl, 1.6 mmol) at 0 °C under 
an argon atmosphere.  After stirring for 1 h, (R)-(+)-1,1′-Bi(2-
naphthylamine) (120) (227.4 mg, 0.8 mmol) was introduced in 
small potions.  The resulting solution was continued to stir at 0 °C 
for 1 h, at room temperature for 16 h, and then at reflux for 3 h.  
After filtration and removal of solvents under reduced pressure, the residue was dissolved in 
small amount of CH2Cl2 and purified by column chromatography on silica gel with hexane-
ethyl acetate mixture (1 : 1) to afford 121 (347 mg, 64%) as white solid.  1H NMR (400 MHz, 
CDCl3): δ 7.00–8.54 (m, 14 H), 3.92–4.08 (m, 2 H), 2.92 (s, br, 2 H), 2.42 (s, br, 2 H), 1.77 (s, 
br, 4 H), 1.49 (s, br, 3 H), 1.09 (s, br, 20 H).  13C NMR (100 MHz, CDCl3): δ = 171.4, 170.9, 
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154.8, 153.6, 134.4, 132.1, 131.2, 129.8, 128.4, 127.8, 125.8, 124.9, 124.4, 121.0, 120.3, 80.1, 
61.8, 61.3, 60.4, 46.8, 46.3, 31.0, 29.6, 28.1, 24.0, 23.2, 21.1, 14.2. 
 
121 (243 mg, 0.36 mmol) was then treated with 20% (v/v) 
trifluoroacetic acid in CH2Cl2 (4 mL).  After stirring for 1 h at room 
temperature, the solution was concentrated under reduced pressure to 
give a TFA salt as a white solid, which was dissolved in 98% formic 
acid (1.5 mL).  The solution was cooled down to 0 °C, acetic 
anhydride (1 mL) was added dropwise at the same temperature.  The 
resulting mixture was allowed to stir at room temperature overnight, and then evaporated to 
dryness.  The yellow residue was purified by column chromatography on silica gel and eluted 
gradually with CH2Cl2-Methanol mixture (50 : 1 (100 mL); 40 : 1 (100 mL);  30 : 1 (100 mL); 
20 : 1 (200 mL)) to afford 118 (146 mg, 76%).  IR (KBr): 3380, 3250, 3055, 2974, 2878, 
1657, 1502, 819 cm–1.  1H NMR (400 MHz, CDCl3): δ 8.36 (s, 0.4 H, CHO), 7.80–8.15 (m, 7 
H), 7.05–7.47 (m, 7 H), 3.95–4.22 (m, 2 H), 1.18–2.02 (m, 8 H), 2.54–3.18 (m, 4 H).  13C 
NMR (150 MHz, CDCl3): δ = 170.8, 170.0, 169.4, 166.7, 164.0, 163.1, 161.4, 159.5, 158.6, 
155.9, 134.6, 134.3, 134.0, 133.5, 132.5, 132.4, 132.2, 132.1, 132.0, 131.9, 131.6, 129.6, 
129.5, 129.2, 128.3, 127.9, 127.6, 127.1, 127.0, 126.5, 125.8, 125.4, 125.0, 123.9, 123.4, 61.0, 
58.4, 58.3, 58.0, 57.6, 46.0, 45.9, 45.7, 43.8, 43.4, 30.1, 29.9, 29.7, 28.3, 27.8, 27.6, 26.8, 26.7, 
23.6, 23.5, 23.0, 22.4, 22.1, 21.7, 20.7.  HRMS: m/z calcd for C32H30N4O4: 534.22616; found: 
534.22622.  Elemental anal.: calcd (%) for C32H30N4O4 (534.62): C 71.89, H 5.65, N 10.48; 
found: C 69.21, H 5.69, N 9.97. 
 
7.4 Synthesis of oxazoline thioureas(In cooperation with Mike Kotke) 
  
7.4.1 Synthesis of L-amino alcohols[266] 
 
(2S)-2-amino-3-methylbutan-1-ol (130a) 
A 1-L three-neck round-bottom flask was fitted with a magnetic stirbar, a reflux 
condenser, and an additional funnel.  The flask was charged with sodium 
borohydride (9.11 g, 240.8 mmol) and 200 mL of anhydrous THF.  L-valine 
(11.72 g, 100 mmol) was added in one portion.  The remaining neck was sealed with a septum 
and an argon line attached, and the flask was cooled to 0 °C in an ice bath.  A solution of 
iodine (25.38 g, 100 mmol) in THF (66 mL) was poured into the addition funnel and added 
slowly and dropwise over 30 min resulting in vigorous evolution of hydrogen.  After addition 
of the iodine was complete and gas evolution had ceased, the flask was heated to reflux for 18 
h and then cooled to room temperature, and methanol was added cautiously until the mixture 
became clear.  After stirring 30 min, the solvent was removed by rotary evaporation leaving a 
white paste which was dissolved by addition of 200 mL of 20% aqueous KOH.  The solution 
was stirred for 4 h and extracted with methylene chloride (3 × 200 mL).  The organic extracts 
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were dried over sodium sulfate and concentrated in vacuo, the residue was distilled under 
reduced pressure to yield 130a (8.03 g, 78 %) as a colorless solid, mp 32 °C. 
 
(2S)-2-amino-3-phenylpropan-1-ol (130b) 
L-Phenylalaninol was prepared from L-phenylalanine by the general 
procedure described above.  The crude material was recrystallized from 
toluene to yield 70% of 130b as a colorless crystal: mp 90–92 °C, 1H NMR 
(400 MHz, CDCl3): δ 7.15–7.30 (m, 5 H), 3.60 (dd, J = 10.8, 4.0, 1 H), 3.36 (dd, J = 10.4, 7.0, 
1 H), 3.08 (m, 1 H), 2.76 (dd, J = 13.4, 5.1, 1 H), 2.49 (dd, J = 13.4, 8.6, 1 H).  13C NMR 
(100 MHz, CDCl3): δ = 138.7, 129.2, 128.6, 126.4, 66.4, 54.1, 41.0. 
 
(2S)-2-amino-4-methylpentan-1-ol (130c) 
130c was prepared from L-isoleucine by the general procedure described above.  
The crude product was distilled under reduced pressure to yield 68% of 130c as a 
colorless solid: mp 38–40 °C, 1H NMR (400 MHz, CDCl3): δ 3.53–3.57 (dd, J = 
10.6, 3.9, 1 H), 3.22–3.26 (dd, J = 10.6, 7.9, 1 H), 2.91 (m, 1 H), 2.63 (br, 3 H, NH and OH), 
1.70 (m, 1 H), 1.19 (m, 2 H), 0.93 (d, J = 6.4, 3 H), 0.90 (d, J = 6.4, 3 H). 13C NMR (100 
MHz, CDCl3): δ = 66.6, 50.4, 43.2, 24.5, 23.2, 22.0. 
 
(2S)-2-amino-3-methylpentan-1-ol (130d) 
130d was prepared from L-isoleucine by the general procedure described above.  
The crude product was distilled under reduced pressure to yield 78% of 130d as a 
colorless solid: mp 32 °C, 1H NMR (400 MHz, CDCl3): δ 3.60–3.64 (dd, J = 
10.7, 3.8, 1 H), 3.28–3.33 (dd, J = 10.7, 8.4, 1 H), 2.65 (m, 1 H), 1.45 (m, 1 H), 1.37 (m, 1 H), 
1.16 (m, 1 H), 0.86–0.91 (m, 6 H).  13C NMR (100 MHz, CDCl3): δ = 64.1, 56.9, 38.1, 25.2, 
15.0, 11.2. 
 
(2S)-2-aminopropan-1-ol (130e)[267] 
Lithium aluminum hydride (17.0 g, 0.43 mmol) was suspended in 600 mL of 
anhydrous THF at 0 °C.  L-Valine (20.0 g, 0.22 mmol) was added slowly in small 
portions.  The reaction mixture was refluxed overnight and then cooled to room temperature.  
Saturated K2CO3 solution was added slowly.  Filtration and evaporation of solvent gave a 
colorless oil.  Distillation of the crude oil under reduced pressure yielded 130e (6.0 g, 36%) as 
a light yellowish oil.  1H NMR (400 MHz, CDCl3): δ 3.50 (m, 1 H), 3.23 (m, 1 H), 2.99 (br, 4 
H), 1.04 (m, 3 H).  13C NMR (100 MHz, CDCl3): δ = 67.7, 48.1, 19.2. 
 
7.4.2 General procedure for oxazoline formation. 
 
2-(4,5-Dihydro-1,3-oxazol-2-yl)aniline (131a) 
An oven-dried 50 mL 2-neck round-bottom flask was fitted with a magnetic 
stirbar and a reflux condenser.  Under argon atmosphere, the flask was charged 
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with anthranilonitrile (2.95 g, 25 mmol) and 2-aminoethanol (4.6 g, 75 mmol), in anhydrous 
PhCl (40 mL), using ZnCl2 (0.51 g, 3.75 mmol) as a catalyst.  The mixture was refluxed about 
36 h to give a red solution.  The solvent was removed and the crude product was dissolved in 
CH2Cl2.  After washing with H2O, the organic layer was dried over Na2SO4 and the solvent 
was removed in vacuo.  The residue was purified by column chromatography on silica gel 
using hexane/EtOAc (19:1) as eluent to yield 131a (1.46, 36%) as a yellow solid.  IR (KBr): 
3388, 3269, 2934, 2875, 1631, 750 cm–1. 1H NMR (400 MHz, CDCl3): δ 7.70 (dd, J = 7.9, 1.6, 
1 H), 7.20 (m, 1 H), 6.70 (dd, J = 8.3, 0.8, 1 H), 6.66 (m, 1 H), 6.06 (br, 2 H, NH), 4.31 (t, J = 
9.4, 2 H), 4.10 (t, J = 9.4, 2 H). 13C NMR (100 MHz, CDCl3): δ = 164.9, 148.5, 132.0, 129.6, 
115.8, 115.5, 109.2, 65.8, 55.0. 
 
2-[(4S)-4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (131b) 
This compound was prepared from anthranilonitrile (3.0 g, 25.0 mmol) and L-
phenylalanol (11.2 g, 74.1 mmol) by the general procedure described above.  
The crude product was purified by column chromatography on silica gel using 
hexane/EtOAc (10:1) as eluent to yield 131b (1.5 g, 23.8%) as a white solid.  
IR (KBr): 3395, 3273, 2909, 1630, 751 cm–1.  1H NMR (400 MHz, CDCl3): δ 
7.65 (dd, J = 7.9, 1.7, 1 H), 7.17–7.32 (m, 6 H), 6.61–6.69 (m, 2 H), 6.08 (br, 2 H, NH), 4.59 
(m, 1 H), 4.26 (m, 1 H), 4.01 (m, 1 H), 3.12 (dd, J = 13.7, 6.2, 1 H), 2.75 (dd, J = 13.7, 7.9, 1 
H).  13C NMR (100 MHz, CDCl3): δ = 164.3, 148.9, 138.6, 132.3, 129.8, 129.4, 128.7, 126.6, 
116.2, 115.9, 109.2, 70.4, 68.3, 42.4.  HRMS: m/z calcd for C16H16N2O: 252.12571; found: 
252.12260.  Elemental anal.: calcd (%) for C16H16N2O (252.32): C 76.16, H 6.39, N 11.10; 
found: C 76.16, H 6.32, N 11.07. 
 
2-[(4S)-4-Isobutyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (131c) 
This compound was prepared from anthranilonitrile (2.95 g, 25.0 mmol) and L-
isoleucinol (8.78 g, 75.0 mmol) by the general procedure described above.  The 
crude product was purified by column chromatography on silica gel using 
hexane/EtOAc (9:1) as eluent to yield 131c (0.9 g, 16.5%) as a white solid.  IR 
(KBr): 3416, 3278, 2953, 1640, 746 cm–1.  1H NMR (400 MHz, CDCl3): δ 7.68 
(dd, J = 7.9, 1.6, 1 H), 7.19 (m, 1 H), 6.63–6.70 (m, 2 H), 6.10 (br, 2 H, NH), 4.33–4.42 (m, 2 
H), 3.86 (m, 1 H), 1.86 (m, 1 H), 1.65 (m, 1 H), 1.39 (m, 1 H), 0.98 (t. J = 6.4, 6 H).  13C 
NMR (100 MHz, CDCl3): δ = 163.4, 148.5, 131.8, 129.5, 116.0, 115.6, 109.3, 71.4, 65.2, 
45.8, 25.7, 22.9, 22.6.  HRMS: m/z calcd for C13H18N2O: 218.14136; found: 218.14213.  
Elemental anal.: calcd (%) for C13H18N2O (218.30): C 71.53, H 8.31, N 12.83; found: C 
71.65, H 8.29, N 12.75. 
 
2-[(4S)-4-(sec-Butyl)-4,5-dihydro-1,3-oxazol-2-yl]aniline (131d) 
This compound was prepared from anthranilonitrile (2.95 g, 25.0 mmol) and L-
leucinol (8.78 g, 75.0 mmol) by the general procedure described above.  The 
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crude product was purified by column chromatography on silica gel using hexane/EtOAc (9:1) 
as eluent to yield 131d (2.3 g, 42.1%) as a white solid.  IR (KBr): 3464, 3287, 2962, 1638, 
749 cm–1.  1H NMR (400 MHz, CDCl3): δ 7.66 (dd, J = 7.8, 1.5, 1 H), 7.16 (m, 1 H), 6.61–
6.67 (m, 2 H), 6.10 (br, 2 H, NH), 4.27 (m, 2 H), 4.19 (m, 1 H), 3.97 (m, 1 H), 1.62 (m, 2 H), 
1.22 (m, 1 H), 0.93 (t. J = 7.4, 3 H), 0.86 (d, J = 6.7, 3 H).  13C NMR (100 MHz, CDCl3): δ = 
163.4, 148.5, 131.8, 129.5, 115.9, 115.5, 109.1, 71.5, 68.3, 39.5, 26.0, 14.7, 11.4.  HRMS: 
m/z calcd for C13H18N2O: 218.14136; found: 218.41210.  Elemental anal.: calcd (%) for 
C13H18N2O (218.30): C 71.53, H 8.31, N 12.83; found: C 71.07, H 8.31, N 12.83. 
 
2-[(4S)-4-Isopropyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)aniline (131e) 
This compound was prepared from anthranilonitrile-2 (2.54 g, 10.0 mmol) and 
L-valinol (3.09 g, 30.0 mmol) by the general procedure described above.  The 
crude product was purified by column chromatography on silica gel using 
hexane/EtOAc (9:1) as eluent to yield 131e (1.5 g, 44.2%) as a white solid.  
IR (KBr): 3452, 3324, 3203, 2974, 1667, 698 cm–1.  1H NMR (400 MHz, 
CDCl3): δ 7.24 (s, 1 H), 7.10 (s, 1 H), 5.57 (br, 2 H, NH), 4.41 (dd, J = 9.1, 7.6, 1 H), 4.10–
4.21 (m, 2 H), 1.83–1.91 (m, 1 H), 1.04 (d, J = 6.7, 3 H), 0.97 (d, J = 6.9, 3 H).  13C NMR 
(100 MHz, CDCl3): δ = 160.9, 148.3, 133.2, 132.9, 132.6, 132.3, 132.2, 131.9, 131.6, 131.2, 
127.2, 124.5, 121.8, 115.7, 112.0, 72.8, 70.0, 32.7, 18.8, 18.4.  HRMS: m/z calcd for 
C14H14N2OF6: 340.10103; found: 340.10040.  Elemental anal.: calcd (%) for C14H14F6N2O 
(340.26): C 49.42, H 4.15, N 8.23; found: C 49.38, H 4.03, N 8.56. 
 
2-[(4S)-4-Methyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (131f) 
This compound was prepared from anthranilonitrile (2.96 g, 25.0 mmol) and L-
alaninol (5.6 g, 74.5 mmol) by the general procedure described above.  The crude 
product was purified by column chromatography on silica gel using 
hexane/EtOAc (9:1) as eluent to yield 131f (2.4 g, 54.5%) as a yellow solid.  1H 
NMR (400 MHz, CDCl3): δ 7.67 (dd, J = 7.9, 1.5, 1 H), 7.16 (m, 1 H), 6.61–6.66 (m, 2 H), 
6.06 (br, 2 H, NH), 4.33–4.43 (m, 2 H), 3.80 (m. 1 H), 1.31 (d, J = 6.4, 3 H).  13C NMR (100 
MHz, CDCl3): δ = 163.4, 148.4, 131.8, 129.5, 115.9, 115.5, 109.0, 72.1, 62.0, 21.6.   
 
2-[(4S)-4-(sec-Butyl)-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)aniline 
 (131g) 
This compound was prepared from anthranilonitrile-2 (2.0 g, 7.87 mmol) and 
L-leucinol (2.76 g, 23.61 mmol) by the general procedure described above.  
The crude product was purified by column chromatography on silica gel using 
hexane/EtOAc (9:1) as eluent to yield 131g (1.34 g, 48.0%) as a white solid.  
IR (KBr): 3432, 3321, 3199, 2979, 1668, 874 cm–1.  1H NMR (400 MHz, 
CDCl3): δ 7.21 (s, 1 H), 7.07 (s, 1 H), 5.54 (br, 2 H, NH), 4.36 (m, 1 H), 4.26 
(m, 1 H), 4.09 (m, 1 H), 1.69 (m, 1 H), 1.58 (m, 1 H), 1.22 (m, 1 H), 0.94 (t, J = 7.5, 3 H), 
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0.88 (d, J = 6.8, 3 H).  13C NMR (100 MHz, CDCl3): δ = 160.8, 148.3, 133.2, 132.9, 132.6, 
132.23, 132.19, 131.9, 131.5, 131.2, 127.2, 127.1, 124.5, 124.4, 121.8, 121.7, 119.0, 115.7, 
112.0, 111.7, 71.3, 69.5, 39.0, 26.1, 14.5, 11.4.  HRMS: m/z calcd for C15H16F6N2O: 
354.11613; found: 354.11649.  Elemental anal.: calcd (%) for C15H16F6N2O (354.30): C 
50.85, H 4.55, N 7.91; found: C 50.90, H 4.44, N 7.62. 
 
2-[(4S)-4-Isobutyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)aniline (131h) 
This compound was prepared from anthranilonitrile-2 (2.0 g, 7.87 mmol) and 
L-isoleucinol (2.76 g, 23.61 mmol) by the general procedure described above.  
The crude product was purified by column chromatography on silica gel using 
hexane/EtOAc (9:1) as eluent to yield 131h (1.8 g, 64.5%) as a white solid.  
IR (KBr): 3440, 3325, 3201, 2967, 1668, 1642, 696 cm–1.  1H NMR (400 
MHz, CDCl3): δ 7.22 (s, 1 H), 7.08 (s, 1 H), 5.46 (br, 2 H, NH), 4.46 (dd, J = 9.4, 7.9, 1 H), 
4.38 (m, 1 H), 3.96 (t. J = 7.9, 1 H), 1.81 (m, 1 H), 1.66 (m, 1 H), 1.40 (m, 1 H), 0.96 (t, J = 
6.9, 6 H).  13C NMR (100 MHz, CDCl3): δ = 160.7, 148.2, 132.9, 132.6, 131.9, 131.5, 124.5, 
124.4, 121.8, 121.7, 115.74, 115.71, 112.1, 112.0, 111.9, 72.8, 65.1, 45.4, 25.6, 22.8, 22.6.  
HRMS: m/z calcd for C15H16F6N2O: 354.11613; found: 354.11653.  Elemental anal.: calcd 
(%) for C15H16F6N2O (354.30): C 50.85, H 4.55, N 7.91; found: C 51.03, H 4.48, N 7.65. 
 
7.4.3 General procedure for thiourea formation 
 
One oven-dried two-neck round-bottom flask was fitted with magnetic stirbar and an addition 
funnel.  Under an argon atmosphere, the flask was charged with ISO-1 (1.08 g, 4.0 mmol) and 
anhydrous THF (5 mL), followed by dropwise addition of a solution of oxazoline (1.0 equiv.) 
in anhydrous THF (15 mL) under 0 °C.  The resulting mixture was stirred overnight at room 
temperature.  The solvent was removed by rotary evaporation and the residue was purified by 
column chromatography on silica gel using hexane/EtOAc (5:1) as eluent to yield the 
corresponding product. 
 
2-[(4S)-4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl]anilino-3,5-di(trifluoromethyl)anilino 
methanethione (128b) 
This compound was prepared from 131b (1.16 g, 4.6 mmol) and 133 
(1.0 equiv.) by the general procedure described above.  The crude 
product was purified by column chromatography on silica gel using 
hexane/EtOAc (5:1) as eluent to yield 128b (0.9 g, 43.0%) as a white 
solid.  IR (KBr): 3345, 2909, 2791, 1634, 1276, 1120, 699 cm–1.  1H 
NMR (400 MHz, CDCl3): δ 13.03 (s, 1 H, NH), 9.06 (d, J = 8.5, 1 H, NH), 7.83–7.87 (m, 2 
H), 7.71 (s, 1 H), 7.52 (m, 1 H), 7.10–7.32 (m, 8 H), 4.49 (m, 1 H), 4.40 (m, 1 H), 4.09 (m, 1 
H), 2.78 (m, 1 H), 2.66 (m, 1 H).  13C NMR (100 MHz, CDCl3): δ = 178.9, 164.0, 140.1, 
137.8, 132.0, 129.4, 129.0, 128.6, 126.8, 124.6, 123.4, 121.0, 114.5, 71.1, 67.4, 41.9.  HRMS: 
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m/z calcd for C25H19F6N3OS: 523.11475; found: 523.11217.  Elemental anal.: calcd (%) for 
C25H19F6N3OS (523.49): C 57.36, H 3.66, N 8.03; found: C 57.47, H 3.53, N 7.98. 
 
3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-isobutyl-4,5-dihydro-1,3-oxazol-2-yl]aniline 
methanethione (128c) 
This compound was prepared from 131c (0.87 g, 4.0mmol) and 133 
(1.0 equiv.) by the general procedure described above.  The crude 
product was purified by column chromatography on silica gel using 
hexane/EtOAc (5:1) as eluent to yield 128c (0.6 g, 30.6%) as a white 
solid.  IR (KBr): 3190, 2965, 2929, 1640, 1275, 682 cm–1.  1H NMR 
(400 MHz, CDCl3): δ 13.16 (s, 1 H, NH), 8.94 (d, J = 8.4, 1 H, NH), 
8.07 (s, 1 H), 7.84 (m, 3 H), 7.68 (m, 1 H), 7.52 (m, 1 H), 7.17 (m, 1 H), 4.34 (m, 1 H), 4.03 
(m, 1 H), 3.85 (m, 1 H), 1.37 (m, 1 H), 1.11 (m, 2 H), 0.80 (m, 6 H).  13C NMR (100 MHz, 
CDCl3): δ = 178.8, 163.0, 139.7, 139.3, 133.0, 131.7, 129.3, 123.7, 123.2, 121.4, 118.8, 
118.76, 118.7, 115.2, 71.8, 64.6, 45.0, 25.3, 22.5, 22.3.  HRMS: m/z calcd for C22H21F6N3OS: 
489.13040; found: 489.13256.  Elemental anal.: calcd (%) for C22H21F6N3OS (489.48): C 
53.98, H 4.32, N 8.58; found: C 53.43, H 4.28, N 8.59. 
 
3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-(sec-butyl)-4,5-dihydro-1,3-oxazol-2-yl]aniline 
methanethione (128d) 
This compound was prepared from 131d (0.87 g, 4.0mmol) and 133 
(1.0 equiv.) by the general procedure described above.  The crude 
product was purified by column chromatography on silica gel using 
hexane/EtOAc (5:1) as eluent to yield 128d(1.08 g, 55.6%) as a white 
solid.  IR (KBr): 3169, 2966, 1637, 1377, 1277, 682 cm–1.  1H NMR 
(400 MHz, CDCl3): δ 13.10 (s, 1 H, NH), 8.89 (d, J = 8.3, 1 H, NH), 8.12 (s, 1 H), 7.80–7.82 
(m, 3 H), 7.66 (s, 1 H), 7.50 (m, 1 H), 7.15 (m, 1 H), 4.24 (m, 1 H), 4.00 (t, J = 8.3, 1 H), 3.88 
(m, 1 H), 1.19 (m, 2 H), 0.86 (m, 1 H), 0.78 (m, 3 H), 0.61 (m, 3 H).  13C NMR (100 MHz, 
CDCl3): δ = 178.9, 163.1, 139.7, 139.4, 133.0, 132.7, 131.7, 129.3, 123.7, 123.4, 121.5, 118.8, 
115.2, 70.8, 68.6, 38.8, 25.7, 14.0, 11.2.  Elemental anal.: calcd (%) for C22H21F6N3OS 
(489.48): C 53.98, H 4.32, N 8.58; found: C 54.00, H 4.25, N 8.59. 
 
3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-isopropyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-
di(trifluoromethyl)anilinomethanethione (128f) 
This compound was prepared from 131e (1.02 g, 3.0mmol) and 
133 (1.0 equiv.) by the general procedure described above.  The 
crude product was purified by column chromatography on silica 
gel using hexane/EtOAc (5:1) as eluent to yield 128f (0.22 g, 
14.8%) as a white solid.  IR (KBr): 3418, 2971, 1377, 1279, 1131, 
683 cm–1.  1H NMR (400 MHz, d6-DMSO): δ 10.79 (s, 1 H, NH), 
10.05 (s, 1 H, NH), 8.41 (s, 1 H), 8.26 (s, 2 H), 8.08 (s, 1 H), 7.89 (s, 1 H), 4.47 (m, 1 H), 4.16 
N
H NH
S
O N
CF3
CF3
N
H
N
H
S
O N
CF3
CF3
N
H
N
H
S
O N
CF3
CF3
CF3
F3C
Chapter 7   Experimental Section 
 
111 
(m, 1 H), 4.08 (m, 1 H), 1.75 (m, 1 H), 0.90 (t, J = 6.6, 3 H), 0.86 (d, J = 6.8, 3 H).  13C NMR 
(100 MHz, d6-DMSO): δ = 180.7, 157.3, 140.9, 140.1, 130.6, 130.5, 130.3, 130.2, 130.0, 
129.8, 129.7, 127.3, 124.4, 123.7, 121.7, 120.8, 117.8, 72.7, 70.6, 31.8, 18.4, 18.1.  HRMS: 
m/z calcd for C23H17F12N3OS: 611.08952; found: 611.09362.  Elemental anal.: calcd (%) for 
C23H17F12N3OS (611.45): C 45.18, H 2.80, N 7.07; found: C 45.33, H 2.67, N 6.75. 
 
3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]aniline 
methanethione (128e) 
This compound was prepared from 131f (1.76 g, 10.0 mmol) and 133 
(1.0 equiv.) by the general procedure described above.  The crude 
product was purified by column chromatography on silica gel using 
hexane/EtOAc (5:1) as eluent to yield 128e (2.08 g, 46.5%) as a white 
solid.  IR (KBr): 3198, 3042, 2976, 2898, 1639, 1618, 891, 683 cm–1.  
1H NMR (600 MHz, CDCl3): δ 12.96 (br, 1 H, NH), 8.94 (d, J = 8.3, 1 H), 8.69 (br, 1 H, NH), 
7.86 (s, 2 H), 7.80 (dd, J = 7.9, 1.5, 1 H), 7.72 (s, 1 H), 7.51 (m, 1 H), 7.15 (m, 1 H), 4.36 (t, J 
= 8.8, 1 H), 3.99 (m, 1 H), 3.79 (t, J = 8.0, 1 H), 0.90 (d, J = 6.7, 3 H).  13C NMR (150 MHz, 
CDCl3): δ = 179.0, 163.1, 139.6, 139.1, 133.1, 132.9, 132.7, 132.5, 131.7, 124.7, 123.8, 121.8, 
119.4, 115.3, 72.9, 61.4, 20.9.  HRMS: m/z calcd for C19H15F6N3OS: 447.08345; found: 
447.08155.  Elemental anal.: calcd (%) for C19H15F6N3OS (447.40): C 51.01, H 3.38, N 9.39; 
found: C 50.80, H 3.23, N 9.62. 
 
3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-(sec-butyl)-4,5-dihydro-1,3-oxazol-2-yl]-3,5-
di(trifluoromethyl)anilinomethanethione (128g) 
This compound was prepared from 131g (0.77 g, 2.17 mmol) and 
133 (1.1 equiv.) by the general procedure described above.  The 
crude product was purified by column chromatography on silica 
gel using hexane/EtOAc (5:1) as eluent to yield 128g (0.69 g, 
51.0%) as a white solid.  IR (KBr): 3427, 3179, 2972, 1375, 1279, 
683 cm–1.  1H NMR (600 MHz, CDCl3): δ 10.81 (br, 1 H, NH), 
10.10 (br, 1 H, NH), 8.42 (s, 1 H), 8.26 (s, 2 H), 8.08 (s, 1 H), 7.89 (s, 1 H), 4.46 (m, 1 H), 
4.16 (m, 1 H), 1.48–1.58 (m, 2 H), 1.06–1.13 (m, 1 H), 0.79–0.81 (m, 6 H).  13C NMR (150 
MHz, CDCl3): δ = 180.7, 157.3, 140.9, 140.1, 130.7, 130.6, 130.4, 130.2, 130.0, 129.9, 129.7, 
127.1, 125.8, 124.0, 123.6, 123.4, 122.2, 121.8, 121.5, 120.9, 120.4, 117.8, 71.3, 70.2, 38.2, 
25.2, 14.2, 11.1.  HRMS: m/z calcd for C24H19F12N3OS: 625.10537; found: 625.10179.  
Elemental anal.: calcd (%) for C24H19F12N3OS (625.47): C 46.09, H 3.06, N 6.72; found: C 
46.08, H 2.82, N 6.70. 
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3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-isobutyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-
di(trifluoromethyl)anilinomethanethione (128h) 
This compound was prepared from 131h (1.06 g, 3.0 mmol) and 
133 (1.1 equiv.) by the general procedure described above.  The 
crude product was purified by column chromatography on silica 
gel using hexane/EtOAc (5:1) as eluent to yield 128h (0.93 g, 
42.1%) as a white solid.  IR (KBr): 3428, 3177, 2972, 1375, 683 
cm–1.  1H NMR (400 MHz, d6-DMSO): δ 10.71 (s, 1 H, NH), 10.03 (br, 1 H, NH), 8.35 (s, 1 
H), 8.27 (s, 2 H), 8.03 (s, 1 H), 7.83 (s, 1 H), 4.50 (t, J = 8.8, 1 H), 4.28 (m, 1 H), 3.99 (t, J = 
7.9, 1 H), 1.70 (m, 1 H), 1.48 (m, 1 H), 1.30 (m, 1 H), 0.83 (d, J = 6.5, 3 H), 0.86 (d, J = 6.6, 3 
H).  13C NMR (100 MHz, d6-DMSO): δ = 177.3, 159.1, 158.6, 156.2, 150.4, 150.2, 149.3, 
141.5, 140.6, 131.3, 131.0, 130.6, 130.3, 124.9, 124.5, 124.0, 122.2, 121.8, 118.6, 118.0, 
116.4, 115.2, 112.8, 107.0, 72.4, 64.8, 62.2, 60.9, 25.0, 22.7.  HRMS: m/z calcd for 
C24H19F12N3OS: 625.10537; found: 625.10243.  Elemental anal.: calcd (%) for 
C24H19F12N3OS (625.47): C 46.09, H 3.06, N 6.72; found: C 46.16, H 2.86, N 6.78. 
 
2-[(4S)-4-(sec-butyl)-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)anilino-3-
trifluoromethylanilinomethanethione (128i) 
This compound was prepared from 131g (1.06 g, 3.0mmol) by the 
general procedure described above.  The crude product was purified 
by column chromatography on silica gel using hexane/EtOAc (5:1) as 
eluent to yield 128i (0.86 g, 51.2%) as a white solid.  IR (KBr): 3179, 
2968, 1670, 1537, 1136, 699 cm–1.  1H NMR (400 MHz, d6-DMSO): 
δ 10.71 (s, 1 H, NH), 9.88 (s, 1 H, NH), 8.52 (s, 1 H), 7.99 (s, 2 H), 
7.76 (d, J = 7.8, 1 H), 7.60 (dd, J = 9.1, 7.8, 1 H), 7.52 (d, J = 7.8, 1 H), 4.43 (m, 1 H), 4.15 
(m, 1 H), 1.44–1.55 (m, 2 H), 1.03–1.13 (m, 1 H), 0.76–0.82 (m, 6 H).  13C NMR (100 MHz, 
CDCl3): δ = 180.2, 157.4, 140.3, 139.4, 130.2, 129.8, 129.4, 129.2, 127.4, 125.8, 121.5, 121.1, 
119.9, 71.1, 70.0, 25.2, 14.1, 11.2.  HRMS: m/z calcd for C23H20F9N3OS: 557.11779; found: 
557.11459.  Elemental anal.: calcd (%) for C23H20F9N3OS (557.48): C 49.55, H 3.62, N 7.54; 
found: C 49.09, H 3.45, N 7.41. 
 
Synthesis of 2-amino-4,6-di(trifluoromethyl)benzonitrile (134) 
Under an argon atmosphere, to a 3-neck round-bottom flask equipped with 
magnetic stirbar and thermometer was added ethyl cyanoacetate (13.84 g, 0.12 
mmol, 98%), anhydrous powder KOH (2.60 g, 0.04 mol), and dry DMF (120 
mL).  The resulting mixture was stirred vigorously at room temperature, and then was cooled 
down to 0 °C and stirred for 60 min.  The solvent was removed in vacuo.  The residue was 
mixed with 80 mL of 5% NaOH solution and refluxed for 60 min.  The reaction was cooled 
down to room temperature and chloroform (180 mL) was added.  After separation of the 
organic phase, the aqueous phase was extracted with chloroform (2 × 100 mL).  The 
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combined organic phase was dried over Na2SO4, filtered, and evaporated to afford the crude 
product as a brown solid, which was purified by column chromatography on silica gel using 
chloroform as eluent, yielding the product (4.89 g, 48.1%) as a yellow solid.  IR (KBr): 3509, 
3359, 3247, 2234, 1647, 1584 cm–1.  1H NMR (400 MHz, CDCl3): δ 7.26 (s, 1 H), 7.21 (s, 1 
H), 5.02 (br, 2 H, NH).  13C NMR (100 MHz, CDCl3): δ = 151.6, 136.0, 135.7, 135.4, 135.0, 
134.8, 134.4, 134.1, 133.8, 126.5, 126.0, 115.3, 113.3, 111.6, 94.6. 
 
7.5 Synthesis of bifunctional thioureas 
 
3-Bromo-4-dimethylaminopyridine. 
A 1000 mL-round-flask equipped with a magnetic stirbar and a dropping funnel 
was charged sequentially with 4-dimethylaminopyridine (DMAP, 20.0 g, 164.0 
mmol), CH2Cl2 (400 mL), saturated aqueous K2CO3 (400 mL) and 1.3% (w/w) 
nBu4OH (20 mL). The resulting mixture was stirred vigorously while a solution of Br2 (20.8 
mL, 328 mmol) in 100 mL of CH2Cl2 was added dropwise over 30 min. The reaction mixture 
was stirred at room temperature for 15 h, the layers were separated, and the organic phase was 
washed with H2O (3 × 400 mL), dried over Na2SO4,  filtered and rotary evaporated to give the 
crude product as a yellow oil, which was purified by column chromatography on silica gel 
(EtOAc as eluent) followed by distillation to yield 3-bromo-4-dimethylaminopyridine (9.2 g, 
30%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 8.0 (s, 1 H, CH-2), 8.28 (d, J = 5.8 Hz, 
1 H, CH-6), 6.78 (d, J = 5.8 Hz, 1 H, CH-5), 3.00 (s, 6 H, CH3).  13C NMR (100 MHz, 
CDCl3): δ = 156.9, 153.4, 148.7, 113.7, 112.4, 42.4.  MS m/z (%): 202, 201 (100), 200, 199 
(100), 119, 78.  The physical data were in accordance with the literature reported. 
 
General Amination Procedure. 
 
Description to the reaction instruments.  A 500 mL three necked round-bottom flask was 
equipped with mechanic stirring and cooling trap, dried three times and then flushed with 
argon.  The flask was cooled to –78 °C by adding liquid nitrogen to acetone. 
A 0.7 M solution of KNH2 (3–5 equivalents) in NH3 (l) was prepared by adding K (s) (4.86 g, 
124.4 mmol) in small pieces to NH3 (l) (178 mL) containing a catalytic amount of 
Fe(NO3)3•9H2O at –78 °C, after the K (s) disappeared, the solution was warmed to -33 °C 
until the blue colour was dissipated, then cooled down to -78 °C. The 3-bromo-4-
dimethylaminopyridine (5.0 g, 24.9 mmol) was added dropwise as a 0.7 M solution in 
anhydrous Et2O.  After the reaction was complete, the reaction was quenched by the addition 
of NH4Cl (excess) in small portion, the NH3 allowed to evaporate at room temperature, and 
the residue dissolved in CH3OH and filtered from insolubles.  The product mixture was 
purified by column chromatography on silica gel (CHCl3: CH3OH: CH3COOH = 40: 10 :1) to 
give 2-amino-5-bromo-4-dimethylaminopyridine, 2-amino-4-dimethylpyridine. 
 
N
N
Br
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2-Amino-5-bromo-4-dimethylaminopyridine 
 
1H NMR (400 MHz, CDCl3): δ 7.73 (s, 1 H), 6.09 (s, 1 H), 3.02 (s, 6 H).  13C 
NMR (100 MHz, CDCl3): δ = 159.5, 155.4, 141.7, 98.2, 96.1, 42.5.   
 
2-Amino-4-dimethylaminopyridine 
 
1H NMR (400 MHz, CDCl3): δ 7.37 (d, J = 7.4, 1 H), 6.58 (br, 2 H, NH), 6.14 (dd, 
J = 7.4, 2.5, 1 H), 5.94 (d, J = 2.5, 1 H), 3.10 (s, 6 H).  13C NMR (100 MHz, 
CDCl3): δ = 157.2, 153.5, 134.1, 100.1, 88.4, 39.9.   
 
4-dimethylamino-2-pyridylamino-(1R)-1-phenylethylamino-methanethione (135a) 
To a stirred solution of 2-aminoDMAP (480 mg, 3.5 mmol) in ethanol 
(17.5 mL) was added NaHCO3 (294 mg, 305 mmol).  The mixture was 
suspended and vigorously stirred while (R)-1-phenylethylisothiocyanate 
(572 mg, 3.5 mmol) was added in one portion.  The resulting mixture 
was heated to reflux overnight. After the reaction complete, the solvent was evaporated in 
vacuo and the residue was purified by column chromatography on silica gel (n-hexane : 
EtOAc = 4:1~2:1) to afford 135a (300 mg, 30%) as a white solid, mp = 139 °C.  IR (KBr): 
3428, 3224, 2973, 1624, 1507, 695 cm–1. 1H NMR (600 MHz, CDCl3): δ 12.56 (br, 1 H, NH), 
8.36 (br, 1 H, NH), 7.80 (d, J = 6.0, 1 H), 7.40 (d, J = 7.3, 2 H), 7.33 (t, J = 7.4, 2 H), 7.24 (m, 
1 H), 6.23 (dd, J = 6.0, 1.5, 1 H), 5.84 (s, 1 H), 5.68 (m, 1 H), 2.95 (s, 6 H), 1.64 (d, J = 6.9, 3 
H).  13C NMR (150 MHz, CDCl3): δ = 179.0, 155.8, 154.5, 145.8, 143.3, 128.6, 127.0, 126.2, 
103.0, 92.2, 54.9, 39.2, 29.7, 22.5.  HRMS: m/z calcd for C16H20N4S: 300.14086; found: 
300.13898.  Elemental anal.: calcd (%) for C16H20N4S (300.42): C 63.97, H 6.71, N 18.65; 
found: C 63.57, H 6.74, N 19.06. 
 
4-dimethylamino-2-pyridylamino-(1R)-1-(2-naphthyl)ethylamino-methanethione (135b) 
This compound was prepared from 2-aminoDMAP (480 mg, 3.5 
mmol) and (R)-2-naphthalen-2-yl-ethylisothiocyanate (740 mg, 3.5 
mmol) according to the above procedure.  The product was purified 
by column chromatography on silica gel (n-hexane : EtOAc = 
4:1~1:1) to afford 135b (150 mg, 12%) as a white solid, mp = 190 °C.  IR (KBr): 3445, 3234, 
2925, 1624, 1506, 811 cm–1.  1H NMR (400 MHz, CDCl3): δ 12.70 (d, J = 8.0, 1 H, NH), 
8.81 (s, 1 H, NH), 7.79 (m, 5 H), 7.53 (dd, J = 8.5, 1.8, 1 H), 7.41–7.45 (m, 2 H), 7.25 (s, 1 H), 
6.18 (dd, J = 6.3, 2.4, 1 H), 5.93 (d, J = 2.3, 1 H), 5.86 (m, 1 H), 2.82 (s, 6 H), 1.72 (d, J = 6.9, 
3 H).  13C NMR (100 MHz, CDCl3): δ = 179.1, 155.8, 154.7, 145.6, 140.8, 133.4, 132.6, 
128.3, 128.0, 127.6, 126.0, 125.6, 124.9, 124.6, 102.9, 92.6, 54.8, 39.1, 22.5.  HRMS: m/z 
calcd for C20H24N4S: 350.15597; found: 350.15598.  Elemental anal.: calcd (%) for 
C20H22N4S (350.48): C 68.54, H 6.33, N 15.98; found: C 67.95, H 6.27, N 15.84. 
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Synthesis of Isothiocyanate.[299] 
 
(R)-1-Phenylethyl isothiocyanate 
To a solution of R-(+)-1-phenylethylamine (5.0 mL, 39.3 mmol) in anhydrous 
ether (50 mL) at –10 °C were added CS2 (15.0 mL, 249 mmol) and DCC (8.1 g, 
39.3 mmol). The reaction mixture was allowed to warm slowly to room 
temperature during a period of 3 hrs and stirred for a further 12 hrs at room temperature. The 
thiourea which precipitated was removed by filtration and the solvent removed under vacuum. 
The residue was taken up in ether and more of thiourea was filtered. Evaporation of the 
solvent and rapid filtration on silica gel (eluent: n-hexane) gave product (3.2 g, 50%) as a 
yellow liquid.  1H NMR (400 MHz, CDCl3): δ 7.30–7.43 (m, 5 H), 4.93 (q, 1 H), 1.69 (d, J = 
6.6, 3 H).  13C NMR (100 MHz, CDCl3): δ = 140.0, 128.8, 128.1, 125.3, 56.9, 24.8. 
 
 
(1R)-1-(2-naphthyl)ethyl isothiocyanate 
This compound was prepared from R-(+)-1-naphthalen-2-yl-ethylamine (1.33 
g, 7.75 mmol) according the above procedure.  Evaporation of the solvent and 
rapid filtration on silica gel (eluent: n-hexane) gave product (1.25 g, 76%) as a 
white solid.  IR (KBr): 2983, 2131, 1599, 1507, 1453, 1367, 1369 cm–1.  1H NMR (400 MHz, 
CDCl3): δ 7.84–7.89 (m, 3 H), 7.77 (s, 1 H), 7.50–7.55 (m, 2 H), 7.43 (dd, J = 8.5, 2.0, 1H), 
5.08 (q, J = 6.7, 1 H), 1.76 (d, J = 6.7, 3 H).  13C NMR (100 MHz, CDCl3): δ = 137.5, 133.2, 
133.0, 129.0, 128.0, 127.8, 126.7, 126.5, 124.4, 123.3, 57.2, 24.9.  HRMS: m/z calcd for 
C13H11NS: 213.06067; found: 213.06138. 
 
6-amino-2-pyridylamino-3,5-di(trifluoromethyl)anilinomethane-thione (136). 
133 (1.16 g, 4.28 mmol) was added to a stirred solution of 2,6-
diaminopyridine (0.467 g, 4.28 mmol) in ethanol (20 mL).  The 
reaction mixture was heated to reflux for 8 h.  The solvent was 
removed under reduced pressure and the residue was purified by 
column chromatography on silica gel (n-hexane : ethyl acetate = 4 : 1) to give 136 (689 mg, 
42%) as a yellow solid, mp = 181 °C.  IR (KBr): 3428, 3335, 3220, 1610, 1125, 677 cm–1.  1H 
NMR (400 MHz, CDCl3 + d6-DMSO): δ 13.81 (s, 1 H, NH), 9.99 (s, 1 H, NH), 8.00 (s, 2 H), 
7.30 (s, 1 H), 7.01 (t, J = 8.4, 7.9, 1 H), 6.04 (d, J = 7.9, 1 H), 5.85 (d, J = 8.4, 1 H), 5.27 (br, 
2 H, NH).  13C NMR (100 MHz, CDCl3): δ = 178.4, 155.9, 151.3, 140.2, 139.2, 130.4, 130.1, 
124.2, 121.1, 117.3, 101.7, 99.7.  HRMS: m/z calcd for C14H10F6N4S: 380.05249; found: 
380.05249.  Elemental anal.: calcd (%) for C14H10F6N4S (380.31): C 44.21, H 2.65, N 14.73; 
found: C 43.91, H 2.59, N 14.56. 
 
Miscellaneous: Synthesis of  tert-butyl (2S)-2-carbamoyltetrahydro-1H-1-
pyrrolecarboxylate (141)[300, 301] 
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To a stirred solution of L-Boc-proline (2.15 g, 10.0 mmol, 1.0 equiv.), pyridine 
(0.5 mL) and (Boc)2O (3.0 g, 13 mmol, 1.3 equiv.) in anhydrous 1,4-dioxane (50 
mL) was added ammonium dicarbonate (1.0 g, 13.0 mmol, 1.3 equiv.).  After stirring at room 
temperature for 18 h, the solvent was evaporated under reduced pressure and the residue was 
taken up in 50 mL of AcOEt, washed with 50 mL of an aqueous solution of citric acid (20% 
w/w) and 50 mL of brine.  The aqueous layers were mixed and extracted with AcOEt (3 × 100 
mL).  The organic phases were pooled and dried over MgSO4, filtered and evaporated.  The 
residue was purified by column chromatography on silica gel (CH2Cl2 : CH3OH = 10 : 1) 
yielding the product 141 (1.85 g, 86%) as a white solid.   1H NMR (400 MHz, CDCl3, cis and 
trans forms): δ  6.80, 6.14, and 5.90 (3 × br, 2 H, CONH), 4.26 and 4.14 (2 × br, 1 H), 3.31–
3.44 (br, 2 H), 1.82–2.26 (m × br, 4 H), 1.42 (br, 9 H).  13C NMR (100 MHz, CDCl3, cis and 
trans forms): δ = 176.2, 175.2, 155.6, 154.6, 80.3, 61.0, 59.7, 47.1, 46.9, 31.1, 29.0, 28.6, 
28.4, 27.8, 24.5, 23.7.   
 
Synthesis of tert-butyl (2S)-2-[3,5-di(trifluoromethyl)anilino(thioxo)methyl 
carbamoyl]tetrahydro-1H-1-pyrrolecarboxylate (142). 
Under argon atmosphere, to a solution of 141 (857 mg, 4.0 mmol) in 
anhydrous THF (20 mL) was added NaH (480 mg, 20.0 mmol) in 
several portions.  After stirring at room temperature for 10 min, 3,5-
di(trifluoromethyl)phenyl isothiocyanate 133 (1.2 g, 4.4 mmol, 1.1 
equiv.) was dropwise added to the solution.  The reaction mixture was allowed to stir 
overnight and quenched by cautious addition of ethanol (10 mL).  The solvent was evaporated 
under reduced pressure and the residue was purified by column chromatography on silica gel 
(n-hexane : EtOAc = 4 : 1) to give 142 (1.05 g, 54 %) as a white solid.   1H NMR (400 MHz, 
CDCl3, cis and trans forms): δ  12.54, 10.64, 10.24, and 9.26 (4 × br, 2 H, NH), 8.21, 7.91, 
7.68, and 7.34 (4 × br, 3 H, ArH), 4.53 (br, 1 H), 3.41–3.63 (m, 2 H), 1.92–2.29 (m, 4 H), 
1.52 and 1.51 (2 × s, 9 H).  13C NMR (100 MHz, CDCl3, cis and trans forms): δ = 178.7, 
173.3, 171.2, 156.1, 140.0, 139.1, 132.3, 132.0, 131.6, 131.3, 127.1, 127.0, 124.4, 124.3, 
123.5, 121.7, 121.6, 119.6, 118.9, 118.6, 116.5, 81.9, 81.2, 60.6, 47.4, 47.2, 29.0, 28.4, 28.3, 
27.9, 24.5.   
 
Boc deprotection (all the following methods failed). 
1. 25% TFA (v/v) in DCM. 
2. 98% H2SO4 in DCM. 
3. 2 M HCl in AcOEt. 
4. CAN in acetone at 0 °C. 
5. BiCl3 in CH3CN/H2O. 
6. 25% TFA in DCM, Scavengers (S(CH3)2) was added. 
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Note added in proof: while proline-derived thioureas was in preparation, some analogues were 
reported by other groups.[121, 126] 
 
Synthesis of (2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (143) 
To a stirred solution of N-formyl-L-Proline (589 mg, 4.1 mmol), pyridine (0.21 
mL), and (Boc)2O (1.42 g, 6.5 mmol) in anhydrous 1,4-dioxane (21 mL) was 
added ammonium dicarbonate (0.42 g, 5.35 mmol).  After stirring at room 
temperature for 18 h, the precipitation was filtered and dried to yield the product (0.41 g, 70%) 
as a white solid.  IR (KBr): 3331, 3166, 2978, 2879, 1653 cm–1.  1H NMR (400 MHz, d6-
DMSO, cis/trans = 1:1): δ  8.18 and 8.06 (2 × s, 1 H, CHO), 7.54, 7.35, 7.17, and 6.96 (4 × br, 
2 H, NH), 4.32 and 4.13 (2 × dd, J = 8.2 and 4.0, J = 8.4 and 4.0, 1 H), 3.55–3.61 and 3.47–
3.53 (2 × m, 1 H), 3.22–3.39 (m, 1 H), 2.07–2.17 (m, 1 H), 1.67–1.99 (m, 3 H).  13C NMR 
(100 MHz, d6-DMSO, cis/trans = 1:1): δ = 173.6, 173.2, 161.5, 161.0, 58.9, 57.1, 46.2, 43.6, 
30.1, 29.6, 23.5, 22.5.  HRMS: m/z calcd for C6H10N2O2: 142.07368; found: 142.07496. 
 
7.6 Synthesis of Schiff-base thioureas  
 
Preparation of monoammonium salts of (R,R)-1,2-diaminocyclohexane. [302, 303] 
(R,R)-1,2-diaminocyclohexane (810 mg, 7.1 mmol) was dissolved in ether (25 
mL). The solution was stirred vigorously while anhydrous HCl in ether (2.35 
mL, 2.9 M, 7.1 mmol, 1.0 equiv.) was added dropwise over 15 min.  An 
exothermic reaction was observed upon the addition of the acid, and a precipitate was formed.  
After complete addition of the acid, the mixture was allowed to stir at room temperature for 
10 h.  The precipitation was collected by vacuum filtration, washed with excess ether and 
dried in vacuo to give 1 (900 mg, 84%) as a white solid.  1H NMR (400 MHz, D2O): δ 2.29 
(br, 2 H), 1.67 (d, J = 10.4, 2 H), 1.40 (br, 2 H), 0.96 (m, 4 H).  13C NMR (100 MHz, D2O): δ 
= 54.5, 32.2, 24.2. 
 
Preparation of 138 
(R,R)-1,2-diaminohexane mono (hydrogen chloride) (453 mg, 3.0 
mmol) was dissolved in a mixture of methanol and ethanol (50/50, 
v/v, 25 mL).  133 (814 mg, 3.0 mmol, 1.0 equiv.) was added to the 
reaction, and the reaction mixture was stirred at room temperature 
for 40 h.  The solvents were evaporated under reduced pressure and the residue was purified 
by column chromatography on silica gel (CH2Cl2 : CH3OH = 10 : 1~4 : 1) to give 138 (739 
mg, 71%) as a white solid.  IR (KBr): 3247, 3051, 2948, 2869, 1553, 1277, 681.  1H NMR 
(200 MHz, d6-DMSO): δ 8.93 (br, 1 H), 8.41 (s, 2 H), 7.78 (s, 1 H), 4.38 (br, 1 H), 3.12 (m, 1 
H), 2.56 (m, 1 H), 1.96–2.15 (m, 2 H), 1.77 (m, 2 H), 1.15–1.59 (m, 4 H).  13C NMR (50 
MHz, d6-DMSO): δ = 180.8, 142.1, 131.0, 130.3, 130.0, 129.7, 129.0, 125.9, 121.7, 120.5, 
115.9, 54.8, 53.0, 30.4, 29.3, 23.8, 23.1. 
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(1R,2R)-2-(E)-1-[3,5-di(tert-butyl)-2-hydroxyphenyl] methylidene aminocyclohexyl-
amino-3,5-di(trifluoromethyl)anilinomethanethione (137a) 
A 50 mL two-necked flask equipped with a reflux condenser and 
an addition funnel was charge with 2 (168.7 mg, 0.4 mmol), 
K2CO3 (55.2 mg, 0.4 mmol) and distilled water (8.0 mL).  The 
mixture was stirred until dissolution was achieved, then ethanol 
(8.0 mL) was added.  The resulting colorless solution was heated 
to reflux (75~80 °C), and a solution of 3,5-di-tert-butyl-2-
hydroxybenzaldehyde in ethanol (4.0 mL) was added dropwise over 15 min.  The yellow 
solution was stirred at reflux 2.5 h before heating was discontinued.  Distilled water (8.0 mL) 
was added and the stirred mixture was cooled to less than 5 °C under ice bath and maintained 
at that temperature overnight.  The product was collected by vacuum filtration and dried under 
vacuum to give 137a (168 mg, 70%) as a yellow solid, mp = 153 °C.  IR (KBr): 3274, 2968, 
2865, 1628, 1539, 1279, 1138 cm–1.  1H NMR (400 MHz, CDCl3): δ 13.04 (br, 1 H, OH), 
8.45 (s, 1 H), 7.69 (s, 1 H), 7.61 (s, 1 H), 7.52 (s, 2 H), 7.39 (d, J = 2.4, 1 H), 7.13 (d, J = 2.4, 
1 H), 6.23 (br, 1 H), 3.96 (br, 1 H), 3.11 (m, 1 H), 2.28 (m, 1 H), 1.73–1.95 (m, 4 H), 1.22–
1.59 (m, 22 H).  13C NMR (100 MHz, CDCl3): δ = 181.4, 167.2, 157.5, 141.0, 139.6, 136.7, 
132.3, 128.2, 126.9, 126.4, 125.5, 124.1, 121.4, 119.7, 117.4, 59.1, 34.8, 34.2, 33.5, 31.7, 31.4, 
29.4, 29.3, 29.1, 24.6, 23.8.  HRMS: m/z calcd for C30H37F6N3OS: 601.25614; found: 
601.25503.  Elemental anal.: calcd (%) for C30H37F6N3OS (601.69): C 59.88, H 6.20, N 6.98; 
found: C 59.87, H 6.18, N 7.18. 
 
(R,R)-N, N'-Bis(3,5-di-tert-butyl-salicylidene)-1,2-cyclohexane- diamine (141a).[304] 
To a stirred solution of (R,R)-1,2-diaminohexane (228.4 mg, 
2.0 mmol) in anhydrous methanol (8 mL) was added activated 
MS 5 Å (2.0 g) and 3,5-di-tert-butyl-2-hydroxybenzaldehyde 
(0.94 g, 4.0 mmol) under an argon atmosphere.  The reaction 
mixture was stirred at room temperature for 60 min, and then 
filtered through a pad of silica gel and rinsed with methanol several times.  The yellow filter 
cake was then washed with CH2Cl2 (3 × 25 mL).  The CH2Cl2 organic phase was collected 
together and washed with water (2 × 30 mL) and brine (30 mL).  After dried over Na2SO4, the 
solvent was removed under vacuo, and the product 141a was isolated as a yellow powder 
(1.01 g, 93%), mp = 209 °C.  IR (KBr): 3439, 2962, 2871, 1630 cm–1.  1H NMR (400 MHz, 
CDCl3): δ 13.73 (s, 2 H), 8.32 (s, 2 H), 7.32 (d, J = 2.4, 2 H), 7.00 (d, J = 2.4, 2 H), 3.33 (m, 2 
H), 1.48–2.00 (m, 6 H), 1.43 (s, 20 H), 1.25 (s, 18 H).  13C NMR (100 MHz, CDCl3): δ = 
165.8, 158.0, 139.9, 136.4, 126.7, 126.0, 117.9, 72.4, 35.0, 34.1, 33.3, 29.5, 24.4.  HRMS: 
m/z calcd for C36H54F6N2O2: 546.41851; found: 546.42225.  Elemental anal.: calcd (%) for 
C36H54N2O2 (546.83): C 79.07, H 9.95, N 5.12; found: C 78.87, H 10.00, N 4.91. 
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(R,R)-N, N'-Bis(salicylidene)-1,2-cyclohexanediamine (141b) 
This compound was prepared on a 2.0 mmol scale according to the 
above procedure.  After work up, 141b was obtained in 89.0% yield.  
1H NMR (200 MHz, CDCl3): δ 13.33 (br, 2 H), 8.25 (s, 2 H), 7.11–7.28 
(m, 4 H), 6.74–6.90 (m, 4 H), 3.23–3.37 (m, 2 H), 1.21–1.96 (m, 8 H).  
13C NMR (50 MHz, CDCl3): δ = 164.7, 160.3, 132.1, 131.5, 118.6, 
116.8, 72.6, 33.1, 24.2. 
 
 
Synthesis of Jacobsen catalyst (137b and 137c) 
 
Coupling of Boc-L-tert-leucine with diethylamine, followed by deprotection 
N-Boc-L-tert-leucine (4.00 g, 17.29 mmol) in CH2Cl2 (159 mL) was added O-
benztriazole-1-N,N,N’,N’-tetraethyluromium hexafluorophosphate (HBTU, 
7.20 g, 19.03 mmol, 1.1 equiv).  The white suspension was stirred for 5 
minutes, followed by the addition of diisopropylethylamine (3.5 mL, 20.75 mmol, 1.2 equiv) 
and diethylamine (2.0 mL, 19.03 mmol).  The reaction mixture was then stirred for 48 h at 
room temperature.  The mixture was combined with CH2Cl2 and water and the organic layer 
was separated, washed with 1N hydrochloric acid (3 times), and dried over MgSO4.  The 
solvent was removed in vacuo to afford the crude Boc-protected amide as a colorless oil.  The 
oil was dissolved in trifluoroacetic acid (TFA, 20 mL) at 0 °C.  The reaction mixture was then 
stirred for 1 h at room temperature.  All volatile compounds were removed in vacuo and the 
residue was dissolved in water and treated with KOH (10% aqueous solution) at 0 °C.  The 
resulting mixture was extracted with CH2Cl2 and the combined organic layers were dried over 
MgSO4.  After filtration and then evaporation of the solvent, the crude product was purified 
by flash chromatography (5-10% EtOAc in hexanes) yielding L-tert-leucine diethylamide as a 
colorless oil (2.90 g, 15.57 mmol, 90%).  1H NMR (400 MHz, CDCl3): δ 3.72–3.63 (m, 1 H, 
CH2CH3), 3.60–3.52 (m, 1 H, CH2CH3), 3.37 (s, 1 H, CHNH2), 3.22–3.12 (m, 1 H, CH2CH3), 
3.10–2.99 (m, 1 H, CH2CH3), 1.74 (br s, 2 H, NH2), 1.19–1.14 (m, 3 H, CH2CH3), 1.11–1.07 
(m, 3 H, CH2CH3), 0.95 (s, 9 H, C(CH3)3).  13C NMR (100 MHz, CDCl3): δ = 173.8, 57.7, 
53.8, 42.8, 42.4, 40.3, 35.1, 26.4, 14.7, 13.0.  
 
Preparation of 137b[169] 
Saturated aqueous NaHCO3 (5 mL) was added to a solution of L-
tert-leucine diethylamide (300 mg, 1.61 mmol) in CH2Cl2 (9 mL) at 
0 °C.  The mixture was stirred for 30 minutes, then the stirring was 
stopped and thiophosgene (141 μL, 1.78 mmol, 1.1 equiv) was 
added to the organic phase by syringe.  The resulting orange mixture was stirred at 0 °C for 1 
h.  CH2Cl2 (22.5 mL) was added, and the organic phase separated.  The aqueous phase was 
extracted with CH2Cl2 (3 × 20 mL).  The combined organic extracts were dried over MgSO4 
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and concentrated, yielding (S)-2-isothiocyanato-N,N-diethyl-3,3-dimethylbutanamide as a 
solid, which was used without further purification. 
The crude product was dissolved in CH2Cl2 (15 mL) and (1R, 2R)-2-(2,5-dimethyl-pyrol-1-
yl)cyclohexylamine (369 mg,1.93 mmol,1.2 equiv) was added in different portions.  The 
reaction mixture was allowed to stir for 14 h at room temperature.  All volatile compounds 
were removed in vacuo and the residue was purified via flash chromatography (10-20% 
EtOAc in hexanes) yielding the compound 137b as light salmon solid (600 mg, 1.43 mmol, 
89%), mp = 128 °C. 1H NMR (400 MHz, CDCl3): δ 6.32 (br d, J = 8.4 Hz, NH), 5.82 (br s, 1 
H, NH), 5.70 (s, 2 H, ArH), 5.44 (br s, 1 H, CH(CH3)3), 4.36 (m, 1 H, CH cycl.), 3.86–3.79 
(m, 1 H, CH cycl.), 3.73–3.62 (m, 2 H, CH2CH3), 3.31 (m, 1 H, CH2CH3), 3.04 (m, 1 H, 
CH2CH3), 2.48–2.20 (m, 8 H, ArCH3, CH2 cycl), 2.02–1.79 (m, 4 H, CH2 cycl.), 1.48–1.33 
(m, 2 H, CH2 cycl.), 1.24 (t, J = 7.1 Hz, 3 H, NCH2CH3), 1.10 (t, J = 7.1 Hz, 3 H, NCH2CH3), 
0.95 (s, 9 H, C(CH3)3).  13C NMR (100 MHz, CDCl3): δ = 181.9, 170.7, 128.7, 127.1, 108.5, 
105.9, 60.0, 59.4, 55.8, 42.9, 40.1, 36.3, 33.9, 32.3, 26.8, 25.8, 24.7, 14.6, 12.9.  HRMS: m/z 
calcd for C23H40N4OS: 420.29173; found: 420.28980.  Elemental anal.: calcd (%) for 
C23H40N4OS (420.66): C 65.67, H 9.58, N 13.32; found: C 65.14, H 9.54, N 13.68. 
 
Synthesis of Jacobsen catalyst (137c).[59]  
Saturated aqueous NaHCO3 (10 mL) was added to a solution of L-tert-
leucine diethylamide (600 mg, 3.22 mmol) in CH2Cl2 (18 mL) at 0 °C.  
The mixture was stirred for 30 minutes, then the stirring was stopped 
and thiophosgene (282 μL, 3.54 mmol, 1.1 equiv) was added to the organic phase by syringe.  
The resulting orange mixture was stirred at 0 °C for 1 h.  CH2Cl2 (30 mL) was added, and the 
organic phase separated.  The aqueous phase was extracted with CH2Cl2 (3 × 40 mL).  The 
combined organic extracts were dried over MgSO4 and concentrated, yielding (S)-2-
isothiocyanato-N,N-diethyl-3,3-dimethylbutanamide as a solid, which was used without 
further purification. 
The crude isothiocyanate was dissolved in freshly distilled dichloromethane (30 mL) and 
(R,R)-1,2-diaminocyclohexane (404.5 mg, 3.54 mmol, 1.1 equiv) was added in one portion.  
The reaction mixture was allowed to stir at room temperature for 30 min and concentrated in 
vacuo. Crude product was purified by flash chromatography on silica gel (Eluent: 2 M 
solution of ammonia in methanol/dichloromethane = 1/9, stain with ninhydrine) to afford the 
corresponding amine (776 mg, 70%) as a straw yellow solid. 1H NMR (400 MHz, CDCl3): δ 
7.71 (br s, 1 H, NH), 6.50 (br s, 1 H, NH), 5.46 (d, J = 8.8 Hz, 1 H, CH(CH3)3), 3.74–3.63 (m, 
2 H, CH2CH3), 3.38–3.29 (m, 1 H, CH2CH3), 3.00–2.91 (m, 1 H, CH2CH3), 2.47–2.42 (m, 1 
H, CH cycl.), 2.18–1.96 (m, 6 H, CH2 cycl. NH2), 1.86–1.83 (m, 1 H, CH cycl.), 1.64 (m, 2 H, 
CH2 cycl.), 1.24 (t, J = 7.1 Hz, 3 H, CH2CH3), 1.06 (t, J = 7.1 Hz, 3 H, CH2CH3), 0.98 (s, 9 H, 
C(CH3)3).  13C NMR (100 MHz, CDCl3): δ = 182.7, 171.0, 55.8, 50.6, 43.0, 40.0, 36.2, 34.8, 
32.3, 27.0, 24.8, 14.6, 12.8. 
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Schiff base formation (137c).  
 
A 25 mL-round-bottom flask equipped with a stirbar was 
charged with amine 2 (300 mg, 0.876 mmol) prepared in the 
previous step and anhydrous methanol (4 mL) was added with 
stirring.  Once the solution became homogeneous, oven dried 
sodium sulphate (1.0 g) was added.  In a separate flask, 3,5-di-
tert-butyl-2-hydroxybenzaldehyde (205.2 mg, 0.876 mmol, 1.0 equiv) was dissolved in 
anhydrous methanol (4 mL), then transferred to the reaction mixture.  An additional 3 mL of 
methanol was used to effect quantitative transfer of the aldehyde into the reaction mixture.  
The reaction mixture was stirred for 90 min, than concentrated under reduced pressure with 
the sodium sulphate still present.  The resulting mixtures was combined with n-hexane (25 
mL) and filtered through a fine, glass frit, and the solids were rinsed with n-hexane (25 mL). 
The filtrate was concentrated in vacuo to yield 476.6 mg of JK-2 as a bright yellow solid 
(97% yield), mp = 131 °C. (Spectra data are referred to JACS 2002, 124, 12964. Compounds 
exists as a ~7 : 1 mixture of rotamers: the major rotamer is donated by *.  1H NMR (400 MHz, 
CDCl3): δ 13.38 (br s, 1 H, OH*), 11.63 (br s, 1 H, OH), 9.86 (s, 1 H, CH=N), 8.37 (s, 1 H, 
CH=N*), 7.58 (d, J = 2.4 Hz, 1 H, ArH), 7.33 (d, J = 2.3 Hz, 1 H, ArH*), 7.05 (d, J = 2.3 Hz, 
1 H, ArH*), 6.56 (br s, 1 H, NH*), 6.40 (br s, 1 H, NH*), 5.51 (d, J = 9.35, 1 H, CH(CH3)*), 
3.87 (br s, 1 H, CH cycl.*), 3.74–3.60 (m, 2 H, CH2CH3*), 3.34–3.25 (m, 1 H, CH2CH3*), 
3.16 (br s, 1 H, CH cycl.*), 3.00–2.92 (m, 1 H, CH2CH3*), 2.12 (m, 1 H, CH2 cycl.*), 1.88–
1.62 (m, 4 H, CH2 cycl.*), 1.47–1.35 (m, 3 H, CH2 cycl.*), 1.42 (s, 9 H, C(CH3)3), 1.40 (s, 9 
H, C(CH3)3*), 1.32 (s, 9 H, C(CH3)3), 1.26 (s, 9 H, C(CH3)3*), 1.22 (t, J = 7.1 Hz, 3 H, 
CH2CH3), 1.07 (t, J = 7.1 Hz, 3 H, CH2CH3), 0.90 (s, 9 H, C(CH3)3*), 0.87 (s, 9 H, C(CH3)3).  
13C NMR (100 MHz, CDCl3): δ = 197.4, 181.2, 170.8, 166.0, 159.1, 158.0, 141.6, 139.9, 
137.6, 136.4, 131.9, 127.9, 127.0, 126.2, 120.0, 117.9, 71.1, 60.2, 56.7, 42.9, 40.1, 36.3, 35.02, 
35.0, 34.2, 34.1, 33.1, 31.6, 31.5, 31.3, 31.1, 29.5, 29.3, 27.1, 26.8, 24.1, 23.5, 22.7, 14.6, 14.1, 
12.9, 12.7. Elemental anal.: calcd (%) for C32H54N4O2S (558.86): C 68.77, H 9.74, N 10.02; 
found: C 68.52, H 9.82, N 9.48. 
 
Preparation of 2-pyrrolylcyclohexylamines.[56] 
In a round-bottomed flask equipped with relux condenser, acetic acid (302 µL, 
5.28 mmol, 1.0 equiv.) and 2,5-hexanedione (620 µL, 5.28 mmol, 1.0 equiv.) 
were added sequentially to a solution of (R,R)-diaminocyclohexane (604 mg, 
5.28 mmol, 1.0 equiv.) in methanol (26 mL).  The mixture was heated to 50 °C 
and stirred for 60 minutes, then cooled to 23 °C and concentrated in vacuo.  The residue was 
partitioned between dichloromethane (100 mL) and 4 M aqueous sodium hydroxide (100 mL). 
The organic phase was separated, and the aqueous extracted twice with dichloromethane (100 
N
H2N
HO
t-Bu t-Bu
N
H
N
O
N
H
S
N
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mL).  The combined organic extracts were dried (Na2SO4) and concentrated.  The residue was 
purified by chromatography on silica (5% methanol in dichoromethane), yielding the product 
as a yellow oil (409 mg, 2.13 mmol, 81% yield).   1H NMR (400 MHz, CDCl3): δ 5.76 (d, J = 
11.5 Hz, 2 H, ArH), 3.64–3.57 (m, 1 H, NH2CH), 3.28–3.22 (m, 1 H, NCH), 2.36 (br s, 3H, 
CH3), 2.23 (br s, 3 H, CH3), 2.07–2.03 (m, 1 H, CH cycl.), 1.94–1.78 (m, 4 H, CH2 cycl.), 
1.46 (br s, 2 H, NH2), 1.40–1.34 (m, 2 H, CH cycl.), 1.26–1.16 (m, 1 H, CH cycl.) .  13C 
NMR (100 MHz, CDCl3): δ = 129.8, 126.8, 107.9, 105.3, 63.6, 52.9, 35.4, 31.3, 26.2, 25.1, 
15.3, 13.7. 
 
Boc-L-tert-leucine.[305] 
(Boc)2O (3.64 g, 16.68 mmol) was added to a solution of L-tert-leucine (2.00 
g, 15.25 mmol) and NaOH (0.67, 16.80 mmol) in water/tert-butyl alcohol (20 
mL/20 mL).  The reaction mixture was stirred overnight at room temperature 
and was then extracted three times with 50 mL of ethyl acetate.  The combined organic layers 
were washed with satd NaHCO3 solution (50 mL), and the combined water phases were 
acidified to pH 1.5–2.0 with 6 M HCl.  The water phase was extracted four times with 50 mL 
of ethyl acetate, and the combined organic layers were washed with brine (2 × 50 mL), dried 
over Na2SO4, and evaporated in vacuo to give Boc-L-tert-leucine (2.85 g, yield 81.0% ) as a 
colorless solid.  1H NMR (400 MHz, CDCl3): δ 10.54 (br, 1 H), 5.14 (d, J = 9.5 Hz, 1 H), 
4.14 (d, J = 9.5 Hz, 1 H), 1.46 (s, 9 H), 1.03 (s, 9 H).  13C NMR (100 MHz, CDCl3): δ = 
176.8, 155.6, 80.0, 61.6, 34.5, 28.3, 26.5. 
 
N
H
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N2-(1-adamantyl)-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (104) 
N
H
N
O
OH
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N2-pentacyclo[7.3.1.14,12.02,7.06,11]tetradec-1-yl-1-formyltetrahydro-1H-2-pyrrole-
carboxamide (105) 
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N2-cyclohexyl-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (103)  
N
H
N
O
OH
Chapter 7    Experimental Section 
126 
8 7 6 5 4 3 2 1 ppm
0.
00
0
1.
38
9
1.
40
6
1.
41
8
1.
43
5
1.
63
2
1.
90
0
1.
90
6
1.
91
0
1.
91
6
1.
92
8
3.
37
9
3.
38
8
3.
40
5
3.
48
0
4.
47
2
4.
48
1
4.
49
2
4.
95
5
4.
97
3
4.
99
1
7.
15
5
7.
17
6
7.
19
5
7.
20
5
7.
22
5
7.
23
0
7.
24
3
7.
25
2
7.
25
7
7.
26
1
7.
27
6
8.
21
4
3.
15
0.
72
3.
02
0.
45
0.
83
1.
01
1.
11
0.
18
0.
79
1.
02
0.
16
5.
48
0.
83
1.
00
 
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
0.
99
21
.5
2
22
.7
3
22
.8
5
24
.1
3
26
.6
6
30
.3
9
44
.3
7
46
.9
1
48
.8
9
49
.2
1
57
.9
1
60
.9
5
76
.6
8
77
.0
0
77
.2
0
77
.3
2
12
5.
84
12
5.
89
12
6.
04
12
7.
04
12
7.
61
12
8.
57
12
8.
82
14
2.
55
14
3.
51
16
2.
29
16
2.
35
16
9.
14
17
0.
33
 
N2-[(1R)-1-phenylethyl]-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (108) 
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N2-[(1R)-1-(2-naphthyl)ethyl]-(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (109) 
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N2-(1-adamantyl)-(2S)-1-formylhexahydro-2-pyridinecarboxamide (114)  
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N2-pentacyclo[7.3.1.14,12.02,7.06,11]tetradec-4-yl-1-formyltetrahydro-1H-2-pyrrole-
carboxamide (106) 
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N2-heptacyclo[7.7.1.13,15.01,12.02,7.04,13.06,11]octadec-9-yl-1-formyltetrahydro-1H-2-
pyrrolecarboxamide (107) 
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Benzyl (2S)-2-[(2S)-1-formyltetrahydro-1H-2-pyrrolylcarboxamido]-3-methylbutanoate (110) 
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Benzyl (2S)-2-[(2R)-1-formyltetrahydro-1H-2-pyrrolylcarboxamido]-3-methylbutanoate (111) 
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N2-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-dioxan-4-yl]-(2S)-1-formyltetrahydro-1H-2-
pyrrolecarboxamide (112) 
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N2-[(4R,5R)-2,2-dimethyl-5-phenyl-1,3-dioxan-4-yl]-(2R)-1-formyltetrahydro-1H-2-
pyrrolecarboxamide (113) 
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N1-(1-adamantyl)-(2S)-3-methyl-2-methylformamidobutanamide (115) 
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N2-(R)-(1-2-[(2S)-1-formyltetrahydro-1H-2-pyrrolylcarboxamido]-1-naphthyl-2-naphthyl)-
(2S)-1-formyltetrahydro-1H-2-pyrrolecarboxamide (118) 
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(R)-N-formyl-N-methyl-2-phenylpropanamide (116) 
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(S)-(9H-fluoren-9-yl)methyl 1-(N-methylformamido)-1-oxo-3-phenylpropane-2-yl-carbamate 
(117) 
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2-[(4S)-4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (131b) 
NH2
O N
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2-[(4S)-4-Isobutyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (131c) 
NH2
O N
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2-[(4S)-4-(sec-Butyl)-4,5-dihydro-1,3-oxazol-2-yl]aniline (131d) 
NH2
O N
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2-[(4S)-4-Isopropyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)aniline (131e) 
NH2
O N
CF3
F3C
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2-[(4S)-4-Methyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (131f) 
NH2
O N
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2-[(4S)-4-(sec-Butyl)-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)aniline (131g) 
NH2
O N
CF3
F3C
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2-[(4S)-4-Isobutyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)aniline (131h) 
NH2
O N
CF3
F3C
Chapter 7    Experimental Section 
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2-[(4S)-4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl]anilino-3,5-di(trifluoromethyl)anilino-
methanethione (128b) 
N
H
N
H
S
O N
CF3
CF3
Chapter 7   Experimental Section 
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3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-isobutyl-4,5-dihydro-1,3-oxazol-2-yl]aniline-
methanethione (128c) 
N
H
N
H
S
O N
CF3
CF3
Chapter 7    Experimental Section 
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3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-(sec-butyl)-4,5-dihydro-1,3-oxazol-2-yl]aniline 
methanethione (128d) 
N
H
N
H
S
O N
CF3
CF3
Chapter 7   Experimental Section 
 
149 
11 10 9 8 7 6 5 4 3 2 1 0 ppm
0.
84
9
0.
86
6
0.
89
2
0.
90
9
1.
74
2
1.
75
8
2.
49
2
2.
49
7
2.
50
1
2.
50
6
2.
51
0
4.
07
5
4.
09
2
4.
14
0
4.
16
1
4.
18
2
4.
45
2
4.
47
6
4.
49
7
7.
88
5
8.
07
9
8.
25
2
8.
40
9
10
.0
53
10
.7
89
3.
06
3.
37
1.
00
5.
67
1.
02
1.
05
1.
00
1.
00
1.
02
2.
10
0.
98
0.
87
0.
86
 
 
180 160 140 120 100 80 60 40 20 0 ppm
0.
00
18
.0
8
18
.4
3
31
.7
6
38
.7
4
38
.8
5
39
.0
6
39
.2
7
39
.4
8
39
.6
8
39
.8
9
40
.1
0
70
.6
0
72
.6
8
12
1.
69
12
3.
61
12
3.
63
12
4.
40
12
9.
59
12
9.
63
12
9.
96
13
0.
12
13
0.
29
13
0.
45
14
0.
88
15
7.
25
18
0.
71
 
3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-isopropyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-
di(trifluoromethyl)anilinomethanethione (128f) 
N
H
N
H
S
O N
CF3
CF3
CF3
F3C
Chapter 7    Experimental Section 
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3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]aniline-
methanethione (128e) 
N
H
N
H
S
O N
CF3
CF3
Chapter 7   Experimental Section 
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3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-(sec-butyl)-4,5-dihydro-1,3-oxazol-2-yl]-3,5-
di(trifluoromethyl)anilinomethanethione (128g) 
N
H
N
H
S
O N
CF3
CF3
CF3
F3C
Chapter 7    Experimental Section 
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3,5-Di(trifluoromethyl)anilino-2-[(4S)-4-isobutyl-4,5-dihydro-1,3-oxazol-2-yl]-3,5-
di(trifluoromethyl)anilinomethanethione (128h) 
N
H NH
S
O N
CF3
CF3
CF3
F3C
Chapter 7   Experimental Section 
 
153 
11 10 9 8 7 6 5 4 3 2 1 ppm
1.
06
3
1.
07
7
1.
09
6
1.
44
7
1.
45
3
1.
46
6
1.
48
1
1.
49
9
1.
52
2
1.
53
9
2.
47
9
2.
48
2
4.
11
8
4.
14
0
4.
15
5
4.
17
4
4.
42
1
4.
43
6
7.
50
9
7.
52
9
7.
57
7
7.
59
7
7.
61
7
7.
75
3
7.
77
4
7.
99
1
8.
51
5
9.
87
9
10
.7
09
6.
29
0.
98
1.
98
2.
03
0.
98
0.
88
0.
99
1.
00
1.
95
0.
92
0.
87
0.
88
 
 
180 160 140 120 100 80 60 40 20 ppm
11
.1
3
14
.0
5
25
.1
7
38
.0
1
38
.8
4
39
.0
5
39
.2
6
39
.4
7
39
.6
8
39
.8
9
40
.1
0
70
.0
1
71
.1
1
11
9.
90
12
1.
07
12
1.
38
12
1.
46
12
3.
80
12
4.
09
12
5.
22
12
5.
74
12
7.
35
12
8.
78
12
9.
09
12
9.
14
12
9.
41
12
9.
46
12
9.
54
12
9.
81
12
9.
87
13
0.
21
13
9.
37
14
0.
30
15
7.
35
18
0.
20
 
2-[(4S)-4-(sec-butyl)-4,5-dihydro-1,3-oxazol-2-yl]-3,5-di(trifluoromethyl)anilino-3-
trifluoromethylanilinomethanethione (128i) 
N
H NH
S
O N
CF3CF3
F3C
Chapter 7    Experimental Section 
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4-dimethylamino-2-pyridylamino-(1R)-1-phenylethylamino-methanethione (135a) 
N
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N
H
S
N
H
Chapter 7   Experimental Section 
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4-dimethylamino-2-pyridylamino-(1R)-1-(2-naphthyl)ethylamino-methanethione (135b) 
N
N
N
H
N
H
S
Chapter 7    Experimental Section 
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6-amino-2-pyridylamino-3,5-di(trifluoromethyl)anilinomethane thione (136) 
 
 
 
NH2N NH
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S
CF3
CF3
Chapter 7   Experimental Section 
 
157 
 
14 13 12 11 10 9 8 7 6 5 4 3 2 1 ppm
1.
22
2
1.
25
5
1.
27
6
1.
28
3
1.
30
5
1.
31
7
1.
32
8
1.
35
4
1.
35
6
1.
36
8
1.
37
6
1.
39
2
1.
40
6
1.
42
9
1.
44
3
1.
46
1
1.
46
8
1.
75
2
1.
78
4
1.
85
8
1.
88
8
1.
90
8
2.
28
4
3.
11
0
7.
12
8
7.
13
3
7.
26
0
7.
38
4
7.
39
0
7.
51
4
7.
60
7
7.
68
9
8.
44
8
24
.8
1
4.
41
1.
09
1.
02
0.
85
0.
92
1.
00
1.
03
1.
93
0.
99
0.
93
1.
00
0.
89
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
23
.7
3
24
.5
4
29
.0
5
29
.2
7
29
.3
7
29
.4
3
29
.5
8
31
.3
2
31
.3
7
31
.5
4
33
.5
2
34
.1
7
34
.2
6
34
.8
3
35
.0
3
58
.9
8
76
.8
2
77
.0
4
77
.2
5
11
7.
40
11
9.
71
11
9.
99
12
0.
08
12
1.
89
12
3.
69
12
5.
50
12
6.
38
12
7.
88
12
8.
21
13
1.
96
13
6.
68
13
7.
60
13
9.
67
14
0.
96
14
1.
66
15
7.
61
15
9.
11
16
7.
15
19
7.
43
 
of  (1R,2R)-2-(E)-1-[3,5-di(tert-butyl)-2-hydroxyphenyl] methylideneaminocyclo-
hexylamino-3,5-di(trifluoromethyl)anilinomethanethione (137a) 
N
H N
N
H
S
CF3
F3C
HO
t-Bu t-Bu
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List of Symbols and Abbreviations 
 
 
δ NMR chemical shift/ppm 
J    NMR coupling constant/Hz 
λ Wavelength/nm 
Å   Angstrom 
Ac  Acetyl 
Ar  Arene 
Bn  Benzyl 
Boc  t-Butyloxycarbonyl 
Bu  Butyl 
Bz  Benzoyl 
C  Celsius 
c  Concentration 
Cbz  Carbobenzyloxy 
Cat.  Catalyst 
CSA  Camphorsulfonic Acid 
DABCO  1,4-Diazabicyclo[2.2.2]octane 
DBU  1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCC  Dicyclohexyl Carbodiimide 
de  Diastereomeric excess 
DFT  Density functional theory 
DIPEA  N-Ethyl-N,N-Diisopropylamine 
dist.  distilled 
DMAP  4-Dimethylaminopyridine 
DMF  N,N-Dimethylformamide 
DMSO  Dimethyl sulfoxide 
ee  Enantiomeric excess 
eq  equivalent 
er  Enantiomeric ratio 
Fmoc  9-Fluorenylmethoxycarbonyl 
GC  Gas chromatography 
GC-MS  Gas chromatography coupled with a mass spectrometer 
HBTU  Tetramethyluromiumhexafluorophophate 
HOBt  Hydroxybenzotriazol 
HOMO  The highest occupied molecular orbital 
HPLC  High Performance Liquid Chromatography 
IR  Infrared 
Lit.  Literature 
LUMO  The lowest unoccupied molecular orbital 
NMR Nuclear magnetic resonance 
NOE  Nuclear Overhauser Effect 
NOESY  Nuclear Overhauser Effect Spectroscopy.  
Ph  Phenyl 
Phe  Phenylalanine 
ppm  Parts per million 
Pro  Proline 
PTC  Phase Transfer Catalysis 
ROESY Rotational Frame Nuclear Overhauser Effect Spectroscopy 
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r.t.   Room temperature 
SET   Single electron transfer 
Tf   Triflate 
TFA   2,2,2-Trifluoroacetic acid 
TFAA   Trifluoroacetic acid anhydride 
THF   Tetrahydrofuran 
TLC   Thin layer chromatography 
TMS   Trimethylsilyl 
tR   Retention time 
Ts   Tosyl 
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